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THE GREEN LEASHE
THERE’S THIS GREEN MEDICINE THAT I TAKE

IT TAKES OVER MY BODY AND MAKES ME FAKE

IT RUNS THROUGH MY BODY AND THROUGH MY VEINS

UNTIL IT RUNS THROUGH MY BODY AND HITS MY BRAIN

YOU ARE TREATED LIKE A SECOND CLASS CITIZEN FROM DAY ONE

EVEN THOUGH YOU HAVE DONE NOTHING WRONG

YOU ARE TRYING TO GET BACK TO NORMALITY

BUT THEY THINK YOU NEED SYMPATHY

WHEN ALL YOU WANT IS TO BE FREE

THE AUTHORITES TREAT YOU WITH DESPISE

EVEN THOUGH YOU’VE DA BEST LIES

THEY ALL SAY THEY ARE THERE FOR YOU

WHAT ABOUT ALL THE REST OF THE PEOPLE THERE FOR YOU TOO?

IT STARTS TO COME TO PEOPLE YOU TRUST

AND THEN ONCE YOU GET OFF A CLINIC TO DA CHEMIST ­EVERY THING

CHANGES.

YOU COULD BE THERE FIRST AND THEY TALK AND HAVE A LAUGH

BUT WHEN A PAYING OR NON PHY PATIENT COMES, YOU’RE LEFT LIKE

RUBBISH PUT IN A BIN

THEY WAIT TILL THEY ARE GONE AND THEY SAY, RIGHT! COME ON

I’VE BEEN THERE 20­25 MINUTES, IF I WAS COLOURED OF ETHNIC RACE, IT

WOULD BE CALLED RACISM, BUT THEY SAY ‘SELF­ INFLICTED’

YET THEY MAKE MONEY OFF OUR BACKS, I WISH THEY WERE ON THE OTHER

SIDE OF THE TRACKS

I CAN’T GO ON A HOLIDAY ON A WHIM, DA GREEN LEASHE SHE REELS ME IN

THAT’S WHAT I HAVE TO SAY AND BELIEVE

I’M IRISH BORN AND BRED YET I AM A THIRD CLASS CITIZEN

IT’S BLIND RACISM, YET I CAN’T SPEAK OUT, IT’S LIKE THEY OWN YOU

(SIC ­A PARTICIPANT)
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SUMMARY

This study sets out to make a meaningful and useful contribution to the 
discussion surrounding the treatment of heroin addiction in the Republic 
of Ireland. The exploration describes the experiences of service users 
who are receiving methadone treatment in general practice in Dublin 
and provides recommendations for practice. 
A Husserlian phenomenological approach drawing on the psychological 
research methods of Colazzi informed this study. This qualitative 
descriptive genre was coupled with the genre of reflexive methodology 
and utilised the techniques of bracketing interviews and polyvocality. 
The study took place in nine urban general practices in Dublin city. 
Twenty five service users were interviewed in­depth. The data were 
analyzed using the methodology espoused by Collazzi (1978). 
Four themes emerged from the data: Service users’ experience of 
attending general practice for methadone maintenance; The 
significance of methadone for the service user; Service users’ 
understanding of the Methadone Treatment Protocol and The 
experience of addiction and it’s effect on families. 
Service users’ accounts traced the historical steps that influenced the 
introduction of the MTP. Their depictions of their experience of 
treatment shed light on the process of care in general practice and how 
clinical guidelines have been interpreted and developed locally. The 
study identified what it is that affects the delivery of methadone 
treatment from the users’ perspective. It provides insight into the harm 
reduction policy of methadone maintenance and highlights how, from 
the service users’ own experience, the implementation is falling short. 
The data identify that the delivery of methadone treatment requires a 
sustained policy review, informed by a clinical perspective on all issues 
related to regulations, practice guidelines, and treatment resourcing. 
3

The recommendations suggest that to be truly effective, strategies 
which recognize the importance of user involvement need to be 
addressed. 
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CHAPTER 1: LITERATURE REVIEW

1. HISTORY OF METHADONE TREATMENT 
The history of methadone maintenance treatment (MMT) internationally 
dates from the early 1960s. Nyswander and Dole pioneered the 
prescribing of oral methadone, basing their approach on the theory that 
once addicted, opiate addicts suffer from a metabolic disorder, similar in 
principle to disorders such as diabetes. Just as insulin normalizes the 
‘’dysfunction’’ in diabetes, so methadone was proposed to normalize the 
‘‘dysfunction’’ of opiate addiction. Methadone is a synthetic opioid and 
high doses from 80mg to 150mg were advocated to establish a 
pharmacological blockade against the effects of heroin that would 
prevent addicts from experiencing euphoria (Dole & Nyswander 1967). 
The key features were long term treatment, high doses of methadone 
and a comprehensive set of psychological and social services to assist 
the person to reintegrate into mainstream society. 
From this initial approach to treatment, there has followed a plethora of 
literature in relation to the function of methadone, its use as a substitute 
treatment for opiate addiction and the definition of treatment goals. 
These have ranged between long term maintenance, to low threshold 
programmes and detoxification, to achieving abstinence within a period 
of a few years (Dole & Nyswander 1967, Ward et al 1998, Farrell et al 
2000, Ward 2002, Fraser & Valentine 2008). 
The implementation of methadone maintenance as a harm reduction 
initiative has been greeted internationally as a successful policy in many 
respects. In public health, harm reduction describes a concept which 
aims to prevent or reduce negative health consequences associated 
with drug misuse. Harm reduction for drug misusers aims to help them 
avoid the negative health consequences of drug misuse and improve 
their health and social status (WHO 2003). The United States National 
5

Association for Public Health Policy, the Canadian Centre on Substance 
Misuse and the World Health Organization have all endorsed the 
principles of harm reduction in key documents (CCSA 1998, NAPHP 
1999, WHO 1999). MMT has been shown to benefit drug misusers as 
well as providing public health and social benefits and the justification 
for its use is based on the principle that ‘the benefits far outweigh the 
risks associated with it’ (Bell & Zador 2000, Negrete 2001, Ward 
2002:6). This theory and experience has been influential in establishing 
harm reduction policies around the globe but not without the counter­
arguments, which are skeptical about the ‘‘evidence base’’. The 
evidence supports the benefits of MMT as reductions in crime, drug 
related mortality and HIV infection (Harwood et al 1988,Ward et al 
1998, Bell & Zador 2000,Sorenson & Copeland 2000, WHO & UNODC 
2004, Humeniuk & Ali 2005, Irawati et al 2006) and also demonstrates 
that MMT can keep people who are dependant on heroin in treatment 
programmes and reduce their use of heroin (Mattick et al 2006, 
2008,2009). 
Despite having been implemented and evaluated for in excess of forty 
years, methadone maintenance has remained a divisive treatment 
(Ward 2002, Dyer 2002, Lally 2003, Grehan 2007). This is in spite of 
the lack of evidence to prove the effectiveness of psychosocial 
interventions alone for the treatment of opiate dependence or the 
superiority of any other type of treatment (Mayet et al 2004). 
Methadone is one of several medications used in the treatment of 
opioid dependence and the majority of methadone programmes have 
deviated from the original model proposed by Dole and Nyswander 
(Lawless & Cox 2003). Internationally, MMT is a highly regulated 
regime that is subject to complex governance structures. Regulations 
and operational cultures vary between countries such as Australia and 
the United Kingdom (UK) and the United States (US). Treatment 
generally combines general practitioner (GP) and specialist services; 
6

however in the US almost all clients receive their methadone in 
specialist clinics (Fraser & Valentine 2008). The phenomenon of MMT 
as a heavily regulated treatment for heroin dependence has had little 
attention from the perspective of social and cultural theorists and 
debates about the validity of treating addiction as analogous to a 
chronic disease such as diabetes continue to influence both the 
organization of drug treatment and the social recognition of illicit drug 
misuse (Fraser & Valentine 2008:5). 
The introduction of the harm reduction strategy of MMT has been 
controversial in the Republic Of Ireland (RoI) (O’Brien & Dillon 
2000).This strategy presented a significant shift from a historical model 
of abstinence as the policy issues were highly sensitive to a new 
treatment initiative (Butler 2002,Butler & Mayock 2005). Butler (1991) 
identified that although the establishment of services which were aimed 
at harm reduction rather than total abstinence corresponded to similar 
developments in other countries, the important difference was that most 
other counties had some previous history of harm reduction and so did 
not experience such a major ideological shift. A brief overview of the 
historical background is important in order to understand how the 
structure of MMT developed in the RoI. 
1.1. IRISH HISTORICAL BACKGROUND AND THE STRUCTURE OF THE 
METHADONE TREATMENT PROTOCOL 
Opiate misuse in Ireland intensified in the 1980s. Central service 
treatment facilities for drug addiction in Dublin, which had been 
provided since 1969 were becoming overwhelmed by the growing 
number of ‘’out­of­control’’ drug misusers (Butler 1991, Latham 1998, 
Cullen 2000). Internationally the problem of drug misuse was also 
escalating and public health issues associated with HIV infection 
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prompted the first serious efforts to respond to the problem (Morgan 
2001). A governmental task force was established to examine the 
question of drug misuse with particular reference to inner city areas. 
The Government Strategy to Prevent Drug Misuse (DOH 1991) was 
based on the recommendations of that committee. The training of GPs 
in managing heroin addicted clients was recommended and the 
committee stated that they also ‘saw the merit’ of exposing other health 
professionals, such as nurses, to the problems associated with drug 
misuse in the community (DOH 1991:22). Up to this juncture it was not 
possible to ascertain exactly how many patients were in treatment at 
any given time, or how many prescribers or community pharmacists 
were involved in the provision of MMT (O’Connor 2002:22). Methadone 
had previously been prescribed as liquid Physeptone and could be 
dispensed in any chemist. The Report of the Methadone Treatment 
Services Review Group (DOHC 1997) recommended a change in the 
way methadone should be prescribed and dispensed in Ireland. The 
existing Misuse of Drugs Act 1997 (S.I.12) was amended to reflect 
these recommendations (S.I 308 1997, SI.225 1998). This obligated 
GPs to have undergone a period of training before they could prescribe 
methadone and required collation of information about all patients 
treated on a central register (Cahill et al 2003). Dispensing 
arrangements also changed and pharmacists could only dispense 
methadone to those who had a valid drug treatment card. 
The pharmacological intervention of methadone was supported from the 
outset by the Irish College of General Practitioners (ICGP) (NAS 1992). 
The ICGP is the professional body responsible for accreditation and 
training of general practitioners. The role of general practice in the 
treatment of heroin addiction was advocated by a number of key GPs in 
the RoI (Farrell et al 2000:9). GPs were concerned about dubious 
prescribing practices of methadone by unscrupulous doctors and a 
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small minority encouraged the development of a greater role in the 
treatment of drug misuse at community level (Delargy 2000, Farrell et al 
2000). A formal protocol for methadone prescribing was published in 
1993 (DOH 1993). The ICGP issued guidelines on the management of 
drug misuse in 1997 (Cullen et al 2000). In October 1998 the 
Methadone Protocol Scheme (MPS) was initiated to provide a 
framework for the care of opiate misusers in general practice (ICGP 
2002). Updated guidelines Working with Opiate Users in Community 
Based Primary Care were published in 2003 and again in 2008 (ICGP 
2003, 2008). The format for both how methadone is regulated and how 
opiate dependant patients are managed in the RoI is now commonly 
known as the Methadone Treatment Protocol (MTP) (ICGP 2008). 
The ICGP provides Level One and Level Two training for GPs in how to 
treat these opiate misusers (Appendix 2).This is a unique system of 
training which previously facilitated a multidisciplinary team approach to 
care involving professionals such as pharmacists, psychologists, 
practice nurses and midwives who attended the course together, albeit 
on an ad­hoc basis. Since 2008 this training has been provided for GPs 
only as an online learning format. This is in contrast to the UK, where 
the Royal College of General Practitioners (RCGP) advocates that 
treatment of drug misusers is multifaceted and normally requires a 
multidisciplinary response wherever possible. Training is provided in 
collaboration with practice nurses, dispensing pharmacists, practitioners 
with a special interest and addiction specialists (Ford et al 2005). In the 
RoI there has been an absence of organizational drive in recognizing 
this multidisciplinary approach and a lack of targeted resources from the 
nursing profession (Wilkinson & Mistral 2003). As with other countries a 
lack of clear development pathways or support systems for practice 
nurses in this regard has impeded addiction related education and the 
academic pathways have been unclear (Deering 2008). Pharmacists 
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also have been impeded by the lack of multidisciplinary training 
initiatives (O’Connor 2002). 
Methadone maintenance is provided by the National Drug Treatment 
Centre (NDTC), Health Service Executive (HSE) addiction clinics and 
satellite community clinics and GPs. There were approximately 14,452 
opiate misusers aged from 15­64 in 200I (Kelly et al 2004). This 
capture/recapture study identified the rate of 5.6 opiate misusers per 
1,000 of population within a population of approximately 4.4 million, 
similar to previous estimates (Comiskey & Barry 2001, Kelly et al 2004). 
The majority of these are resident in the greater Dublin area. 
Prevalence of recent drug misuse (use in last year) increased from 
5.6% in 2002/03 to 7.2% in 2006/07 among all adults aged 15–64 
(NACD 2006/2007). There are approximately 8,000 clients receiving 
methadone in the Republic of Ireland and almost one­third (32%) of 
opiate misusers currently prescribed methadone substitution are cared 
for in general practice (Delargy 2008). The number fluctuates as for 
example, in 2007, 9,756 received methadone treatment during the 
course of the year, while approximately 8,500 were in receipt of 
treatment in any particular week (NDS interim report 2009:43). The 
protocol offers a structured yet flexible approach to care and 
approximately 300 GPs are currently providing treatment in the RoI. 
Other substitution therapies such as buprenorphine are not available 
within general practice as yet although the National Advisory Committee 
on Drugs have called for a range of options to be made available to 
both drug misusers and practitioners recognising that together they 
should decide the most appropriate course of treatment for the 
individual (NACD 2003). The service, training requirements, 
accreditation criteria and payment structure of the MTP has in the most 
part been primary care led which has advantages and disadvantages 
(Farrell et al 2000). 
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The field of drug misuse treatment has traditionally been influenced by 
much moral discourse (Fry et al 2005) and although the MTP has been 
devised without explicit involvement from those who avail of this 
service­the service user, GPs have had the opportunity to proffer their 
views on this treatment modality as a method of harm reduction. 
1.2. VIEWPOINTS OF GENERAL PRACTITIONERS ON METHADONE TREATMENT 
Prejudices about drug misusing individuals and the use of methadone 
as a treatment option or as harm reduction are sometimes based on the 
premise that methadone treatment simply replaces one drug of 
dependency with another. The attitudes of professionals whether they 
accept this hypothesis or reject it may affect care and indeed how 
services have developed historically. All health care is currently 
informed by such institutional values and how health care is organized 
influences treatment effectiveness (Farrell 2004). Keane (2005) asserts 
that it is the rejection of moral judgment that has made harm reduction 
such an effective and innovative strategy. The European Methadone 
Guidelines advocate assessment of the quality of the service provided, 
acknowledging that the way in which treatment is offered is important 
for its outcome (Vertser & Buning 2000). These guidelines also 
acknowledge differences in historical, cultural, social, economic and 
political backgrounds across Europe and state that ‘every community 
needs to reach its own consensus’ for good clinical practice in 
methadone treatment. What good clinical practice means and how it is 
delivered is a subject which is inevitably linked to professional attitudes. 
The implications of negative attitudes towards drug misusers could be 
important in uncovering moral assumptions that may influence 
treatment (Norman 2001, Latham 2003). From the viewpoint of the 
‘conscientious, explicit, and judicious use of current best evidence in 
making decisions about the care of individual patients’ (Sackett et al 
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1996), the decision to carry out methadone maintenance is one which is 
inevitably based on the physician’s personal ethical stance. Harm 
reduction has been described as carrying ‘connotations of 
permissiveness’, conversely in the field of medicine it is often seen as 
the default approach (Deluca 2000). There are multiple interpretations 
that can be proffered as to why a physician is likely to either get 
involved with or avoid treating drug misusing patients. There are those 
who oppose the ethical imperative for the prescription of methadone 
(Fitzpatrick 2001, Grehan 2007), proponents who advocate methadone 
as a scientifically proven and ethically approved intervention for a 
chronic, potentially fatal illness (Latham 2004) and those who oppose 
the role of doctors in the regulation of lifestyle and individual patient 
behaviour (Fisher 2004). Some cite barriers such as the lack of training 
and fear of practice disruption as reasons for not getting involved (Miller 
et al 2001, Mc Keown et al 2003, Keen et al 2004, Turner et al 2005). 
Merrill and Ruben (2000) assert that lack of training, knowledge and 
experience of GPs in managing drug misuse is pertinent both to why 
GPs are averse to prescribing, and why drug misusers are disinclined to 
seek treatment from their GPs. 
One of the few studies which explored GPs’ attitudes towards the use of 
MMT was conducted in general practice in the RoI (Wilkinson & Mistral 
2003). Survey and interview methods were combined and a 
questionnaire was sent to all of the 275 GPs registered with the 
methadone scheme, plus a further 100 GPs selected at random from 
the register of GPs held by the ICGP who were not prescribing. While 
the majority of GPs who were prescribing methadone strongly agreed 
that many benefits were obtained for the service users, 70% of those 
who did not prescribe felt that all problem drug misusers should be 
referred to specialists and were strongly unwilling to take on methadone 
maintenance clients. They anticipated problems with patients’ behaviour 
and disruption to their practice. There was a 63% (n=236) return rate, 
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63% (n=173) from GPs who were prescribing and 63% (n=63) from the 
GPs who were not prescribing. This was a return rate similar to a study 
of GPs treating drug misusers in Scotland (McKeown et al 2003). 
Qualitative interviews with 28 GPs who were not prescribing, explored 
issues raised by the survey. Those not prescribing were less convinced 
of the merits of MMT than their counterparts. Disparaging comments 
were made about doctors who were on the scheme, with regard to 
competency and financial motives for prescribing. Some described 
patients as being ‘dirty and smelly’, likely to ‘offend other patients’ or 
hanging around the surgery bringing the practice into disrepute. The 
overall picture that emerged from GPs responses was that GPs who 
were prescribing were positive about the benefits of methadone; 
however only half viewed the training as adequate. Although the 
interview material was biased towards those prescribing methadone, 
the responses from these GPs indicated concerns about clinical policies 
and procedures for dealing with ‘dirty urines’ and a wish for more 
flexibility of practice. The detailed responses and written comments by 
GPs both prescribing methadone and those who were not, have 
important implications for the future of services for drug misusers and 
this was an important study which laid a foundation for further research 
with GPs. 
A more recent study conducted by postal survey explored GPs 
subsequent attitudes to the MTP. The survey was sent to the 600 GPs 
on the ICGP drugs’ misuse database who had ever attended for 
substance misuse training (Delargy 2008). Of the 600 questionnaires 
sent 207 responses were received. A response rate of (34.5%) was 
documented. The questionnaire was designed to identify what barriers 
existed to accepting patients for treatment. The majority of respondents 
72% (n=149) already had patients on the MTP at that time while less 
than a third 28% (n=58) did not. Attitudes which focused on the benefits 
of MMT suggested that, similar to the study by Wilkinson and Mistral 
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(2003), GPs overwhelmingly believed that it was now an essential 
service to drug misusers 95% (n=197). Furthermore the majority 96% 
(n=199) felt that the structure of the MTP provided a regular opportunity 
to review patients’ progress and to allow a good relationship with the 
patient (Delargy 2008). The report concluded that most GPs who had 
presented for Level I training showed an ‘untapped willingness’ to 
participate in the programme if requested. The responders’ attitudes 
reflected concern about the problems of illicit drug taking among their 
practice population. Results from postal questionnaires should be 
interpreted cautiously and in this study the response rate was low 
(Edwards 2001) with no documentation as to how these results were 
validated and statistically interpreted. In the absence of other research, 
this survey was useful for gaining cautious insight into the recent 
attitudes of GPs in the RoI. However as they had all participated in 
training, bias can not be excluded. 
There have been other criticisms in relation to GP involvement in MMT 
in the RoI. Barry (2002) when reviewing the tackling of opioid misuse 
over the past two decades stated that although GPs were identified as a 
key group in terms of implementing harm reduction, it took five years, 
the production of two policy documents on methadone prescribing in 
general practice (DOH 1991, DOHC 1997), a change in the law, 
negotiation of a generous remuneration package for GPs and the 
development of a network of health board satellite clinics and addiction 
centres and supports, before it got to the stage where 25% of GPs 
(there are approximately 2,500 in the RoI) in Dublin took part in the 
MTP. There are several other ethical and sociological viewpoints which 
challenge a number of the bio­medical assumptions regarding the 
delivery of MMT. 
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1.3. GENERAL SOCIOLOGICAL AND PUBLIC HEALTH ISSUES OF METHADONE 
TREATMENT 
In spite of GPs attitudes, there are those who feel it is imperative to 
challenge the current status of such treatment as methadone 
maintenance and declare it as a biomedical and public health paradigm 
which should be subject to scrutiny (Ning 2005). Foucault (1926­84), a 
French philosopher, sociologist, and historian claimed that knowledge 
and power are interconnected. He suggested that discipline through 
imposing precise norms is pervasive in society; therefore the idea of 
regulatory technology which aims to create productive and obedient 
subjects (such as those on MMT) presents an opportunity for control 
(Keane 2009). Bourgois in a somewhat similar sociological stance 
describes advocating MMT as representative of the state’s attempt to 
inculcate moral discipline into the hearts, minds, and bodies of deviants 
who reject sobriety and economic productivity (Bourgois 2000:167). He 
uses the concept of bio­power (a term originally coined by Foucault to 
describe state control and regulation of subjects) to reveal how the 
disciplining of patients takes place in a methadone clinic. He believes 
that methadone maintenance forces heroin addicts to comply with bio­
medical and public safety goals (Ning 2005:360). 
Weinberg (2000:617) in his research into the sociology of health and 
illness also introduces challenges in that he argues that the tenet that 
drug addiction is a ‘bona fide disease’ has been historically constructed 
and this idea has been crucial in campaigns to promote therapeutic 
interventions (such as MMT) at the level of public policy. Using this 
theory to foster solutions he suggests that the symptoms of addiction 
should be identified before solutions can be sought. He proposes a 
more sociologically incisive response to addiction which rejects 
biological reductionism (Weinberg 2002). There have also been 
criticisms leveled by doctors at the utopian biomedical gaze which 
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pursues the problematisation of normality and views patients as 
‘’unhealthy’’ if they are not compliant with accepted norms of treatment 
and thus in need of medical intervention A bio­medical model which 
views any deviation from perfection as pathology needing treatment 
denies the sociological determinants of health (Misselbrook 2010). 
However there are public health issues associated with addiction and 
the disease model which can not be ignored and influence service 
provision. To date MMT has almost certainly been instrumental in 
maintaining relatively low rates of human immunodeficiency virus (HIV) 
sero­prevalence among injecting drug misusers worldwide and in 
Ireland (HPSC 2007). MMT, as stated earlier, is effective in the 
reduction of heroin use, drug related mortality, and crime (Ward 
2002).The impact of MMT on hepatitis C virus (HCV) transmission rates 
however is unknown as HCV prevention science is in its infancy and it 
is unknown what intervention works best (Mateu­Gelabert et al 2007). 
Approximately 75% of the intravenous drug misusing population in 
Dublin are infected with HCV and 56% are PCR positive (Kavanagh et 
al 2003, Cullen et al 2003). Demonstrating with certainty that 
programmes that facilitate safe injecting have reduced the occurrence 
of HCV, has proved elusive (Jones et al 2008) and screening in the RoI 
has been identified as being inconsistent with lack of co­ordination 
between primary care providers, addiction treatment centres and 
hepatology services (Smyth et al 2000, Cullen et al 2007). This situation 
is borne out in other studies, for example Canada where there are 
extremely low rates of HCV treatment initiation (Grebely et al 2009). 
From a sociological perspective, public health concerns such as these 
and harm reduction policies have been identified as ‘parallel social 
movements’ (Rhodes 2002:85). Treatment has social as well as public 
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health and medical components, and identifying these social processes 
has been deemed important for the delivery and effectiveness of MMT. 
Ning (2005) produced ethnographic examples from interviews with 
service users (n=40) and staff (n=4 staff) within a methadone clinic in 
Toronto (the team comprised a physician, pharmacist, counsellors, case 
managers, nurse, drug screening technicians, and administrative and 
support staff). Staff and service users described the complex workings 
of power, whereby neither staff nor service user was exclusively 
dominant or exclusively resistant to domination. Service users were not 
mere victims subject to the regulatory bio­power of the methadone clinic 
as suggested by Burgois (2000) but rather were able to make tactical 
responses and negotiate treatment. This work identified that focusing 
on therapeutic interventions alone may preclude a deeper vision of the 
social dynamics at work in treatment settings. Different individuals were 
deemed to have different treatment needs—needs that may or may not 
have coincided with the expectations of the methadone treatment 
programme. 
Holt (2007) theorizes that drug dependence should be viewed primarily 
as a social rather than a health problem. He presented ethnographic 
examples of the lived experience of 77 drug misusers, examining their 
experiences of MMT and that of receiving prescribed medications for 
depression in methadone clinics. Drug treatment services were 
delivered either privately or in a public institution in both metropolitan 
and regional areas of Australia. He suggested that service users 
exercise agency while at the same time find their ability to act curtailed 
by the strictures of treatment itself. The recourse to negotiation was 
deemed an inevitable response by those receiving methadone who 
were trying to adapt to imperfect treatment conditions. He saw this as 
constituting a failure to explain the need for treatment, its 
consequences, and how clients might manage unexpected or unwanted 
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treatment effects. An apparent change in status from ‘autonomous 
agent’ to ‘participant in treatment’ occurred suggesting that part of 
substitution treatments’ desirability is the perception that clients 
relinquish the freedom to pursue a drug­using lifestyle and instead 
willingly participate in treatment (where, by implication, they are subject 
to greater oversight and have less freedom to act autonomously). The 
premise is that participation in treatment ties service users to 
regulations and reduces their capacity for independent action. 
Lilly et al (2000) reporting on findings from a two year ethnographic 
study of methadone treatment delivery in London explored the 'sociality' 
of treatment as being embedded within the negotiation and building of 
social roles and relationships. The study sites were two drug 
dependency units and clients receiving a `shared care’ treatment model 
with GPs at a specialist drugs service where staff co­managed the 
client. Forty interviews were conducted with professionals and 45 clients 
were interviewed.They described the experience of delivering and 
receiving methadone treatment as a social process, involving social 
interaction between the service provider who is a conduit through which 
`treatment’ is delivered and service user who is the recipient. The 
necessity of understanding the delivery of methadone treatment 
services as a social inter­actional process and not merely as a medical 
encounter with a treatment outcome, highlights the practical 
implications of understanding other factors associated with methadone 
treatment. The provision of methadone without understanding the 
dynamics of the treatment environment undermines the concept of 
holistic care and treatment effectiveness. 
Agar et al (2001:76) criticized methadone as a drug which has clouded 
the boundary between treatment and the streets and as such has 
accommodated an addict’s world. ‘’Treatment’’ means taking an opiate, 
rather than requiring that opiate use cease before treatment is started. 
In this respect, compared to any other drug­free treatment, they 
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suggested it has become easier for the service user to experience 
treatment within the context of the “patient” role. 
There is also the view that methadone creates some privileges such as 
stability but at the cost of surrender and domination, invoking the 
metaphor of the ‘‘liquid handcuffs’’ of treatment. The analogy of 
‘‘swapping the dealer for the doctor’’ and still being tied to an addictive 
drug, has been proffered by those on treatment. This description is 
accepted by many. Binaries such as these have been discussed in the 
work of Friedman and Alicea’s (2001) Surviving Heroin who claimed 
their work was a much needed corrective to the narrow stereotype 
promoted by clinicians (Broadhead 2002). Willingness to seek out 
professional help and by so doing following the treatment prescripts of 
medicine infers a structured and normalizing existence which is 
acceptable to many treatment providers who may not question this bio­
medical approach. 
A more complex understanding of methadone as a material which has 
become a socio­cultural phenomenon has been presented by Fraser 
and Valentine (2008) in their book Substance and Substitution. It 
combines interviews (with clients, prescribers, health workers and policy 
makers) with analyses of media representations, medical literature and 
policy documents. They argue that the spilt between the social and 
medical, between the chemical and psychological facets of addiction 
are often enmeshed in the experience of clients. They caution that 
treating MMT as the provision of a drug and little else entails a narrow 
view of the problem. Methadone treatment allows service users a 
degree of autonomy from the demands of an illicit drug using way of life 
but it simultaneously can impose a regime that is equally, or more 
controlling. Keane (2009) when critiquing this work explains that the 
substance of methadone is described as a phenomenon which needs 
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explanation rather than existing as a stable entity upon which the 
politics of MMT is erected. The treatment identities which can be 
created by MMT were also explored in this work and this finding has 
resonance with other studies (McIntosh & McKeganey 2000). Fraser 
and Valentine further explore the discourse about methadone and 
recognize the political, cultural and social issues which arise when the 
problem of drug misuse is perceived as one of deviance. Although the 
role of politics and culture in shaping and provoking methadone 
treatment has been discussed with certain skepticism in the literature, 
these issues can not be explored in isolation. 
Rhodes (2002) advocates an approach to harm reduction which 
considers factors such as those influenced by context. A risk­
environment approach to drug research, policy and practice, highlights 
the parallels and connections in how context influences health and 
vulnerability in general as well as drug­related harm specifically 
(Rhodes et al 2003, Rhodes et al 2005). Rhodes (2009:199) further 
delineates that ‘a risk environment approach is a social science for 
harm reduction which acts first to reduce social suffering'. Addiction is 
recognized by some GPs as a chronic relapsing condition which creates 
social suffering and it is also well recognized that GPs have a pivotal 
role to play in the management of chronic disease (Keen et al 2004, 
Dennis & Scott 2007, Luty & Sujaa 2008, Latham 2010). The primary 
focus of harm reduction intervention policies has been centred on 
individual risk behaviour change (Rhodes 2002), but international 
research has repeatedly highlighted the role of environmental– 
contextual factors in limiting the ability of drug misusers to embrace 
individual behaviour change in order to reduce drug­related harm 
(Moore & Dietze 2005). Weinberg (2002) argues that drugs are used in 
ways that are always personally meaningful to drug misusers and this 
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meaningful use of drugs is always embedded in, and at least to some 
extent, practically responsive to, socially structured contexts of action. 
Criticisms arise when faced with the problems that occur when focus on 
the individual is at the expense of the community and creates an 
inherent imbalance. Reconciling both individual and community health 
is a feature of general practice in urban disadvantaged communities 
and balancing the focus between individual, geographical and social 
factors can prove difficult (Peckham 2004). One instance of this is 
acknowledging that the local level drug dealing environment is an 
important feature of local economies in marginalised communities and 
sharp distinctions between users and dealers are not always easy to 
identify (Fitzgerald 2009). Each community has its own specific 
environmental factors which influence harm and these factors can not 
be generalized. 
These disparate viewpoints and argument in the literature identify that 
there are various well accepted merits associated with MMT however its 
value is compromised by the experience of service users which may not 
always be considered important within the bio­medical approach. While 
there are enormous challenges such as these in our understanding of 
MMT, important ‘‘indicators of success’’ in managing and treating drug 
misusers have been identified such as retention in treatment, both while 
the person is in treatment and as a predictor of what is likely to happen 
after they have left treatment (Caplehorn et al 1994, Gossop et al 
2001). These indicators of success are identified in the literature as 
measures of ‘‘treatment effectiveness’’ from the focus of service 
providers rather than the documented perceptions of service users. 
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1.4. MEASURING AND MAINTAINING EFFECTIVE TREATMENT 
Studies focusing on client retention and treatment duration have been 
criticized as limited if they fail to take account of issues relating to the 
social component of treatment delivery (Lily et al 2000). However in the 
United Kingdom (UK), the National Treatment Agency for Substance 
Misuse (NTA) considers retention to be the best available measure of 
drug treatment effectiveness (Beynon et al 2008). Irish retention rates in 
methadone treatment are impressive (Cox et al 2007) in comparison 
with England, Scotland and Australia (Gossop et al 2000, Darke et al, 
2005, Morris & McKeganey 2006). What influences retention is 
purported to be related to the dose of methadone not the provision of 
ancillary services. For example a meta­analysis of studies comparing 
the provision of methadone maintenance with and without ancillary 
services demonstrated decreased illicit heroin use with ancillary 
services but found no statistically significant additional benefit in terms 
of retention in treatment, RR 0.94 (95% CI, 0.85 to 1.02) (Amato et al 
2005). An observational study of 351 patients in the UK receiving 
methadone maintenance compared with those receiving methadone 
dose reduction found the following retention rates: 88% vs. 86 % at one 
month, 71% vs. 58% at two months, 62 % vs. 50% at one year, and 
42% vs. 30 % at two years (Gossop et al 2001). 
How long an individual spends in particular treatment however is also 
contingent on contextual factors such as the constraints of the 
programme they enter (Lilly et al 2000, Moore & Dietze 2005, Morris & 
McKeganey 2006) the relationship with the prescriber (Wilkinson & 
Mistral 2003), dosage levels, and the philosophy of care. Patients 
retained on MMT for one year in a primary care setting in Sheffield 
which is a specific primary care clinic developed to support GPs, have 
been shown to achieve improvements on a range of harm reduction 
outcomes similar to those shown by studies in other, often more highly 
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structured programmes (Keene et al 2003). The philosophy of the clinic 
which offers a full range of community based treatments for drug 
misusers is to face the reality of heroin addiction without damaging the 
morale of service users by setting unrealistic goals such as abstinence. 
There are limited studies which investigate the effect of drug treatment 
and retention rates in the RoI. One of the few, the first National 
prospective longitudinal multi­site drug treatment outcome study 
(ROSIE) was published in 2006 (Cox et al). This observational study 
evaluated drug treatment effectiveness for 404 opiate users entering 
treatment for the first time or returning to treatment after a period of 
abstinence from treatment. Treatment was conducted either as an 
inpatient in hospital, a residential programme, or in prison; out­patient 
settings were community based clinics, health boards or GPs. At one 
year follow up there were 305 respondents. Treatment modalities were: 
methadone maintenance/reduction 53% (n=215), structured 
detoxification 20% (n=81) and abstinence based treatment 20.3% 
(n=82). The interview schedule focused on data such as drug usage in 
the previous 90 days preceding the interview. Positive outcomes were 
significant reductions in heroin use from 81% at treatment intake to 48% 
at one year, and frequency of use from an average of 42.6 days out of 
90 at treatment intake to 15.8 at one year. Other illicit drug misuse was 
also reduced. The three year follow up published in 2008 identified that 
behavioural changes were sustained over time (ADRU 2008). The 
number of those selling/supplying drugs fell from 30% to 13% and the 
number handling stolen goods fell from 25% to 10%. Once initial 
improvements were achieved between intake and 1­year, it seems that 
participants experienced a period of stabilisation with respect to criminal 
activity and this outcome did not change significantly between 1 and 3 
years. There were reductions in the proportions of participants who 
reported use of non prescribed methadone, cocaine powder, crack 
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cocaine, cannabis, alcohol and non prescribed benzodiazepines at one 
year compared to the baseline interview. These reduced levels were 
maintained between one year and three years for all drugs except 
benzodiazepines (Drugnet 2008). It was observed that 38% of the 
participants recruited in methadone were still in their intake treatment 
setting at 3­years. This study suggests that involvement in drug 
treatment programmes has a positive impact on individuals. The 
findings did not indicate causal relationships between the treatment 
received and the outcomes observed such as behavioural change. The 
study did not randomly allocate participants to treatment settings or 
modality, nor did it employ a control group (i.e. drug misusers with 
similar profiles not attending the treatment). In addition the geographical 
locations of the services chosen reflect the provision of services 
available at national level rather than being a representative sample 
(Cox et al 2007). While longitudinal quantitative studies such as ROSIE 
may identify relationships between variables, these studies can not 
explore the complexities or dynamics within such relationships, nor can 
they explain the meaning behind the correlations. Behavioural change 
may be due to the interaction of three factors: the person, the 
environment, and the intervention, all of which can influence outcomes; 
there is no evidence from the study to suggest what particular 
intervention ‘’works’’ from the service users’ perspective and the factors 
that influence positive treatment responses were not identified. 
The narrowness of the medical model of outcome measurement may 
not sit well with service users’ views of what constitutes treatment 
effectiveness and it is important to identify other factors which influence 
change. Methadone maintenance is a successful management tool; 
however there are factors which limit its effectiveness such as variability 
of treatment programmes (Rettig et al 1995). Treatment effectiveness 
has been shown to be related to patient motivation; problem severity; 
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therapeutic engagement; and intensity of services; as well as linkages 
to community­based social supports (Simpson 2003).Treatment and 
retention are interlinked and may be influenced by professional attitudes 
towards drug misusers which may in turn have an important influence 
on how clinical guidelines are implemented. As identified earlier, the 
assumptions surrounding treatment for addiction have been 
medicalised (Burgois 2000, Weinberg 2000, Weinberg 2002, Holt 2007) 
and this model appears to exist in a vacuum whereby environment and 
contextual factors are often ignored. 
Regardless of the fact that retention in treatment is linked to reduction in 
risk behaviour, as substantial lifestyle changes are sustained over time, 
it is important to appreciate that this may not be the service users’ goal 
(Chalmers et al 2007). Participants on methadone programmes are not 
always willing to commit to indefinite maintenance but would have 
preferences for shorter time­limited methadone treatment (McKeganey 
et al 2004, Peterson et al 2010). Indeed Farrell et al (2000:10) in his 
review of treatment services in Dublin suggested a twin track approach 
that combines detoxification with maintenance which would ensure 
some individuals could have shorter term contact with services and 
would create some treatment capacity by creating a degree of 
throughput for one stream of patients. 
There are other significant problems with MMT such as concurrent 
benzodiazepine misuse, which has historically been a significant issue 
among clients in treatment clinics in Dublin (Corrigan 1986, Hindler et al 
1996, Farrell et al 2000). This situation remains a major concern for 
general practice in the context of MMT (Farrell et al 1994, DOHC 2002). 
Prescription and over­the­counter medications have been implicated in 
many poisoning deaths and benzodiazepines, often in conjunction with 
an illicit substance, have been implicated in more deaths than any other 
drug in Ireland (Lyons et al 2008). The impact of this type of drug needs 
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to be addressed within treatment and prevention services. A systematic 
review of treatment approaches to dose reduction strategies for 
benzodiazepine dependence was carried out in general practice and 
out­patient settings in Australia (Parr et al 2009). Routine care was 
compared with three treatment approaches: brief interventions, gradual 
dose reduction (GDR) and psychological interventions. GDR was 
compared with GDR plus psychological interventions or substitutive 
pharmacotherapies. The nature of treatment offered proved to be 
important and raising the issue of discontinuation at every consultation 
increased the likelihood of ceasing use successfully. Little focus has 
been placed on interventions necessary to facilitate this approach within 
general practice in relation to the orthodox intervention of methadone. 
Engaging with those who have been marginalized due to addiction is a 
particular challenge for inner city primary care (RCGP 2005) and 
working in partnership with a drug misusing patient involves not only the 
individual but also parents, children, relatives, child care agencies and 
drug treatment agencies coupled with an overall commitment to support 
and enhance family relationships and skills (Clarke 1994). 
Understanding how the concept of partnership and relationship building 
affects treatment for the individual on MMT may prove useful for 
improving the harm reduction praxis of methadone treatment in general 
practice. 
1.5. THE ROLE OF PARTNERSHIP AND RELATIONSHIP BUILDING IN 
METHADONE TREATMENT? 
Historically there has been a paternalistic approach to patient care 
which arguably has impeded the building of relationships between 
health care providers and service users (Coulter 1999). Increasingly 
however, partnership models of health care have been advocated and 
enshrined in current international healthcare policy (Duncan et al 2010). 
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Indeed in many treatment plans in primary care, outside of the 
addictions’ field the involvement of patients and patient groups is the 
norm (Rhodes et al 2002, Greenhalgh 2009). Partnership models of 
care have been advocated in several chronic disease management 
guidelines such as diabetes (DoH 2005) and many other long term 
conditions yet patients’ views have seldom been sought regarding how 
chronic illness is managed (Cooper et al 2003). The expert patient 
initiative was launched in 2002 in the UK which embodied the idea of a 
much more active patient, and of a patient centred health care system, 
thus reducing the power of professionals and superseding the original 
paternalistic approach. 
Even before this, understanding that the patient is ‘‘expert’’ was 
identified as crucial to the role of effective care in general practice 
(Balint 1964). Current evidence suggests however that shared decision­
making has not yet been widely adopted by health professionals and 
significant barriers exist. Gravel et al (2006) carried out a systematic 
review of healthcare professionals’ perceptions of shared decision 
making. Perceived negatives identified were time constraints, lack of 
applicability due to patient characteristics and lack of applicability due to 
the clinical situation. Positives identified were provider motivation, 
beneficial impact on the clinical process, and effective impact on patient 
outcomes. They concluded that interventions to foster implementation 
of shared decision­making in clinical practice need to address a broad 
range of factors. They also identified that the majority of published 
studies originated from the UK and the USA which suggests a proactive 
approach to research in the area of shared decision making. 
The RoI has lagged significantly in this area and the ICGP has only 
recently published the Partnership with Patients Report (ní Riain & 
Dempsey 2009:1).This states that ‘the focus of the ICGP is consistent 
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with the patient­centred approach of the Irish National Health strategy 
Quality and Fairness–A Health System for you (2001) and Primary 
Care–A New Direction (2001) and reflects the need to involve the 
knowledgeable patient in building a safer health system described in 
The National Strategy for Service User Involvement in the Irish Health 
Service (2008 – 2013) and the Report of the Commission on Patient 
Safety and Quality Assurance (2008). Drug treatment strategies are 
absent in these reports. 
The complexity of patient participation is that both practitioner and 
service user might offer differing perspectives on what this participation 
constitutes and what role partnership plays in decision making and 
specifically how that translates to the management of drug misuse. The 
individual is the central focus of the GP consultation and the 
significance of partnership and relationship development between this 
individual and his or her GP has been an overlooked dimension in 
addiction research. There is evidence to demonstrate that primary care 
can effectively contribute to individual health (Peckham & Exworthy 
2003) and the ICGP advocate that the GPs’ unique knowledge of the 
patient and their extended family can make a considerable contribution 
to the long term management of those receiving methadone (ICGP 
2008). 
A more useful concept of partnership from the perspective of the 
service user may be to understand the process by which service users 
and physicians attitudes and behaviour facilitate decision making, 
negotiation and sharing control. Sharing control and shared decision 
making is a partnership approach between service provider and service 
user which acknowledges ‘’relationship’’ as key to the process. This 
concept of personal relationship between practitioner and patient alike 
has been viewed as having a pivotal role in general practice (Stokes et 
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al 2004). This relationship has been described as unique, established 
‘on the basis of mutual satisfaction and mutual frustration’ (Balint 1964: 
249). The power issues inherent in the roles of prescriber and recipient 
of methadone complicate this relationship and can militate against an 
equal system of partnership. Criticisms of this type of relationship exist 
as Bourgois et al (1997:155) state that social suffering is inevitably 
viewed ‘through a theoretical lens that privileges power’. 
Physicians’ attitudes have been identified as barriers to informed and 
shared decision making (ISDM) and a major barrier to the practice of 
ISDM by motivated physicians appears to be the need to change well­
established patterns of communication with patients (Towle et al 2006). 
Recent research in general practice has identified the importance of 
GPs eliciting the triad of ideas, concerns, and expectations (ICE) in the 
general practice consultation which has a potential impact on 
medication prescribing (Matthys et al 2009). These ICE components are 
highlighted as key competencies related to shared decision making, 
especially when deciding whether to prescribe medication. Additional 
expertise is required when that medication involves treatment for drug 
misuse. 
There has however been little emphasis placed on any aspect of 
partnership or relationship building in general practice in the RoI. A 
recent qualitative study involving thirty Irish GP trainers highlighted the 
GPs relationship with what the investigators termed a ‘heart lift’ as 
opposed to the phrase ‘heart sink’ patient (O’Riordan et al 2008). 
Among questions posed to the GPs the question of Tell me about a 
patient you like? elicited three themes: easy to like, a challenge, and the 
necessity to renegotiate the doctor­patient relationship. When 
describing a lady in her 30’s who was prescribed methadone, one GP 
expressed the following; she was singularly the most difficult patient I’ve 
ever come across: their relationship had ‘deteriorated’ and she felt I 
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didn’t care. She’s the only person that has told me ...I really failed them. 
This led to an explicit renegotiation of the relationship: The patient 
stopped her drug misuse, she y’know is a delight. 
When the GPs were also asked­ what have you learned about yourself 
as a GP? one theme elicited was the GPs role as a facilitator of 
sometimes chaotic and difficult lives. This study was not specifically 
aimed at GPs’ responses to drug misusing patients in its original 
intention however it does offer narratives which are useful for reflecting 
on the importance of the doctor­patient relationship with patients who 
challenge their assumptions. The authors addressed the limitations of 
the study claiming there was a risk of social desirability bias as the 
decision to restrict the study to trainers may have meant that a 
snapshot of an unusually reflective minority was gained, which may not 
have been reflected in the wider GP community. It is interesting that the 
assumption made by the medical profession regarding ‘’chaotic use’’ 
infers that chaos is constituted as self­evidently bad and the opposite of 
order and stability. The intrinsically ‘’chaotic user’’ has thus partially 
been defined by his or her inability to enact or inhabit stability. This view 
has been frequently accepted in drug misuse discourse and these 
attitudes have the potential to undermine relationship building. Fraser 
and Moore (2008) suggest that blanket assumptions such as these 
pose the risk of failing to grasp fully the dynamics of drug misuse, and 
importantly, some of the reasons why harm reduction measures are not 
always adopted by drug misusers. O’Riordan et al (2008) concluded 
that the process of relationship building can be enhanced by education 
and support such as reflective learning, teaching and training for all 
(Anderson et al 2003). 
Understanding the significance of the doctor–patient relationship may 
be central to exploring who controls the intervention of MMT in general 
practice. Improving the doctor­patient relationship is challenging and 
fear and lack of expertise in how to deal with drug related problems can 
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affect this relationship. Fraser and Valentine (2008:19) describe how 
very privileged professionals have been traumatised by their experience 
of providing methadone treatment and they themselves have been 
subject to serious anxiety, possible danger and isolation in their work 
with service users. Neale (1999:143) recognized that social workers 
also, although familiar with working in partnership with other agencies, 
and trained to make connections between personal troubles and the 
broader social factors involved in client problems, sometimes feel that 
they do not have sufficient resources to deal with complex problems. 
Taking account of the broader family and social circumstances of the 
individual in a one­to­one consultation is complex and meeting the 
needs of drug using parents and their children has been described as a 
formidable challenge (McKeganey et al 2002). In Dublin the 
rehabilitation process associated with drug addiction has been 
described as prolonged, raising many childcare issues for professionals 
(Quigley 2002). Effective and intuitive consultation is at the heart of 
good practice and the ability to engage in a facilitative rather than 
autocratic manner has been advocated in many models of consultation 
(Pendelton 1984, Neighbour 1987, Kurtz et al 1998). Treating drug 
misusers with respect, listening to their concerns and those of their 
families has been actively desired and highlighted by drug misusers 
themselves as crucial to their treatment (Fischer et al 2007). 
Other issues which may arise in the consultation are those which 
involve change and the formation of identity. Drug misusers’ 
experiences of recovery from heroin addiction and the desire for a new 
identity and a different style of life were evident in a study carried out by 
McIntosh and McKeganey (2001). They conducted 70 semi­structured 
interviews with recovering addicts in Scotland and these accounts 
consistently described a process of trying to recover or repair what they 
experienced as a ‘’spoiled identity’’ as a result of drug addiction. The 
31

need for training in the area of identity formation and change was 
recognized in this study. It is true that few people make an immediate 
and once­only transition from drug misuse to abstinence (McKeganey et 
al 2004). Redefining the ‘’sense of self’’ and reconstructing the identity 
of the recovering drug misuser has been identified as a process which 
requires experienced care (Etherington 2008). How that process of 
transition is facilitated in general practice and how users’ experiences of 
methadone treatment services influence individuation, recovery and the 
formation of identity has had limited research focus. It is uncertain what 
training is required to address this process of recovery in treatment from 
the perspective of the user. Mistral and Velleman (2001) surveyed GP’s 
in Wiltshire and suggested that carefully focused education, training and 
support could increase effectiveness for the service user on MMT. 
However this was only if the primary care practitioners were willing. 
Taking into account the service user's perspective might support 
identity formation leading to some improved outcome for the patient on 
MMT. Factors that impact on retention and therapeutic engagement 
such as the relationship between patient outcomes and elements of the 
therapeutic process­namely the treatment environment, patient needs, 
and delivery of services should be addressed in the consultation 
(Simpson et al 1997). While practical approaches to care are extremely 
important there are other aspects to the therapeutic relationship and 
patient participation which require negotiation with patients in relation to 
a range of issues (Haidet et al 2006). There is no doubt that therapeutic 
commitment is required when working with those addicted to drugs. 
What is regarded as therapeutic and a desirable result by the service 
provider may be viewed less favourably by the service user. Service 
user for the purpose of this study is defined as the individual who is 
receiving the intervention of methadone maintenance in the setting of 
general practice. Achieving a therapeutic effect may require a high 
degree of physician and patient negotiation and a process of 
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engagement with service users which has hitherto been noticeable by 
its absence. 
1.6. SERVICE USERS’ VIEWS OF METHADONE TREATMENT 
Opiate users’ views of methadone treatment have been investigated 
internationally although most of these studies have been focused within 
specialist treatment centres (Fischer et al 2002, 2007, 2008, Gourlay et 
al 2005, March Cerda et al 2006, Madden et al 2008). March Cerda et 
al (2006) explored the views of 30 service users about their methadone 
treatment programme. This was provided at drug treatment centres 
located in Barcelona and Granada. The care provided by therapeutic 
teams relied on three main intervention areas: medical, psychological 
and social care. Despite the generally positive outcomes of MMT 
expressed, its main limitation lay in the lack of a comprehensive 
approach to users' individual needs. Strengthening bio­psychosocial 
intervention emerged as an essential prerequisite to progress towards 
users' rehabilitation. Madden et al (2008) surveyed 432 clients receiving 
treatment at 9 public clinics in New South Wales, Australia. Client 
perceptions were assessed across a number of treatment domains, the 
clinic environment; service provision; clinical relationships; medication; 
and treatment outcomes. Participants reported being ‘mainly satisfied’ 
with their treatment but caution was expressed as to what a consumer 
reasonably expects to receive from a service, as issues of treatment 
satisfaction can be dependant upon service users‘ ’expectations’ and 
’relative experience’. If service users have low­level expectations of 
quality and they receive a service which meets these criteria, they were 
considered likely to rate that service as ‘acceptable’. 
Attitudes of recipients (n=29) of unsupervised injectable opiate 
treatment (IOT) for opiate addiction were explored in two community 
drug teams in northwest England (Orgel et al 2009). Most of the 
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respondents’ attitudes were positive describing personal and social 
benefits: reduction or cessation of illicit drug misuse; health gains; more 
normal lifestyle; and reduced criminal activity. Orgel concluded that IOT 
recipients were not a homogeneous group and had different needs and 
goals which needed to be voiced and heard. As recipient views have 
been in the most part neglected in the literature, in this work the 
individual voice was recognized as being crucial and adds to the debate 
about treatment effectiveness. A further small Australian study explored 
the experiences of stigma and programme regulation experienced by 10 
service users (Gourlay et al 2005). Although a comprehensive approach 
to user’s individual needs has been advocated in each of these studies 
none were carried out in general practice. 
Fischer et al (2002) identified that service user conflict can result in a 
number of possible outcomes, including the premature termination of 
treatment; staff deciding on the appropriate outcome, the client 
appealing to the governance structure of the agency, brokered 
compromise, and staff skillfully eliciting client consent for staff 
decisions. Fischer et al (2007, 2008) have also highlighted the 
complexity of user involvement. Examining client/staff conflict and user 
involvement in drug misuse treatment decision­making they conducted 
79 in­depth interviews with new treatment clients in 2 residential and 2 
community drug treatment agencies. They identified that services are 
more likely to be successful if clients have some choice about, and 
involvement in deciding, what treatment/s they actually receive. They 
suggested that factors such as the perceived characteristics, needs and 
expectations of drug misusers, attitudes of professionals, the dynamics 
of treatment encounters, treatment programme design and structural 
factors affecting service provision all require consideration. They found 
that staff can deploy user involvement as a strategy for managing 
conflict and soliciting client compliance to treatment protocols. This was 
34

a comprehensive study of both residential agencies and community 
agencies and the researchers acknowledged that many areas of user 
involvement were not addressed. Those involved in community 
agencies however valued flexibility, tailoring of services to meet 
individual needs and establishing effective channels of communication. 
Some critics feel that the result of promoting user involvement in drug 
treatment has weakened the users' voice and given health 
professionals the authority to define users' needs for them (Rhodes & 
Nocon 1998). Others have the opinion that user involvement brings with 
it a wealth of advantages ranging from quality assurance of service 
delivery, positive client outcomes, effectiveness and efficiency as well 
as higher morale for staff and wider support from agencies (Polley 
1995). Policy analysts have stated that the knowledge held by service 
users can be critical in the effective crafting of strategy; their first­hand 
experience and understanding of the problems and of the solutions that 
work can feed into policy development processes appropriately (Pike 
2008:106). 
Neale advocates for an emphasis on users' views which is consistent 
with developments in many other service areas, particularly the focus 
on user rights, accountability, empowerment, choice, and participation 
(Neale 1999). She has conducted several studies exploring drug 
misusers’ views of receiving methadone and the conditions attached to 
the prescribing process and contends that evaluations of methadone 
treatment from the users’ perspective provide an important resource in 
both the substitute prescribing process and in other forms of 
professional interventions in the lives of drug misusers (Neale 1998 a & 
b, 1999 a & b). 
Despite service users’ emphasis on the necessity of their involvement in 
all parts of their treatment programme (Hunt 2002, Montagne 2002, 
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Murray 2005), the terms ‘‘user involvement’’ and ‘’empowerment’’ have 
been expressed loosely and without precision in the literature. 
Government policy in the UK clearly states that those with drug 
problems should be involved in decisions relating to their own 
treatment. Service users however have had minimum representation 
and limited decision­making power at the level of policy formation 
(Zibbell 2004).There is also little evidence to support the effect of user 
involvement and decision making in drug services (McKeganey et al 
2004, Nilsen 2006). 
User involvement has been relatively slow to develop and there are 
differing opinions as to how user involvement impacts on service 
delivery (Fischer et al 2007). What empowerment means from the 
users’ experiences of methadone treatment services is therefore 
uncertain. Patient empowerment often means encompassing patient 
choice and a more collaborative approach between patients and 
professionals when it comes to making clinical decisions (Appelby & 
Dixon 2004). Treolar et al (2007) recommend the inclusion of service­
user perspectives to ensure that services are not wrongly targeted and 
that evaluation of those services does not underestimate or 
misrepresent their value to clients. While service providers have made 
efforts to engage consumers in service planning and delivery these 
efforts appear to be ineffectual because of poor communication 
between providers and service users (Bryant et al 2008).There is little 
evidence that Irish service users needs and wishes have been actively 
sought in the field of substance misuse let alone their involvement in 
treatment programme design in the RoI. 
1.7. METHADONE SERVICE USERS’ VIEWS IN IRELAND 
Historically there has been limited experience in encouraging service 
user consensus viewpoints in the RoI and there is a scarcity of literature 
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pertaining to service users’ views of methadone treatment in general 
practice. McEvoy et al (2008) when reviewing the literature for the 
National Strategy for Service User Involvement in the Irish Health 
Service (2008 ­2013) suggested that some of the most provocative and 
intelligent discussions on service user involvement are to be found in 
literature that is outside the usual parameters of scientific databases 
and literature. Studies such as these, although small, portray largely 
negative reactions of service users to treatment programmes (O’Connor 
2003, UISCE 2003, Lawless & Cox 2003, O ‘Reilly et al 2005, O’Reilly 
& O’Connell 2006, Ballymun Youth Action Project 2007­2008) and also 
negativity in relation to service provision (Wilkinson & Mistral 2003). 
Service user feedback in the RoI has been accused of being 
idiosyncratic, based on personal experience and needs rather than on 
the wider picture of service commissioning and delivery (Velleman et al 
2001). 
O’Connor (2003) in her doctoral thesis, examined patient satisfaction 
with the pharmaceutical aspect of methadone treatment services 
provided using both qualitative (combination of group and 15 individual 
interviews) and quantitative methods (a cross sectional survey of 217 
participants).The findings from the study identified that although clients 
were pleased with the introduction of community pharmacy services 
there was tension in the pharmacist/patient relationship due to 
conflicting pharmacist attitudes and unequal power relations. O’Connor 
acknowledged limits to the generalisability of her findings due to her 
sampling methods. 
The Union for Improved Services, Communication and Education for 
Service Users (UISCE) is historically one of the few users’ forums which 
exist in Dublin. The group is composed of users, ex­users and 
professionals who believe that the voice of the drug misuser is integral 
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to the development of drug policy and in realizing an effective treatment 
response (O’Reilly et al 2005). UISCE collated the opinions and 
observations of north Dublin inner­city drug misusers receiving 
methadone in 2003. Both quantitative (survey) and qualitative (focus 
groups) approaches were employed. They utilised action research 
methodology involving 214 drug misusers who had been in receipt of 
methadone for an average of 8.5 years­53% (n=113) were male and 
47% (n=101) were female. The initial purpose of the report was to 
ascertain if methadone Drug Tariff Formula (DTF) was meeting the 
needs of the people to whom it was prescribed and 88% (n=188) of 
responders felt that it was not as effective as the previously prescribed 
Physeptone in staving off withdrawals. Users’ views were ignored and 
UISCE identified high levels of dissatisfaction with methadone and a 
broader and complex range of problems faced by clients within drug 
treatment services. Service users described negative attitudes from the 
professionals working in the drug treatment centres and expressed that 
they had ‘no say’ in treatment decisions. They also identified that many 
of the respondents had been at the receiving end of medical sanctions 
for what they described as minor infringements of their drug treatment 
programme. The sampling method, rationale for the sample size chosen 
and the response rate were not documented, so the generalisability of 
the study is debatable (Long 2004). The high levels of dissatisfaction 
with methadone DTF were similar to O’Connor’s findings and other 
issues came to light, which highlighted a much broader and complex 
range of problems faced by clients within drug treatment services. They 
described an unequal system of maintenance, which was structured in 
a way that militated against client involvement and added to the sense 
of powerlessness. The need to develop a partnership approach where 
clients could discuss their particular needs with their doctor and a ‘tailor­
made’ treatment programme be devised for them was identified. 
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Lawless and Cox (2003) carried out an evaluation of a methadone 
prescribing service in Dublin City during 2001­2002. They employed 
both quantitative (31 clients with baseline data and follow up of 17 at 18 
months representing a 55% follow­up rate) and qualitative research 
methodologies (focus groups; two with clients and one with service 
providers). The Opiate Treatment Index covered six main outcomes; 
drug misuse, HIV risk taking behaviour, social functioning, criminality, 
health status and psychological adjustment. Of those who remained at 
follow up, analysis revealed reductions in the quantity and frequency of 
both licit and illicit drug consumption, less criminality, improvements in 
social functioning, consistent health but an increase in sexual risk 
behaviour. The qualitative information highlighted that although the 
provision of methadone as a treatment option was regarded favourably 
by the service users the mode of delivery of the treatment was in need 
of review. Clients reported extreme variations in the prescribing 
practices of GPs as some were purported to regard treatment as a 
purely abstinence focused approach with others regarding it as drug 
substitution. Although the study employed small numbers and was not 
situated in general practice, a key advantage of GP involvement in the 
treatment of opiate misusers in the treatment clinic was identified as 
normalising opiate use by integrating drug treatment with mainstream 
medical services ‘thereby reducing stigma involved’(p117). 
O ‘Reilly et al (2005) assessed the views of 25 drug misusers in three 
focus group discussions concerning their experiences of health services 
in Dublin. This was a collaborative study of the Participation and 
Practice of Rights Project (PPR) and UISCE and a general practice. 
The participants were selected by UISCE. Among various problems 
identified with the health services and access to them were that 11 of 
the 25 participants did not have a GP and complained that they were 
constantly refused registration by GPs. This was a small study and 
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strong inferences may not be made. The sampling methodology and 
inclusion criteria were unclear as a combination of methods were used 
including asking for volunteers, meeting drug misusers in the street and 
going into the flat complexes searching for volunteers. Consensus 
opinion from focus groups may not always be the view of the individual. 
Many of those interviewed were not on MMT in general practice. 
Nevertheless negative attitudes and reluctance to take drug misusers 
on to their practice lists was noted as is evident in other international 
studies (McKeown et al 2003). 
A further small study was conducted in a north inner city general 
practice in Dublin (O’Reilly & O’Connell 2006). Forty one of forty seven 
clients attending were interviewed with a questionnaire that had both 
closed and open questions. Results showed that 44% (n=18) of clients 
reported having an agreed plan with their doctor regarding ‘where their 
treatment was going’, 61% (n=25) stated that their doctor decided the 
amount of methadone they were prescribed, with 34% (n=26) stating 
that they could influence the dose which was decided by doctor and 
client together. Just fewer than 50% (n=24) felt that they had a say in 
deciding the prescribed dose with 44% (n=11) wanting to be more 
involved in decisions regarding their treatment. A separate system of 
care was identified suggesting that methadone service users were not 
treated as ‘regular clients’ but consulted with at an alternative time than 
other patients. The authors concluded that the MTP of the ICGP 
encouraged retention and long term maintenance and conflicts with 
users desire to be ’off’ methadone. Services were urged to take account 
of this and tailor packages with service users to allow them experience 
progression in treatment as well as shared responsibility for decisions 
and trust. A ‘one size fits all’ approach was described which did not 
adequately take account of service users’ goals. This study reflected 
the views of drug misusers situated in one GP surgery only and these 
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were treated at a separate time to other patients which is not a 
universal practise in Dublin. This situation enforces a segregation which 
supports the concept of marginalisation and could prevent the holistic 
approach of partnership in general practice services. It is arguable from 
the findings of this study that the goal of ‘‘normalising’’ drug treatment 
was unachievable as a separate system of care was operating i.e. 
situating a treatment clinic service in the same premises as a GP 
surgery. The study, though not generalisable, offered for the first time a 
view of how service users viewed their care in a general practice 
setting. 
The guidelines of the ICGP do encourage reduction strategies, 
maintenance and scope for detoxification and it is debatable from these 
findings whether these guidelines are being implemented. Guidelines 
are however produced to provide a framework which does not 
substitute for clinical judgment (ICGP 2008). Deviation from 
recommended guidelines is common as some GPs face difficulties in 
managing multiple drug dependencies which may reflect the nature of 
the presenting drug problems (Matheson & Pitcairn 2003). James et al 
(2009) conducted a study to explore the health concerns of 261 clients 
attending a MMT programme in an addiction treatment service in 
Dublin. Clients identified a high level of health­related concerns, such 
as psychosocial health concerns, particularly mood­related and 
concerns about HCV, diet, and sexual and mental health. A further 
study investigated the health concerns of clients attending a community 
addiction service in Dublin. Four main areas of concern were identified 
as smoking, depression, poly­drug misuse and HCV (Connor et al 
2007).There was no information on how many questionnaires were 
distributed or the response rate although females accounted for 38.3% 
of the sample. Although reliability of these Irish studies may be called 
41

into question due to both sampling and reporting inaccuracies, they 
reflect all that is available in the literature at the current time. 
The recommendation in the National Drugs Strategy (NDS) 2001­2008 
(DOTSR 2001) suggests that drug misusers’ views should be taken into 
account at all stages of their treatment, however the reality appears to 
be different. The reality is that there is a lack of evidence to support the 
practice of user involvement in their treatment decisions in the RoI. 
There are no national service standards and guidelines and no 
mechanism for recording when or how treatment ends, which is a 
critical indicator of treatment quality and effectiveness (Buckley 2009). 
There are also no drug service user charters such as those which have 
been developed in other countries such as Australia (O'Brien 2004). 
The drug misuser cannot be fully liberated from the power relations 
inherent in both policy formation and treatment planning as the 
structural inequality between service providers and service users has 
not yet been formally acknowledged. Quality of care has not been 
rigorously assessed in general practice in relation to patients on MMT 
from their perspective therefore no baseline data from which to examine 
these and other pertinent issues exist. Audit is carried out by the ICGP 
but as found in one Scottish study, the model of audit undertaken is 
important. The lack of a ‘universally acceptable yardstick, against which 
quality of care can be measured’ represented concern in this study 
(Scott et al 1999:1793). Instances of substandard care and 
shortcomings in clinical care were uncovered by this enquiry and this 
process provided useful opportunities to improve the future 
management of patients who were being prescribed methadone. 
The Report on the Working Group on Drugs Rehabilitation (DOCRG 
2007) recognizes that families of service users who have a direct role in 
the recovery process should be seen as service users in their own right, 
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however these recommendations have yet to be incorporated into the 
proposed NDS 2009­2016 and no service user has been invited to join 
the strategy task force. In an overview of the previous NDS (2001­2008) 
the assertion is made that it is ‘through open, informed and critical 
debate, involving all players and drawing on all possible sources of 
information and all perspectives, that the insights gained from strategic 
implementation, and practical and acceptable options for resolving 
critical strategic tensions, are found’ (Pike 2008:104 ). Neale (1998) 
suggests that methadone is a controversial but useful substitute drug, 
the prescribing of which requires careful and continuous monitoring. To 
this end, evaluations of methadone should consider the views of those 
receiving as well as those providing services. 
There has been a serious lack of debate in relation to service users’ 
views in the RoI and thus a need to involve these players. The 
legislation for methadone maintenance was intended to normalise drug 
treatment in primary care (ICGP 2002, 2003, DOHC 2005) yet the 
success of this intention has not been evaluated from the perspective of 
those who are using the service. The values held by treatment 
providers may not be shared by service users or indeed may be valued 
differently. There may be a discourse between the bio­medical model 
and patient views as insufficient knowledge exists about the complexity 
of methadone treatment and the inter­relationships of the various 
factors contributing to success or failure of treatment in general practice 
in the RoI. 
Information gathering is essential for effective clinical management of 
patients with chronic disease (Billings & Stoeckle 1999) and identifying 
what patient choices are among the options for treatment of heroin 
addiction necessitates exploration. How service user’s views are 
harnessed requires investigation as it has been acknowledged that they 
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have the potential to provide support for methadone prescribing 
regimes (Stone & Fletcher 2003) and their experience of treatment can 
be influenced by how care is delivered (Neale, 1998 a & b, 1999 a &b, 
McIntosh & McKeganey 2000, 2001, Fraser & Valentine 2008). The lack 
of emphasis and debate in the Irish literature surrounding service users’ 
perceptions of their current treatment underlined the urgency of the 
planned research and also emphasized the gaps that exist. 
1.8. RESEARCH AIMS 
This study was undertaken against a background of little qualitative 
work on the lived experience of those attending general practice in the 
RoI and none that explored the methadone service users’ perspective 
of their treatment solely within this environment (Stern 1980, Field & 
Morse 1994).The dearth of empirical data highlighted the importance of 
studying the experience of methadone treatment in general practice. It 
was uncertain whether discrepancies existed between the reality of the 
situation for the drug misuser and what the MTP advocates in general 
practice. Alternative perceptions had not been addressed and the 
significance of exploring the insight and understanding of service users’ 
experiences had been markedly absent and indeed overlooked in 
previous studies. It was unknown whether partnership in treatment 
existed between treatment provider and service user. ‘Actual care 
versus ideal practice’, one of the recommended avenues for research 
advocated by the ICGP research strategy (2003­2008) needed to be 
investigated and highlighted. 
Using the intervention of the MTP this study focused on the meanings, 
perceptions, and processes that occur within the context of treatment 
and ‘offers a way to explore and understand service users’ needs and 
thereby plan responses’ (EMCDDA 2009:18). 
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The aim therefore was to explore how the MTP was being implemented 
in general practice from the perspective of the service user. 
Objective 1: To describe service users’ lived experience of the MTP. 
Objective 2: To describe service users’ experience of being involved in 
decision making and management of their treatment. 
Objective 3: To discern whether there are shortcomings and benefits of 
experiencing methadone treatment in General Practice in Dublin. 
Objective 4: To identify what steps may be required to address any 
limitations or deficiencies in treatment by considering the perspective of 
the service users in the context of current practice. 
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CHAPTER 2: METHODOLOGY

2. INTRODUCTION 
The research design was developed in response to the study aims. In 
determining what strategy was necessary for the study a thorough 
review of possible methods was undertaken. This implies a linear 
structuring to the thesis which is not entirely representative of the 
emergent design which was not fully formed at an early stage. The 
debate between which design method to employ in any study, either 
quantitative or qualitative, can be argued and many feel that 
polarization is no longer a particularly useful basis for rationalizing a 
specific approach. Alvesson and Skoldberg (2005) assert that it is not 
methods but ontology and epistemology which are the determinants of 
good social science. They identify that these aspects are often handled 
better in qualitative research and recognize the common view that the 
choice between qualitative and quantitative paradigms cannot be made 
in abstract, but must be related to the particular research problem and 
research objective. A distinction which they discuss as more interesting 
than that between the paradigms is one that distinguishes between 
reflective research and research in which the knowledge subject can 
avoid all critical examination since it ‘has been established as 
methodological reason’ (Kittang 1977.33). This discussion influenced 
the researcher to merge two methodological approaches within the 
design of the study set within a qualitative model. These approaches 
were Phenomenology and a specific Reflexive methodology. 
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2.1. RESEARCH DESIGN AND RATIONALE FOR USING A QUALITATIVE 
APPROACH 
The underlying nature of the investigation was that the emergent 
process demanded an in­depth understanding of the lived experience of 
the service user on methadone. The goal of qualitative research is that 
theory or hypotheses are not established ‘a priori’ and imposing such 
hypotheses on the experience of service users would not have been 
consistent with the research question posed. Phenomenology can be 
identified as one style of qualitative inquiry but one which involves a 
particular conceptual and methodological foundation (Seamon 2002). It 
is a useful methodological approach when the focus of inquiry is narrow 
(experiences of methadone treatment in general practice), the 
respondents represent a clearly defined and homogenous bounded 
unit, within an already known context (urban general practice within 
Dublin) (Crabtree & Miller 1999). The heart of the phenomenological 
method indicates a way of study whereby the researcher seeks to be 
open to the phenomenon and to allow it to show itself in its fullness and 
complexity through the researcher’s own direct involvement and 
understanding. This style of study arises through first hand, grounded 
contact with the phenomenon as it is experienced by the researcher 
(Seamon 2002). The researcher has been involved in managing 
patients on a MTP for fourteen years as a practice nurse, clinical nurse 
specialist and for the past four years as an advanced nurse practitioner. 
Guided by a Husserlian phenomenological research epistemology, it 
was considered possible to emphasize and describe service users’ 
experience of treatment. The choice to use a Husserlian approach was 
based on the focus of the study which was descriptive rather than 
interpretive (Bolton 1987). Interpretive phenomenology such as 
Heideggerian studies take the process further by analyzing what the 
participants’ descriptions of their lived experience really means. 
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Descriptive studies are sometimes the only practical way of studying 
some topics in drugs research and are helpful as they are thought 
provoking and can suggest further questions that can be investigated 
using a different approach (Preston 1996). Cresswell (2003) 
recommends that a choice is required when developing a description of 
an individual or setting. To study individuals he suggests narrative or 
phenomenology as useful strategies whereas exploring processes, 
activities and events are served well by both case study and grounded 
theory and broad culture–sharing behaviour of individuals and groups 
are described best by using an ethnographic approach. Thus 
Husserlian Phenomenology was chosen to be the overarching 
qualitative method and philosophy which informed the design of this 
research project. This methodology was considered and used 
appropriately in the pilot study (3.1). When the methodology was 
reassessed after this preparatory process was carried out it was 
recognized that this qualitative method provided a fitting way to 
continue to investigate the situation. 
2.2. PHENOMENOLOGY 
Phenomenology has been described as a philosophy, an approach and 
a method that possesses a reverence for experience (Olier 1981). It is a 
research philosophy that finds its roots originally in Kant’s seminal work 
– Critique of Pure Reason (1724­1804) (cited in Cooper 1999). Kant 
proposed that any objects we can experience must conform to what we 
contribute to experience through our cognitive powers. Husserl, the 
Moravian born philosopher (1859­1938) added his view to Kant’s theory 
of knowledge and published­The idea of Phenomenology in 1907. He 
described the aim of phenomenology as providing fundamental 
descriptions, free from distortion by theoretical presuppositions and 
prejudices (Cooper 1999). The notion of ’’phenomenological reduction’’ 
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was described, which is a central tenet of this approach. The 
phenomenologist’s first task, if he is to expose and describe, is not to 
doubt, but rather simply to ‘‘bracket’’ or abstain from his or her natural 
beliefs. This bracketing is a radical approach to research as it involves 
ignoring an assumed relationship to a material world. This bracketing or 
abstention is referred to as ‘’epoche’’ (from the Greek word cessation) 
and it is the first stage of the research process in Husserlian 
phenomenology. Abstention is necessary in order to focus solely on the 
mental acts of cognition (focusing on the things themselves).This 
means that the subject of interest is approached without any 
preconceived expectations or categories and therefore the method is 
not restricted by the impositions of such structures (Omery 1983). 
Epoche or phenomenological reduction involves two stages. The first 
stage, eidetic reduction, is reduction from particular facts to general 
essences, that is, suspending what one already knows about the 
phenomenon under investigation. The second stage, the transcendental 
or phenomenological reduction, frees phenomena to come directly into 
view, rather than be viewed through the preconceptions of the 
researcher, because temporarily, the natural attitude is suspended 
(Morse 1994). 
Husserl explained that everything that is transcendent must be 
assigned to the ‘‘index of indifference’’ an index which indicates that it is 
not the researchers concern to make judgments (Cooper 1999).This 
enables the researcher to ‘’intuit’’ or see the essence of knowledge or 
the phenomenon under investigation. When the looking and noticing 
and looking again are complete a more definitely reflective process 
occurs, aiming at grasping the full nature of the phenomenon. 
The final step in the phenomenological research process is the intuitive 
integration of the textural and structural descriptions into a unified 
whole. This is the synthesis of the process that presents the meaning of 
the phenomenon under study. Moustakas (1994:101) concludes that 
49

through epoche, phenomenological reduction, imaginative variation and 
synthesis, one learns to ‘see naively and freshly again, to value 
conscious experience, to respect the evidence of one’s sense and to 
move towards an inter­subjective knowing of things, people and 
everyday experience’. The focus of the study was to understand the 
phenomenon from the perspective of the study’s’ participants. In other 
words, the phenomenologist pays attention to specific instances of the 
phenomenon with the hope that these instances, in time, will point 
toward more general qualities and characteristics that accurately 
describe the essential nature of the phenomenon as it has presence 
and meaning in the concrete lives and experiences of human beings 
(Seamon 2002). 
2.2.1. METHODOLOGICAL CHALLENGES OF PHENOMENOLOGY 
Husserls’ pursuit of the idealist philosophy prompted him to advocate 
‘ideal bracketing’. This is based on the researcher’s epistemological 
position and theoretical framework of descriptive phenomenology and is 
a philosophical model which was used as a standard point from which 
to contrast and develop ideas (Gearing 2004). 
It was acknowledged from the outset of this study that any ambition on 
the part of the researcher to claim authority in determining ‘‘how things 
are’’ or ‘’how best to interpret a phenomenon’’ would be problematic as 
the researcher is involved in the clinical setting of methadone 
maintenance as a practitioner and is influenced by professionalism in 
that specific area. One description of a professional has been 
expressed as an individual who exhibits a high degree of independent 
judgment, based on a collective, learned body of ideas, perspectives, 
information, norms and habits and who engages in professional 
knowing (Baskett & Marsick 1992). If this is an accepted definition the 
question of how professionals can listen to, and learn from their clients 
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is problematic unless they step outside these learned behaviours. The 
research setting resembled the clinical setting where power and 
influence may have been associated with the procurement of a 
methadone prescription. There was a potential for inherent bias that 
could arise from the researcher’s personal practice knowledge and 
professional background. Acquired consulting skills associated with 
managing patients receiving methadone may have influenced the 
researcher to make assumptions about interpretation ahead of data 
analysis and so influence its construction. It was necessary to confront 
these concerns at the outset and to widen the focus of methodological 
thinking in research paradigms in order to cope with the complexity of 
these issues. 
Reflection and reflexivity in the guise of ‘‘bracketing’‘ was an essential 
part of the method of inquiry but the process of bracketing appeared ill 
defined and a specific methodological technique of how the reader 
could assess the degree of researcher influence presented a challenge 
to validity. Gearing (2004) suggests that ‘the growing disconnection of 
the practice of bracketing in research from its origins in phenomenology 
has resulted in its frequent reduction to a formless technique, value 
stance, or black­box term’. Existential bracketing adopts only the first 
component of bracketing, that is, the setting aside of suppositions 
(Moustakas, 1994). This can present methodological challenges for the 
researcher as there is no one shared form of bracketing which has an 
accepted understanding nor can researchers assume that others 
universally share their conceptualization or operationalisation of 
bracketing (Gearing 2004). A specific explicit methodology was 
therefore required to reduce ambiguity and imprecision. 
To address these limitations and to produce a study within which data 
were collected and analyzed ‘in ways that did not prejudice their subject 
matter’ (Ahern 1999) a creative layering of reflexive methodology was 
utilized in the form of bracketing interviews. This was a means of both 
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widening the perspective in the work and making reflection an integral 
part of the study. Thus the two distinctive approaches of Husserlian 
descriptive phenomenology and reflexive methodology were combined 
and blended throughout the study. This reflexive ambition 
acknowledged that the researcher was left ‘‘open’’ to interpretation and 
criticism which represented a novel version of reflexivity for the purpose 
of the study. 
2.3. REFLEXIVE METHODOLOGY 
Reflexivity is an approach which is based on the assumptions­and 
implies­that no element is totalized; that is, they are all taken with a 
degree of seriousness, but there is no suggestion that any one of them 
is the bearer of the ‘right’ or ‘most important insight’ (Alvesson & 
Skoldberg 2005:249). Methodological concepts such as bracketing 
have evolved beyond phenomenological philosophy and although 
reflexive bracketing has its origins in phenomenology it is also 
recognized in other qualitative research. Simply acknowledging that 
bracketing was used without describing the bracketing process 
employed in the research can critically undermine the scientific value of 
an investigation and subsequent findings (Gearing 2004). Sensitive 
research such as exploration of drug misusers’ experiences presents 
methodological, ethical, and emotional challenges. 
Rolls & Relf (2006) interviewed bereaved children and their families and 
identified ‘bracketing interviews’ as a method of managing both the 
researcher’s methodological tension between subjectivity and 
objectivity, and the problems that can arise when undertaking 
emotionally and ethically challenging research. Reflexive bracketing 
makes transparent the researcher’s personal values, background, and 
cultural suppositions by exposing them to the reader who interprets. In 
this way a more open­minded creative interaction between theoretical 
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frameworks was demonstrated. Both of these approaches were 
dependant on the experiences of both the researcher and the 
researched. 
Reflexive interpretation is described as the opposite to empiricism and 
theoreticism (the use of a single abstract framework offering a 
privileged understanding) and what also has been described as 
‘‘reflective reductionism’’. The idea is to ‘’allow room’’ for elements other 
than the problematisation of text authority relations and to avoid the 
latter dominating (Alvesson & Skoldberg 2005:249).The technique of 
the bracketing interviews fulfilled this important aspect of reflexivity as 
these interviews were observed at regular intervals throughout the main 
study. In reflexive work it is important to divide a research project into 
different phases with respect to the reflective elements and sequence 
interpretations (Alvesson & Skoldberg 2005). Including definitive phases 
during which the researcher interpreted her empirical work in reflective 
terms it was possible to generate more interesting interpretations into 
the results. 
The contribution of bracketing interviews was considered not only as a 
means of ‘‘laying bare’’ assumptions of the researcher but the 
methodology was expanded to include the voice of the researcher and 
bracketing interviewer alongside the voice of the participants. 
Polyvocality and reflexivity are useful strategies employed in qualitative 
inquiry and show evidence of the emergence of the design, the shifting 
nature of the methodology, continuous review of the literature and 
progressive subjectivity of the researcher (Denzin & Lincoln 2000). 
It is recognized however throughout the study that there is no naïve 
assumption that the totality of any experience can be captured. The 
reality is that no matter how extensive the recollection and recording of 
data related to that experience has been the process has been 
selective (Piantanida & Garman 2009). 
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2.4. ETHICAL CONSIDERATIONS 
The evaluation of potential risks inherent in any research is required 
before the study begins. Ethical approval was obtained from both the 
ICGP Research Ethics Committee and also the School for Health 
University of Bath, Research Ethics Panel. Informed consent, 
willingness to participate in the study and assurance that the 
participants could withdraw from the study was a prerequisite of the 
inquiry (Appendix 3). The best judges of whether an investigation will 
cause harm or cause offence may be the members of the population 
from which the participants in the research are drawn (British 
Psychological Association 1985). It was acknowledged that the 
research relationship with vulnerable groups is inherently an unequal 
one and the use of key informants at the pilot stage was utilised partly 
as a method of participatory action. 
Research participation and findings can be influenced by a therapeutic 
relationship with the respondent. Acknowledging this the researcher 
was precluded from interviewing her own clients at the Liberties Primary 
Care Centre. An assistant researcher skilled in qualitative interviewing 
was employed for this purpose. This researcher was employed as a 
post­doctoral fellow in the Department of Anthropology in the National 
University of Ireland Maynooth. She was skilled in the use of various 
research methodologies and worked in conjunction with the principle 
researcher. Her technique at interview was to get a general picture in 
which the specific topic of interest could be situated and then further 
explored. It was explained to the participants that the assistant 
researcher was not an independent interviewer but that the 
responsibility for the outcome of the research lay with the principal 
investigator. Other particular ethical issues which had to be considered 
were those which addressed the potential of coercion for participants, 
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both those in the researcher’s own practice and those in the GP 
practices which were involved in the study. Drug misusers are not listed 
in the category of ‘especially vulnerable’ populations (Gorelick, Pickens, 
& Bonkovsky, 1998) but drug misusers do provide unique challenges. 
Co­morbid conditions that could affect their ability to comprehend the 
requirements of the research, including co­morbid psychopathology, 
cognitive impairment secondary to substance use, or limited 
educational attainment are all possible difficulties. Many drug misusers 
have legal involvement and charges ‘‘pending’’ therefore freedom to 
make a choice to participate in the research may have been limited by 
these circumstances. The collection of personal sensitive information 
regarding illicit drug misuse presents issues in relation to consent, 
privacy and the balance of risks and harms (Fry & Hall 2005).The notion 
of calling the participant a ‘‘key informant’’ for example concerned one 
interviewee in particular as he felt this identified him as a ‘‘rat’’ or police 
informant. Ning (2005:356) also noted that she was cautioned to avoid 
this standard anthropological term in her ethnographic study of a 
methadone clinic in Toronto as it may have been seen as betraying ‘the 
secret code of solidarity between drug misusers’. 
It was also important to acknowledge that freedom to make a choice to 
participate in the research may have been limited by the service users’ 
understanding of the research intent and they may have found the 
prospect of a study reflecting their views as potentially intimidating. 
Research which was carried out at the clinical site where methadone 
was prescribed had the potential for influencing the participants 
negatively. Their responses may have been influenced by the fact that 
their GP had asked them to participate and they may have wished to 
comply with his /her wishes as they may have considered that refusal 
could have jeopardized their treatment. Equally this may have been a 
deterrent for some to become involved. It was acknowledged that the 
very fact that participants would be talking about their own experiences 
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and raising awareness of the role methadone has in their lives could 
potentially upset patients and/or change the way they view or manage 
their situation. Re–reading the transcripts of their stories shown to them 
for the purpose of validity, the participants would be required to refocus 
on their interpretations of their experiences which heretofore may not 
have occurred to them. While this ensured that participants had the 
opportunity to voice their responses to the study, it was documented in 
the patient participation leaflet that difficult issues pertaining to any 
aspect of the study could be followed up by telephone with the principle 
researcher (Appendix 4). 
There was also acknowledgement of procedures to deal with situations 
when confidentiality may have potentially needed to be broken, for 
example if the participant revealed evidence of suicidal ideation or child 
misuse or neglect. Participants were informed of this policy prior to 
interview and it was stated that the researcher would be obliged to 
inform their GP if any of these issues arose. Access to care was 
inherently provided as participants were in receipt of ongoing 
continuous interaction with their GP. If during the course of interviewing 
it was identified that the participant was in need of further support or 
care which was beyond the scope of the researcher’s brief there was 
assurance that the participant could be referred back to the care of their 
GP. This was necessary in one instance when the participant disclosed 
previously undisclosed issues of rape to the interviewer. The participant 
was encouraged during the course of the interview to discuss these 
issues with the GP. This was carried out and it was acknowledged 
during the course of the interview that the consent form had 
documented this possibility. Participants were informed of all 
procedures that ensured confidentiality. As a member of the practice 
team identified potential participants, it was acknowledged that the 
practice team then remained uninformed of the interview material and 
had no access to interview transcripts. Audio tapes were kept in a 
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secure place, accessed only by the researcher and the transcriber who 
was bound by a signed confidentiality agreement. This was the same 
transcriber who had transcribed the previous study (The perceptions 
and experiences of practice nurses in relation to patients on a MTP), is 
employed in health services transcription and was knowledgeable in 
understanding local slang terms. Tapes and transcripts of the interviews 
will be destroyed after a period of five years. Access to research data 
was limited to the lead researcher, transcriber, supervisory team and 
technical support only. 
Ethically research should be designed, reviewed and undertaken to 
ensure integrity and quality. As research should also be conducted in 
order to ensure the professional integrity of its design (REF 2005) a 
pilot study was carried out to confirm feasability. 
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CHAPTER 3: METHODS

3. INTRODUCTION 
This chapter outlines and critiques the methods used to conduct the 
work which was divided into stages, Phase 1 and Phase 2. The specific 
objective of Phase 1 was to conduct a pilot study to train the researcher 
in as many elements of the research process as possible and at the 
same time identify any potential problems with the design of the main 
proposed study. The rationale was to draw attention to specific practical 
problems in following the research procedure so that early 
shortcomings in the process could be identified, thus endeavouring to 
ensure feasibility in the main study. Valuable lessons were learned 
which informed and benefited the work. 
3.1. PHASE 1­THE EFFECT OF THE PILOT PHASE ON THE EVOLVING DESIGN 
The pilot phase of the study (Phase 1) was conducted between 
November 2007 and April 2008 as part of the Doctorate in Health 
programme­Unit 7. It provided structure and direction to the project and 
addressed the multiple levels of reflection required before the main 
study began. It served several other pragmatic functions not least to 
raise the researcher’s awareness of the various interpretive levels that 
would be required throughout the study. Methodological, conceptual 
and pragmatic lessons were learned from a preliminary investigation of 
three service users receiving methadone in two general practice sites. 
Both the researcher’s practice and another practice were used 
exclusively for the pilot phase. During the pilot phase, these three 
service users who could articulate and engage with the process of 
interviewing were interviewed. The researchers (both principal and 
assistant researcher) had prior knowledge of these participants. These 
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were considered to be key informants as these relationships had been 
cultivated over time by both researchers. Previous involvement with 
service users’ groups was considered to be advantageous as these 
participants would have had knowledge of the local community and 
would have been aware of how the MTP had historically and culturally 
impacted on service users. Two were actively involved in service users’ 
groups and education within their respective communities. This 
‘‘cultivation of relationship’’ was a crucial consideration for the main 
study. This method served as a way of informing the researcher about 
the community, prior to embarking on the main study. This proved to be 
effective as the principal researcher was assisted in comprehending 
various aspects of the environment which were previously hidden from 
her lens as a practitioner. The methodological approach of 
phenomenology was tested and was proved apposite for the study. 
Three main outcomes from the process of piloting were identification of 
a sampling methodology, preparation of the site and preparation of a 
topic guide. 
3.1.1. LESSONS LEARNED: SAMPLING FRAME 
Factors known as ‘sensitizing concepts’, (Patton 1991:391) such as 
length of time a patient is in treatment, were initially considered to be 
important to include in the sampling frame. It was considered that 
identifying participants who were receiving treatment for longer than 
one year would more adequately reflect continuity of care in general 
practice. One of the informants however did not fulfil the initial criteria 
and in the light of the wealth of data that was elicited from this 
interviewee, it was decided to review the inclusion criteria for the main 
study. The decision was taken to include all service users registered 
with their GP for MMT without defining a rigid time frame of treatment. 
Wilmot (2005) warns that in sampling strategies the full range of 
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dimensions and information needed to inform the sample selection 
should be covered. The effect of under­coverage could have 
misrepresented the results. This information concerning the clear 
definition of the sampling frame informed and proved valuable for the 
main study. The logic and power of purposeful sampling in selecting 
information rich cases are identified in Patton’s typology (1990) and this 
sampling strategy was consistent with the methodological approach of 
phenomenology. Thus the sampling methodology was purposive within 
a maximum variation sampling strategy. 
An alternative approach to sampling, such as snowball sampling was 
considered. Snowball sampling implies that the researcher makes 
contact with a small group and then uses this group to establish contact 
with others (Bryman 2004). Snowball sampling is often used in drug 
services’ research, however due to the nature of this inquiry it was 
important to provide a discrete and confidential environment where 
other drug misusers could not influence the interview, as individual 
views rather than cohort views were sought. If snowball sampling had 
been utilised, maximal variation strategies would have been 
compromised. If snowball strategies had been considered appropriate, 
the use of incentive payments to encourage recruitment would have 
been considered. This may have biased a response rate which included 
those not naturally predisposed to volunteering and service users may 
have had to be rejected on the basis of not being able to articulate their 
experiences. This may well have caused bias. Given the aims and 
objectives of investigating care in general practice, the sampling 
strategy provided confirmation that those interviewed were indeed 
currently in receipt of methadone treatment from a general practitioner 
rather than a treatment centre and had been selected on the basis of 
being comfortable articulating their story. 
In some respects the service users may have felt privileged to have 
been chosen as participants. Conversely, it has to be acknowledged 
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that this sampling methodology excluded service users who have 
difficulty in communicating and were not identified by GPs as being 
confident in an interview situation. 
Situating the study in the general practice surgery had the benefit of 
grounding the inquiry within the domains of consulting times as it was 
important not to interfere with the working day of practitioners. Situating 
interviews outside the practice may have been dependant on snowball 
sampling techniques which would not have had the same potential for 
safeguarding the location for the researcher. The participants were also 
safeguarded by this approach as ethical issues were disclosed (such as 
rape, 2.4) and required GP intervention. 
3.1.2. PREPARATION OF SITE 
Another lesson learned was to prepare and adequately familiarise the 
GPs with the inclusion and exclusion criteria prior to the selection of 
potential participants. It was obvious during the pilot phase that the 
criteria appeared vague and there was insufficient explanation and 
communication with the GPs prior to interviewing. Obtaining the 
voluntary participation of GPs in quality of care research is a major 
problem with research within general practice, as providing medical 
care to sick patients may not dovetail straightforwardly with acting as 
research gatekeepers (Borgiel et al 1989). GPs may receive 
comprehensive specifications, but time and workload pressures may 
make it difficult for all but the most enthusiastic staff to get involved in 
research (Shakespeare 2006). With this in mind a simple letter outlining 
the process and a step by step guide was devised to achieve clarity and 
enable a more streamlined approach to recruiting. This was piloted with 
three GPs who gave guidance on the framing of the guide. All agreed 
that the recruitment process appeared straightforward and this guide 
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was used for the main study, preventing any further uncertainty 
(Appendix 5). 
3.1.3. PREPARATION OF TOPIC GUIDE 
Developing and testing the adequacy of the topic guide was a vital 
feature of the pilot project. An interview topic guide was used to ensure 
that a number of pertinent issues were addressed. The preparation of 
the topic guide was important to make sure that relevant topics were 
covered. It is understood that no interview is completely devoid of 
structure as, if the corollary were the case, there would be no guarantee 
that the data gathered would be appropriate to the research question 
(Mays & Pope 1997).This being the case the interviewers were free to 
explore, probe and ask questions deemed interesting to the 
participants. The topic guide was piloted and reshaped and refined 
following each interview until an understandable dialogue was facilitated 
for Phase 2 of the work. Both interviewers gained insights from the 
previous interview which were used to improve interview schedules and 
specific questions (van Teijlingen & Hundley 2001).Certain aspects of 
the questioning such as What is it like to be a methadone patient in 
general practice? were changed to; What is it like to be receiving 
methadone in general practice? (Appendix 6). The former line of 
questioning could have been perceived as labelling and insensitive to 
the participants and as a core question could have potentially been 
misunderstood. It was important for the interviewer to remain open in 
the presence of new and unexpected descriptions of the participants’ 
experience so therefore there was no rigid adherence to a specific line 
of questioning. The phenomenological interviewer does not shape the 
questions as tests of ready made categories or schemes of 
interpretation but is required to keep the focus on non­theoretical 
descriptions of the experience (Polkinghorne 1989:49). 
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3.2. PHASE 2 
As a result of reflecting on the process of the pilot study the following 
criteria for selecting participants was utilised for phase 2. 
INCLUSION CRITERIA 
a) Those willing to participate and provide informed consent i.e. no 
coercion or incentives were offered. 
b) Those who attended a doctor qualified to treat at Level I i.e. stable 
patients and those who attend a doctor qualified at Level 2 i.e. less 
stable patients. 
EXCLUSION CRITERIA 
a) Those who refused to be involved 
b) Severe psychiatric co­morbidity as assessed by their own GP. 
Colazzi (1978:58) states that experience with the investigated topic and 
articulateness suffice as criteria for selecting subjects. 
c) Over 20 years of age, as MMT is not encouraged as first line 
treatment for adolescents and in general they are not in treatment in 
general practice (ICGP 2008). 
3.2.1. RECRUITMENT SPECIFICATION­PHASE 2 
Recruiting to primary care studies is complex and the difficulty of 
recruitment in primary care is under emphasised in the literature (Dyas 
et al 2009). The step by step guide (3.1.2) was utilised for recruitment in 
Phase 2 which was conducted between August 2008 and January 
2009. This recruitment specification detailed both the recruitment 
strategy for GPs and a letter explained the purpose of the research and 
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how the research was to be conducted and for whom (Appendix 5). An 
initial letter was sent to GPs six months prior to the start of the study 
and subsequently followed up by a combination of email and telephone 
contact to ensure agreement with the recruitment methods and consent 
to the project. The rationale for site selection is given in 3.2.2. 
As the actual sampling and recruitment took place in the field, the 
potential respondents who fulfilled the sample criteria and the overall 
sampling strategy were dependant on the invitation issued by the GP. 
This meant that recruitment was subject to the ‘gatekeeper syndrome’ 
(Wilmot 2005). The GP gatekeepers were the people who had the 
power and the influence to keep the research project from being 
investigated. The insight of the GP was paramount to effective 
recruitment as he or she were the only ones who could attest to the 
suitability of the participants’ abilities to engage with the process. Each 
GP was asked to identify service users whom they considered had 
sufficient experience of the topic of the research i.e. methadone 
treatment. The second requirement was that a service user should have 
the capacity to provide ‘full and sensitive descriptions of the experience 
under examination’ (Polkinghorne 1989:47). This method of participant 
recruitment was effective but not without difficulties (3.2.3). Gate­
keeping as part of a research project is a complex process. In order to 
facilitate gate­keepers the researcher needs strong interpersonal skills, 
a sound understanding of ethical principles and knowledge of who can 
be approached for advice and when to do so (Lee 2005). Other gate 
keepers approached were at an organizational level such as the 
research committee of the ICGP who supported the study with a 
research grant and suggested the support of the national GP drug co­
ordinator at a professional level. The use of the GP as gate keeper to 
target these service users was a deliberate decision to ensure that 
vulnerable patients were protected and a method of ensuring that the 
participants would be able to provide rich material. Rich responses to 
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the research question were produced and enabled an in­depth 
descriptive account to be generated. Using the GP prescriber as gate 
keeper undoubtedly may have influenced the accounts of service users 
however the fact that negative experiences with these GPs were elicited 
during the in­depth interview, without probing, suggests that this 
approach was useful. A voucher for 20 euro for a local department store 
was given after the interview had occurred. Neither the GPs nor the 
participants were informed of the voucher prior to interview as this 
knowledge may have also have been used as an incentive to recruit 
clients on the part of the GP, if this were known. If offered, it would be 
doubtful if the rich experiences shared by those who genuinely wished 
to contribute would have been tapped into or if confidentiality could 
have been maintained within this chosen cohort. Each participant 
volunteered to participate when approached, without this knowledge, 
some suggesting that being involved provided a way of ‘’giving 
something back’’ to the GP for the care which they had received in 
treatment.Thus those who responded to invitation by their GP 
expressed that they genuinely wished to tell their story and give voice to 
their experiences. 
Recruitment had to be monitored regularly with potential barriers such 
as these and other pragmatic problems encountered such as 
participants’ lack of mobile phone credit. These issues were addressed 
iteratively as the study progressed (Dyas et al 2009). As 
phenomenological research interacts in a personal manner with those 
asked to provide examples of their experience, the researcher, 
assistant researcher and participants were all research instruments 
utilised for obtaining these descriptions (Polkinghorne 1989:47). 
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3.2.2. GAINING ACCESS TO RESEARCH SITES 
The same general practice sites where access had previously been 
granted in 2003, in addition to the independent pilot site, were utilized, 
building on the researcher’s previous study exploring The Perceptions 
and Experiences of Practice Nurses in Relation to Patients on a 
Methadone Treatment Protocol (Latham 2003). A particular strength of 
the study was that these sites were identified early in the study by 
means of personal contact and gaining access was planned months 
before the research took place. GPs were known to the researcher due 
to the previous study carried out in their surgeries and this proved to be 
a very valuable inroad for both the preparatory work and the main 
study. 
Willingness to participate was ascertained by the GP prior to 
engagement in the research study. Participants were approached with 
the use of a participant information leaflet (Appendix 4) which had been 
left with the GP. This leaflet was read with the participant to explain how 
interviews were to be carried out and information about the aims of the 
study provided. Assurance was given that at any stage of the research 
process the participant was at liberty to withdraw from the study. The 
prospective participant was afforded time between understanding and 
reading consent and before signing and engaging in the study. Although 
the participant leaflet had been left with the GP prior to the researcher 
gaining consent, the leaflets were re­read with the participant prior to 
the interview again. Consent was obtained by the researcher. Informant 
wishes and constraints were taken into account and the standard 
patient consent form for participation in non­clinical trials, developed by 
the Research Ethics Committee of the ICGP, was used in the study 
(Appendix 3). 
It was acknowledged that the setting of an interview affects the content 
and it is unknown to what extent the site influenced the full exploration 
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of service users’ experiences. However the wealth of data which were 
provided to the researcher by the participants did explore and illuminate 
both negative and positive experiences with treatment provision. There 
is no doubt that locating the interviews in general practice may have 
inhibited honesty and may have impacted upon the service users’ 
account regarding their experiences of treatment as service users may 
have felt that their treatment could have been adversely affected by not 
consenting to the research. On the other hand several of the service 
users who did give consent to the GP did not respond to repeated 
phone calls from the researcher to be interviewed which may suggest 
that they agreed with the GP at the time of consultation but 
reconsidered once they reflected on the implications of involvement. 
3.2.3. OUTCOMES OF SAMPLING 
Minimal exclusion criteria and maximum variation sampling favoured an 
inclusive selection process that provided the possibility of a large 
sample and it did not seem difficult for the GPs to provide several 
candidates. Not everyone approached to take part was agreeable, 
particularly as the length of the interview which was indicated in the 
participant information leaflet proposed an hour. Although this is 
speculative, the refusals were possibly not related to the research topic 
but rather the length of time required for the interview as two service 
users defaulted at the interview time citing difficulties with managing the 
length of time required. Deficiencies in the sample were avoided 
however as there was a sufficient pool of participants in each practice to 
provide coverage. The refusals may, in part, be as a result of 
misunderstanding of the recruitment strategy on the part of the GPs. 
Some endeavoured to recruit those who were rushing to the chemist to 
get their prescription of methadone and were possibly beginning to 
withdraw when approached. The influence of methadone as a drug on 
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the interview process is a variable which may have impacted on the 
articulation of the experience as illustrated by the words of one of the 
interviewees cause you know it suppresses your feelings and that like. 
Three accepted the invitation to be interviewed but did not turn up or left 
the surgery once their methadone prescription had been picked up, 
despite assurances to the GP and researcher that they would attend. 
One of these was a client in the researcher’s own practice who despite 
reminders and assurances did not arrive to be interviewed by the 
assistant researcher. Nevertheless those that were recruited (n=25) 
proved attentive to the research aims and provided rich descriptions of 
their experiences which informed the study. 
The sample comprised 25 people, 14 females and 11 male service 
users from Dublin, all white and of Caucasian race. Age range was from 
23­43 years. Nineteen of the participants were parents and the majority 
had 2 children. Eighteen had achieved either the Irish academic 
qualifications of Junior or Group certification and 6 had completed their 
Leaving certificate. Five females and 5 males knew they had HCV with 
one of the sample unaware as they had chosen not to be tested. 
Current methadone dose ranged from 20­150 mgs/per day. Those 
patients in treatment longer were receiving higher doses. Years in 
treatment ranged from 1­12 years with the majority in treatment longer 
than 5 years. The 9 practice sites visited for the purpose of the study 
were well equipped surgeries with secretarial support, IT facilities and 
all had the services of at least one if not two practice nurses. There 
were 13 practice nurses, 42 GPs and 487 methadone patients 
registered with these 9 practices. The combined patient lists were 
approximated at 270,000 patients (Appendix 6 Figure 5). 
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3.2.4. DESCRIPTION OF SITES 
The site for each interview was context bound within urban general 
practice surgeries in Dublin city. The researcher utilized a consulting 
room in each designated surgery which was provided at no cost by the 
GPs. Situating the interviews in these settings served several pragmatic 
functions: 
a) It provided a venue to conduct the interviews in an area which was 
free from distractions and quiet. 
b) It was a well known and locally accessible site which was routinely 
accessed by the interviewees. 
c) It was considered a safe place for interviewing and identifying the 
clients as the interviewer had no known reference point prior to the 
interview. 
3.3. DATA COLLECTION 
The method of phenomenology involves drawing on three sources to 
generate descriptions of experiences: 
a) The researcher’s personal self reflections on the incidents of the 
topic that they have experienced. These were extracted from the 
bracketing interviews and field notes. 
b) The participants in the study who describe the experience under 
investigation in response to the interview. These were drawn from in­
depth interview transcripts, text messages and telephone 
conversations. 
c) Depictions of the experience from outside the context itself–i.e. 
previous investigations (Polkinghorne 1989).These were extracted from 
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the masters’ study The perceptions and experiences of practice nurses 
in relation to patients on a MTP (Latham 2003) and current experience 
presented by one of the participants who reflected on the aims of the 
study and presented his feelings and experiences in poems. 
These three main data sources were utilized when gathering data. 
Other data were collected such as descriptive statistics, memos and 
charts which were created by the researcher (Appendix 7). 
3.4. THE RESEARCHER’S SELF REFLECTIONS 
During the process of data collection it was acknowledged that 
reflection did not conform to any linear process as the researcher 
became more immersed in the data and creative thought developed 
(Appendix 7). The use of self reflection was utilized as a way of 
approaching the topic afresh without prejudicing the study. Awareness 
of presuppositions and biases provided some protection against the 
imposition of the researcher’s expectations on the study however this 
approach was further strengthened by the ongoing reflection which was 
documented during the bracketing interviews. Five bracketing 
interviews were carried out. These interviews lasted between thirty 
minutes to one hour (3.5.1). 
3.4.1. THE PHENOMENOLOGICAL INTERVIEW 
The second source of data was from the participants themselves. The 
phenomenological method is described as ‘a process of learning and 
constructing the meaning of the human experience through intensive 
dialogue with persons who are living the experience’ (Liehr & Marcus 
2002:144). This dialogue was facilitated by in­depth interviews which 
were used to explore the evaluation of the ‘‘lived in and through’’ 
experience of receiving methadone treatment in general practice. Data 
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gathered and generated from the original sources of those who had and 
were experiencing methadone treatment in general practice were the 
central focus of the information. 
Phenomenological researchers need reports of the experience under 
investigation ‘as it actually appears in a person’s consciousness’ 
(Polkinghorne1989:46). Characteristically, interviews were open­ended 
requiring enough time to explore the topic in­depth. Interviews lasted 
anything from 45 minutes to an hour and a half. This format allowed the 
researcher to follow the informant’s lead asking for explanations and 
examples of their accounts which were meaningful and culturally salient 
to the participant and rich and explanatory in nature. The topic guide 
revised as a result of the pilot was used to ensure that a number of 
pertinent issues were addressed (Appendix 6). This type of interview 
approach was useful for eliciting information about specific topics. As 
qualitative data collection and analysis is often progressive, the 
subsequent interviews proved more informative as this process of 
gaining insight from the previous interviews was used to improve the 
topic guide further. Data were collected by the use of two audio tape 
recorders. This permitted both transcription by the transcriber and 
simultaneous listening by the researcher. Continuous refinement was 
beneficial to gaining understanding of the phenomenon (van Teijlingen 
& Hundley 2001). The descriptions proffered required the researcher to 
tease out the details and context that constituted the experience and it 
was often in the latter stage of the interview that descriptions became 
clearer and richer. The in­depth interview technique proved an 
appropriate method of facilitating this process. 
In a consultation, the differences are overt between doctor and patient 
as the consultation is usually patient initiated and problem orientated 
unlike the research interview which is researcher initiated (Hoddinott & 
Pill 1997). Minimizing social differences such as status, educational 
level, expertise and appearance can be difficult as found in other 
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studies in general practice (Hoddinott & Pill 1997). The researcher 
attempted to minimize these differences by dressing in casual clothes. 
Although a familiar environment was used where there was a definitive 
power imbalance between prescriber and service user, this was 
somewhat addressed by the researcher sitting in the patient’s chair and 
the service user sitting in the doctor’s chair. Given the complexity of the 
issues of engaging a hard to reach population every effort was made to 
redress this imbalance by ensuring a relaxed interviewing style and 
treating service users as experts in their own care. This in some way 
served to shift the power balance from one of service user to expert 
reporter. 
The aim of phenomenological enquiry is to ‘reveal and unravel the 
structures, logic and inter relationships’ that are obtained in the 
phenomenon under inspection (Polkinghorne 1998:50).This is a lengthy 
process which required that an accurate essential description be 
gleaned from a myriad of lengthy dialogue and reflected a coherent 
understanding of the experience of methadone maintenance in general 
practice. 
3.4.2. PREVIOUS INVESTIGATIONS 
The third source was the use of data from the previous explorative 
study which originally focused on the perceptions and experiences of 
practice nurses in relation to methadone treatment. Experiences which 
practice nurses expressed from their own perceptions of how they 
managed patients on a treatment protocol informed this study. Issues 
directly related to the current study were extrapolated from the text of 
the previous explorative study (Latham 2003) in order to illuminate 
further the experiences reflected in the current study and build on the 
knowledge gained from the previous investigation. 
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3.5. ROLE OF THE BRACKETER 
In phenomenological psychological research, self reflection is typically 
used as a preparatory step to gathering data. It is acknowledged that 
the researcher has been influenced by diverse approaches to the 
treatment of drug addiction (Appendix 8 Reflection). A reflexive approach is 
one in which reflection on the research and the influence of the 
researcher is emphasized throughout the study. This process 
acknowledged the context and subjectivity of the researcher and how 
this affected both the data gathering process and the analysis of that 
data (Hale at al 2007). Although these influencing factors were 
identified and were subsequently ‘’bracketed’’, value judgements made 
during the process were noted and explicated as the project 
progressed. Rolls and Relf (2006) state that bracketing interviews 
require an experienced bracketer who understands the nature of a 
supervisory relationship with the researcher that differs from both 
academic and personal supervision, and who also has an 
understanding of the demands of research. With this in mind the 
expertise of the chartered counselling psychologist attached to the 
researcher’s GP practice was drawn upon to fulfil the function of 
facilitating this approach. 
Her considerable experience working with addicted clients and her own 
academic experience as tutor, practitioner and supervisor was essential 
to this role. 
3.5.1. FIRST BRACKETING INTERVIEW 
Bracketing initially presented a particular challenge in the pilot study to 
the researcher as a tension existed between the dialectic process of 
investigating the nature of the participants’ experience and at the same 
time holding onto the clinical experience of being a practitioner (Rolls & 
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Relf 2006). It was important to consider that the interaction with the data 
that occurred for the practitioner/researcher could have influenced how 
that data was constructed. Crotty (1998) asserts that assumptions can 
shape the meaning of research questions, the purposiveness of 
research methodologies and the interpretability of research findings. 
The first bracketing interview began the process of laying bare the 
researcher’s position as a practitioner while consistently admitting the 
ambiguity of the position of researcher/practitioner role. Excerpts from 
the bracketing interview were subsequently interspersed with the data. 
The voices of the psychologist and that of the principle researcher were 
used as a method of contributing to the multiple perspectives and 
voices which were part of the reflective process. The convention of 
intertwining quotations with the researcher’s interpretations and 
describing the narrative outcome in relation to the general literature on 
methadone treatment is a strategy identified by Cresswell (2003).The 
methodological approach of presenting the data in this way meant that 
each interpretation was approached ‘afresh’ without preconceived 
notions about what might be uncovered during the investigation 
(Polkinghorne 1989). 
Bracketing Interview 1

Psychologist (P) How do you get yourself into those clients’ shoes?

Researcher (R) It’s very difficult if you’ve never experienced it, you can not

understand …if you’ve never taken heroin, if you’ve never taken methadone.

This excerpt describes the initial conflict the researcher had in 
‘’suspending the natural attitude’’ and understanding the phenomenon 
of the substance of methadone as treatment. Methodologically, this was 
also a challenge as the phenomenologist’s first task is simply to 
‘bracket’ or abstain from his or her natural beliefs (‘epoche’) (Omery 
1983).This initial interview set out the importance of bracketing the 
researchers’ experiences and the potential for impact on data collection. 
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It was identified early in the study that there was ‘no one way street 
between the researcher and the object of study; rather, the two affected 
each other mutually and continually in the course of the research 
process’ (Alvesson & Skoldberg 2005:29). 
3.5.2. SECOND BRACKETING INTERVIEW 
The second interview took place when a third of the data had been 
collected. This interview helped access the unconscious assumptions 
and values that may have impacted on the conduct of the research 
(Rolls & Relf 2006). Identifying that boundaries were being maintained 
between the researcher/practitioner roles, it was apparent that the 
researcher was more content and confident moving into the role of 
researcher and setting aside the natural instinct of clinician. The 
following excerpt describes the researcher’s response to being 
approached by a receptionist to test the urine of a research participant 
and how this was managed. 
Bracketing Interview 2 
P. And obviously you’ve got to put that to one side and be impartial in the research 
don’t you? 
R Absolutely, the receptionist asked me would I like to test the girls urine, and the girl 
herself said to me­ ‘’I thought you were testing the urine cause I heard you were a 
nurse?’’ and I said, ‘’well, I’m not a nurse today, I’m a researcher and I have no right to 
test your urine…. and I certainly am not getting involved in this aspect of your care’’. 
P So you are keeping those boundaries? 
R Yep, I kept those boundaries very quickly and there wasn’t a problem there… 
went in as a researcher I didn’t go in as a nurse… I went in (to the treatment 
environment),… and I felt it was a… more informed view of what it is to ask questions 
outside the clinical mode. 
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3.5.3. THIRD BRACKETING INTERVIEW 
The third bracketing interview was carried out when almost all of the 
data had been collated. A further three interviews were scheduled in 
two surgeries and it was necessary to reflect on the personal responses 
within the context of the data obtained and how to interpret that data as 
professional background is an important influence on data interpretation 
(Barbour & Featherstone 2000). This interview explored how the 
researcher was feeling about listening to the service users’ experiences 
within the confines of the interview. There is no ability to control the time 
frame of the interview to a ten minute discussion as is usual within the 
confines of a consultation. Therefore more details of the nature of the 
lived experience are expressed. 
Bracketing Interview 3 
P Ok and the stuff I was looking at last month vicarious trauma any of that? 
R Yeah, I think, eh yeah, certainly some of the stories I’ve heard I have gone home 
and thought my goodness these are horrific stories! I know that when I see patients 
normally I’m used to their life story but I don’t spend an hour talking to them, I spend a 
very short length of time with them, this is time… I’m really being allowed into their 
lives and experiences… and it is painful for them and me. 
3.5.4. FOURTH BRACKETING INTERVIEW 
The third and fourth interview focused on the interface between the 
researcher as a person and the research data that was explored. It also 
addressed the responsibility of the researcher in presenting the data. 
This interview explores the determination of the researcher in exposing 
the elements of poor prescribing practices that have been recounted. 
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Bracketing Interview 4 
R well talk about danger! the issue is that you know when I report these experiences 
they’re not going to be well received in many quarters, they will be received well with 
those who are really passionate about looking after people properly. 
P and how are you going to, how are you going to legislate for that? 
R I can’t legislate for it, I can only produce what is my experience and produce what it 
is­ the client’s experience. 
3.5.5. FIFTH BRACKETING INTERVIEW 
The final interview occurred when all the data were collected and 
analyzed. This interview revealed the emotional response of the 
researcher to the work. 
Bracketing Interview 5­Final 
P …disseminating it onto paper, were you aware of anything, any process within 
yourself, from an emotional perspective that might be happening? 
R Yeah, and I wrote a reflective piece at the very end of the last practice that I was 
going to and I was crying because mm… I realised that, mm… the places where I was 
going were sad, sad places (crying) and my experience is not that. 
P So there is a whole depth of experience behind what you’re seeing that is difficult to 
go into? 
R (crying) well, I was on my own in the car and I just was driving around and it was so 
grey, and I could see hoodies, people in hoodies you know? going to different places, 
and I thought this is such a different scene to what I’m used to. I am in practice, I’m 
inside, I have a nice desk, I mm… the patient comes into me and it’s my environment. 
But me going to their environment or even just driving through it, it’s just a different 
world. 
These bracketing interviews exposed the researcher’s personal 
responses to the work in a novel way as it assisted in processing 
experience as data. 
All bracketing interviews were audio­taped and transcribed and 
embedded in the research data. The potential for bias was laid bare and 
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the ideas, views and experiences of the researcher as practitioner and 
in the role of investigator with those interviewed were exposed as part 
of this process. 
Other reflective material in the text such as personal reflective data 
written by the researcher in memos, field notes and journal entries were 
also interspersed with the data to identify further subjective responses 
to the process. This shed further light on competing and ambivalent 
positions experienced by the concurrent roles of practitioner and 
researcher. 
Final Bracketing Interview 
R I really think the bracketing process has helped because … the researcher has 
come through quite strongly by the very end of it, not the practitioner… and it’s set me 
on a different level now as a practitioner, I’m much more enquiring. 
The idea of reflection in the bracketing interviews was not only to 
reduce the naivety of the researcher in relation to the constructed 
nature of data interpretation but also the main reason was to ‘lift ‘ the 
project to generate more interesting, innovative and well judged 
interpretations and qualified results (Alvesson & Skoldberg 2005:286). 
This would not have been possible with a purely quantitative design. 
The researcher learned to see naively and freshly again, valuing the 
conscious experience, respecting the evidence of the senses. The 
addition of polyvocality enhanced the discourse throughout the text and 
enabled truth to be based on more than one form of data. Thus the 
study was allowed to move towards an inter­subjective knowing of 
things, people and everyday experience by using blended 
methodological approaches (Moustakas 1994). 
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CHAPTER 4: DATA ANALYSIS

4. INTRODUCTION 
The goal of data analysis is to reach a place of understanding of the 
experience through the development of an integrated statement about 
the experience (Laverty 2003). The search for meaning, clarity and 
discrimination began at the outset of the analysis of the in­depth 
interviews. A description of themes informed and created knowledge of 
the essence of the MTP in general practice from the perspective of the 
service user. 
4.1. ANALYSIS OF IN­DEPTH INTERVIEWS 
The rationale for using a Husserlian phenomenological approach to 
data collection is given in Chapter 2. Giorgi (1969) Van Kaam (1975) 
and Colaizzi (1978) all have developed psychological research methods 
for data analysis based on phenomenology (Polkinghorne 1989). For 
the purpose of descriptive studies the steps espoused by Colaizzi are 
advocated for data analysis. The appropriateness of this choice of 
method is supported by several descriptive studies (Corben 1999, 
Baillie 1996, Koch 1995). Data collection and analysis are intertwined in 
phenomenological research methods and the researcher listened to the 
audio tapes as soon as possible once the interview had taken place and 
read the transcript simultaneously to acquire an initial feeling and 
understanding of the whole experience. The following procedural steps 
were then carried out in a disciplined way to produce a structural 
definition of the findings. 
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1) The transcribed interviews were read more thoroughly so that the 
researcher became immersed in the data (comprehending). This served 
as a foundation for the next step. 
Computer Assistance 
Each transcript was imported into the software package NVivo8, which 
provides computer assisted qualitative data analysis software. Each 
transcript was assigned its own identifying folder and linked to the 
participant’s voice which was integrated into the software and could be 
accessed and listened to simultaneously throughout the process of 
analysis. 
2) Significant statements and phrases directly related to the 
phenomenon being investigated were identified, highlighted, extracted 
and transformed into the words of the researcher from these transcripts. 
The research question was constantly addressed to determine whether 
what the participant said illuminated and was relevant to the 
exploration. 
Computer Assistance 
This was the first step of coding determined as preliminary coding. This 
coding process was expressed as individual free nodes (Appendix 8). 
Free nodes are a stand alone repository where broad, thematic 
participants’ accounts are placed. 
3) Then the researcher attempted to spell out the meaning of each 
significant statement (synthesizing).These statements reflected the 
essential point of the selected text. 
4) These synthesized statements were collected and organized into 
further clusters of themes (theorizing). 
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Computer Assistance 
This was the second step of coding expressed as tree nodes in NVivo8 
(Appendix 9). 
5) The individual themes were then clustered to produce a further 
reduction into general themes that were common to all the subjects’ 
transcripts. Not surprisingly, some clusters overlapped and were 
merged, because this is a complex human experience made up of 
many facets, impossible to demarcate. 
Computer Assistance 
These themes were further broken down from tree nodes to child 
nodes. Tree nodes are similar to free nodes with two exceptions: They 
can have relationships with other nodes and thus may be grouped into 
themes. They can have ‘children’ and thereby have a hierarchy on 
these synthesized statements imposed on them (Appendix 9). 
6) The researcher returned the transcript of the interview to the 
participants as soon as the verbatim transcribing was done in order to 
confirm whether it accurately reflected the essence of their lived 
experience as expressed at the time of interview (18 wished to read 
their interview).Two service users expressed literacy difficulties as a 
reason for not reading the transcripts. Follow­up discussion post 
reading of the individual transcript was carried out by telephone (15 
responded to telephone calls).Any relevant new data expressed were 
worked into a revised final description. 
Revision of the themes was an iterative process occurring as a result of 
continual reflection as the interviews progressed. The researcher 
moved back and forth between the meaning statements and the revised 
lists until the themes were accurately reflected in the clusters. The final 
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result of the zig­zag process was the finding of the research–the overall 
description of the experience expressed in four overarching themes and 
meaning units which provided the essential structural definition. 
7) One further step which Collazzi did not carry out was to calculate the 
percentages of the occurrence of synthesized statements across the 
transcripts. 
Computer Assistance 
At the outset it is important to highlight that frequency of occurrence of 
references does not equate with social significance of the topic (Bowling 
2002) but is useful for the purpose of transparency and reader 
information and reference is made for each concept and meaning 
explored in the presentation of findings. This further progression in the 
analysis was made possible by the use of NVivo8. 
4.2. DESCRIPTION OF DATABASE COMPILATION 
NVivo8 is a specialist package developed solely as a computer aided 
qualitative data analysis system (CAQDAS) and is recognized globally 
as a reputable tool for managing and supporting this type of analytical 
work. NVivo has two principal benefits. These are: 
� Efficiency 
� Transparency 
NVivo offers efficiency, because it allows the researcher to explore 
avenues of enquiry which would not be possible by a manual system as 
the amount of data generated from in­depth interviews is vast. To 
conduct a manual colour coding or cut and paste system places 
restrictions on time due to the sheer volume of exploration required. 
Such efficiency allows the researcher to explore the data in further 
depth and the inductive process was facilitated by total immersion in the 
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process of identifying the emerging themes.This allowed the researcher 
to rule out as well as rule in propositions or emerging hypotheses 
throughout the analytical process. 
NVivo maintains a clear audit trail which facilitates transparency. The 
process and stages of coding are tracked in such a way as to facilitate 
the researcher in clearly demonstrating a rigorous approach to data 
analysis. These are demonstrated as screen dumps of free nodes, tree 
nodes and child nodes which display the in­depth analysis which was 
undertaken by the researcher (Appendix 9). 
4.3. DATA SOURCES 
The study endeavoured to collect rich and in­depth qualitative material 
in an explicit way.The concurrent analysis of data was facilitated by 
integrating the bracketing interviews, field notes, and memos. The 
reintegration of data from these interviews in the analysis stage 
exposed the personal values and judgments of the researcher. This un­
bracketing was an attempt to ensure that the researcher’s personal 
suppositions did not affect the study adversely and added to the depth 
and methodological rigour. It also served to identify for the reader the 
life world of the research and the researcher (Stapelton & Taylor 
2004).This model engages the researcher in a two stage process 
involving both thoughts and feelings, and utilizes two forms: a narrative 
form through conversation with a bracketer and a textual form that can 
also be analyzed and made available, as part of the audit trail. This 
lends authenticity to process and to the knowledge generated through 
it. 
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4.3.1. FIELD NOTES AND OBSERVATIONS 
Observations from the field were recorded as field notes and text 
messages from the participants were noted as memos after the 
interview was completed by the participant. Linking memos to the audio 
sound byte facilitated a holistic approach to the data and meant the 
analysis was not conducted solely on the text from the transcript. 
4.3.2. MEMOS 
Memos served three purposes in this study. These were: 
1) Giving Context to Sources 
2) Generating Proposition Statements 
3) Defining Nodes 
1) GIVING CONTEXT TO SOURCES 
A memo, setting out details of interactions with the participants gave 
context to the study. Memos from follow up interviews were physically 
attached to the transcript document and served to remind the 
researcher of the broad context of the research later in the data 
analysis process. 
2) GENERATING PROPOSITION STATEMENTS 
This process entailed noting memos that were attributed to individual 
nodes which helped in summarizing the contents. They served as 
preliminary drafts of the findings of the research. 
3) DEFINING NODES 
This was used as a process of tracking thinking processes. Memos 
were used to record the researcher’s thoughts throughout the process 
of breaking down the data and defining all nodes. This assisted study 
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supervisors to clearly understand definitions. It also served to ensure 
coding consistency against such stated definitions. 
4.3.3. DIGITAL DATA 
Audio recordings from interviews were imported into the database 
which facilitated linkage of the transcripts to the text. This offered a 
holistic view of the data as the audio data added richness to the 
meaning and nuances in the text which were further illuminated by 
listening to the participant. In this way, important qualitative aspects of 
the data were captured. Emotion was not apparent through text alone. 
An example of this is when one of the participants discussed the fact 
that she had been treated poorly in the maternity hospital. She had 
tears in her eyes and this emotional response was linked to the relevant 
text in the transcript. The responses of the researcher during her final 
bracketing interview were emotional also and although pauses could be 
applied to text the reaction could not be noted in text alone. 
4.4. QUERYING THE DATA 
TEXT SEARCH QUERY 
This enabled the listing of all sources that contain specified text. This 
provided a method of coding sources by facilitating a search for words 
and coding the occurrences at a particular node. 
WORD FREQUENCY QUERY 
This facility listed words and the number of times they occurred in 
selected items. Collating which words appeared most frequently helped 
to identify themes and concepts (e.g. the word ‘’different’’ was 
mentioned 195 times with the majority of references made to how 
general practice was different to the treatment clinics). 
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CODING QUERY

This function gathered content based on how it was coded e.g.

the content where women talked about methadone and their babies.

MATRIX CODING QUERY 
This function created a matrix of nodes based on search criteria. For 
example, experiences and attitudes about general practice by gender. 
COMPOUND QUERY 
This facility combined text and coding queries when it was necessary to 
search for specified text in or near the coded content. 
CHARTING 
Charts were created to visually represent the coding data and to display 
matrix query results (Appendix 9). 
4.5. RIGOUR 
The rigour of the methodology is judged by unique criteria appropriate 
to the research approach. Rigour in the context of a phenomenological 
study can be demonstrated by ensuring the methodology is congruent 
with the philosophy used. In phenomenological research, bracketing, 
which has been incorporated into intentional focusing on the 
experience, is one factor that is central to the rigour of the study. In 
Husserlian phenomenology techniques such as bracketing, form part of 
the method of transcendental phenomenology. These processes allow 
an accurate interpretation of the phenomenon in the context of the 
prevailing philosophy (Seamon 2002b). Credibility, auditability, 
fittingness, and confirmability have been proposed as reasonable 
criteria for evaluation (LoBiondo­Wood & Haber 2002). 
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4.6. CREDIBILITY 
The credibility of qualitative research depends on the use of credible 
data, a credible analytical process and a credible mode of presentation 
of the results. To ensure credibility, transcripts of their own interviews 
were shown to the participants. Each participant was asked to verify 
and comment on the interview and provide any extra information which 
they felt was relevant. This ensured that an accurate account of their 
experience was documented. 
The transcripts from three of the interviews were analyzed separately 
by the supervisory team both in the pilot study and a further three in the 
main study. Similar themes were extracted and generated from this 
process and there was close agreement on the basic themes but each 
analyst may have ’packaged' the themes differently (Armstrong et al 
1997). This afforded further credibility as Mays & Pope (1997) caution 
that research which relies exclusively on observation by a single 
researcher is limited to the perceptions and introspection of that 
investigator. Barbour (2001) asserts that the degree of concordance 
between researchers is not really important but what is valuable is 
alerting researchers to all potentially competing explanations. This was 
achieved by discussing both data construction and the analytical 
process with two supervisors. The use of an assistant researcher was 
beneficial and insightful to the method development and analysis 
throughout the pilot study and was used to prevent practitioner/client 
bias in the main study as it is debatable whether the researcher/ 
practitioner may have in some way influenced the behaviour and 
speech that was witnessed in the first pilot interview. 
Data consolidation or merging was also facilitated by NVivo to create 
new variables (not simply transformed ones) that were then investigated 
or analyzed (Kane et al 2001). This served to protect the narrative 
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structure of the data so avoiding the problem of de­contextualisation or 
data fragmentation (Mays and Pope 2000). 
4.7. AUDITABILITY 
The construction, data collection and analysis of data provide an 
auditable account of the research process. The inferences that have 
been made in the findings are supported by the decision trail of 
transformation of the raw data into phenomenological informed 
expressions and the synthesis of the transformed meaning units into the 
general structural descriptions. It was possible to present sufficient 
original evidence in the descriptive account ‘to satisfy the skeptical 
reader of the relation between the interpretation and the evidence’ 
(Mays & Pope 1996) by using NVivo as it maintained a visible audit trail 
(Appendix 9 Screen Dumps & Analysis). All processes and stages of coding 
were tracked in such a way as to facilitate the researcher in clearly 
demonstrating rigour. The descriptions of the participants accurately 
reflected their experiences and the influence of the researcher 
practitioner’s bias was laid bare in the bracketing interviews. 
Bracketing Interview 1 
R Yeah, at first I think you challenged me that I was constructing the data myself and I 
didn’t like that challenge because I felt, No!, this is a very open experiential type of 
research but in fact, yes, I had to look at that and realize that I was constructing the 
data­just by the very framing of the study and just also saying I wanted to ‘tap into 
experiences’.So I found that very challenging, and in many ways I suppose it was the 
first line in the sand that I drew in the pilot study as Husserl says ‘suspend the natural 
attitude’ and come outside the process and look at it in a different way. 
The transcription of data is accurate and has been verified both by 
participants, transcriber, and researcher. In the analysis of the 
transcriptions, conclusions other than those offered by the researcher 
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have been discussed in the findings (Polkinghorne 1989:57). The 
interpretation of a sample of interview transcripts has been undertaken 
by four independent researchers, namely the principal researcher, 
academic supervisor, practice based supervisor and the research 
assistant who was consulted during the pilot phase prior to embarking 
on interviews for the main study. 
4.8. FITTINGNESS AND CONFIRMABILITY 
The concept of fittingness refers to the everyday reality of the 
participants described in enough detail so that others in the discipline 
can evaluate the importance for their own practice. The data were 
voluminous and provided rich descriptions which will be useful to other 
practitioners and revealed context rich material so that practice and 
policy can be influenced and guided by the findings. Likewise the 
uniqueness of these findings may be transferable to other general 
practices and have impact upon service users and provide lessons for 
the discipline of nursing and other multidisciplinary professionals and 
settings. Components such as these are necessary to demonstrate 
confirmability which was facilitated and complemented by the use of 
NVivo8. 
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CHAPTER 5: FINDINGS

5. INTRODUCTION 
Writing a story or poem is organic, synthesizing elements from the 
muddle of experience , weaving them to create a coherent artifact which 
communicates a seemingly single strand (Bolton 2005:39)­ and so it is 
with the multiple experiences described by service users attending 
general practice for the purpose of methadone maintenance. 
In order to honour the commitment made to service users and practice 
sites all place names, institutions, informant names and GPs names are 
disguised. Male to female ratio showed a majority of male GPs. There 
were a sufficient number of female GPs to ensure anonymity in 
mentioning their gender. The use of pseudonyms provides anonymity in 
the following reports from service users. 
The data were analyzed using the methodology espoused by Collazzi 
(1978) as outlined in Chapter 2. Four themes emerged from the data. 
These were: 
1) Service users’ experience of attending general practice for 
methadone maintenance. 
2) The significance of methadone for the service user. 
3) Service users’ understanding of the MTP. 
4) The experience of addiction and it’s effect on families. 
Each theme is discussed as a separate finding. 
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5 .1 THEME 1

SERVICE USERS’ EXPERIENCE OF ATTENDING GENERAL

PRACTICE

Figure 1 Theme I Service Users’ Experience of Attending General Practice 
(NVivo Model) 
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5.1.1 SERVICE USERS’ EXPERIENCE OF ATTENDING GENERAL PRACTICE 
This major theme was derived from the developed themes in which the 
participants described their experiences of attending general practice as 
a service user. These experiences were explored both within the 
exemplar of receiving methadone treatment and the perceptions service 
users shared in relation to general practice as a whole. Significant 
statements and phrases directly related to general practice were 
identified by analyzing the 25 in­depth interview transcripts. There were 
106 significant statements from 23 sources which pertained to service 
users’ perceptions of the benefits of attending general practice (these 
were expressed and collated as free nodes (Appendix 9 Screen Dumps). 
The transformed meaning was further broken down into distinct 
meaning units which were attributed to the lived experience of service 
users in general practice as opposed to the experience of attending a 
treatment clinic. These fitted into certain ‘known’ categories by the 
researcher but the experience was described beyond the knowledge of 
the practitioner – Bolton (2005:12) calls this genre of writing as ‘writing 
beyond what you know, starting at the known part and writing into the 
unknown; that is where the service user describes that part in their own 
language. In presenting these findings the technique of polyvocality is 
used to explore practitioner bias. Excerpts from bracketing interviews 
are interspersed with the data and bracketed within margins within the 
discussion of the findings. ICGP guidelines are also displayed where 
required within margins (highlighted in green). 
There were 84 references from 22 sources relating to clinic services. 
The overall description of the experience in general practice was 
described by the majority of service users as a comparator to past 
experiences within treatment clinics. Although no specific question was 
asked about the treatment clinics the experience featured highly in the 
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majority of service users’ accounts. Key aspects of attending general 
practice were identified as: a place to be treated as an individual, a 
place to get clean, a place which is confidential, a place to reduce, 
a place to develop relationships and a place to sort things out. 
5.1.2 KEY ASPECTS OF ATTENDING GENERAL PRACTICE 
General practice was consistently described throughout this derived 
theme as a ‘different place’ and a place to be treated as an 
individual. There were 31 significant references from 15 sources 
identifying the importance of being treated as an individual in general 
practice. The frequency of the word ‘’place’’ was mentioned 114 times 
and the word ‘’different’’ 195 times. The majority of service users 
expressed their preference to be treated in general practice. In the 
following descriptions the service users describe the difference. 
Daithi but in a clinic …’cause they treat you all the same, you see, they see so many 
drug addicts in there that they paint them all with the same brush you know?....in a 
clinic it’s completely different than a GP practice, you know ? 
The experience in general practice however was highlighted as being 
different to this. 
Craig… like you’re not treated like a … like a … you’re not treated… here (in general 
practice) you’re not... they don’t treat you like you’re an outcast, 
Sean eh, the dread of going down there,(Treatment Clinic) the way you were treated, 
to start first of all by the security guards going in like you would be going in there day 
after day after day. (General Practice). Much different, much difference, much more 
friendly eh which makes it much more easier for me to open up and tell you if I’ve had 
a slip or tell you if something has gone wrong or whatever you know? 
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These accounts emphasize the institutional environment of the clinic 
and the highly regimented mechanisms in place for managing security. 
There were 36 references from 18 sources describing how the 
treatment clinic had never been perceived as a place to become drug 
free in contrast with general practice. The following descriptions focus 
on the importance of treatment context as general practice is viewed by 
the service user as a place to get clean. This place was described as a 
setting where it is possible to have a plan to separate from the 
environment of attending a treatment clinic and the peer pressure 
exerted by other drug misusers which is inevitably a deterrent to 
becoming heroin free. 
Sean People nowadays and going back years, they never seen (the clinic) as a place 
to get clean… People stand around outside offering you drugs, offering this, so you 
have none of that (in general practice) and that is a good thing. 
Padraig cause it’s all around you isn’t it? 
The importance of treatment setting and environment was a perspective 
which was also shared by professionals as the following extract 
describes: 
Erica I think I was only down about a year and ehm the doctor down there (in clinic) 
he was kinda saying because there was a lot of stuff going on outside after the clinic, 
you know? swapping things and selling the stuff …and he said to me, you will start 
doing stuff if you stay down here and he said he would try Dr.X as he said he would 
try and get me a GP in the area. 
The importance of confidentiality in general practice was also seen by 
the service user to be of significant benefit to them. There were 86 
references from 23 sources emphasizing that this setting was 
conducive to privacy and a place which is confidential. Comparing 
the setting of the GP surgery with that of a treatment clinic the issue of 
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loitering which takes place outside a clinic was described. Entering a 
clinic and entering a surgery the following comparisons were made: 
R I’m interested in your views on what it is like to come to the GP?

Rhiana I find that it’s more private, you know, people don’t know your business

because you can be here for anything like? …the flu, whatever you’re here for, you

feel normal.

Attracta you’re not picked out …you’re not just fingered cause you’re… it’s your

normal GP do you know what I mean?

Field Note re Attracta 
She was apologetic in her approach to being interviewed at first, frequently tearful. 
Padraig What happens here stays here you know what I mean? It doesn’t go any 
further. 
The significance of this discreet confidential service in relation to 
employment was highlighted by the following participant: 
R And confidentiality is important to you? 
Daithi Yeah particularly if you’re working, if you have to hold down a job which a lot of 
drug addicts, like meself they can work and…if their employer found out they were on 
methadone to tell you the truth they probably wouldn’t get a job. 
Although the value of confidentiality for the service user was defined as 
beneficial within the confines of a consultation with their GP, there were 
significant limits to confidentiality. Three service users described the 
reception area as a location where standards were lowered. It was 
obvious to other patients in the reception area why the service user was 
attending and service users described how other drug misusers who 
attended the same practice knew why they were there. 
95

Olwyn… it’s (ha ha) mad cause people know what days you get your phy on. 
Helen…and people are meant to stand back to keep it confidential …. like confidential 
but they go to the wrong folder and the folder with the methadones are kept in a red 
folder and I have to say, no, it’s that folder and everyone up in (the locality)... I swear 
to God everyone knows the red folder is for methadone. So my friend she says did 
you ever see them up there like? people call it ‘getting the red folder’ and all like, they 
know well, they’re on Methadone and I’m .like…yeah… and I’m one of them. 
General practice was identified as being potentially beneficial in two 
important aspects of treatment­reduction in dosage of methadone and 
control over treatment. Meaning units derived from 112 references 
obtained from 24 sources described the treatment context as a place to 
reduce. 
The ICGP guidelines advocate that once a level of stability has been reached the 
patient may wish to consider working towards abstinence by slowly reducing their 
methadone dose over time. The advantages of reductions in methadone when on 
maintenance can be planned and each successful step helps to reinforce progress 
and boost self esteem (ICGP2008:21). 
The experience of those who were reducing in dosage and had a plan 
to reduce is described in the following extracts: 
Sean (10mls­reduced from 44 in the last year and stopped taking illicit

benzodiazepines) I will work myself right down to the two and then I will stop.

R If you wanted to go up on 60 mls or if you wanted to go down? Would you be able to

say it?

Daithi (60mls) Course I would, I could discuss that with me doctor yeah, I have.

R: Have you done that?

Daithi Yes, me doctor has in the past upped my dosage and at times

I’ve asked him to put it down and other times I’ve asked him to increase it, and he has

done it yeah, that’s no problem.
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Sibh (32 mls) I’d never been where I am today only for coming here. I was on 80 mls 
and they wouldn’t let me come down (in clinic)…I was on Triptazole and they wouldn’t 
take me off them, they wouldn’t help me to come off them …and I wanted to come 
down. And I came here and they gradually have done that now in the four years that I 
have been here! 
There was however dissent to the notion of who has ‘control’ over 
reduction from three sources. Some of the service users explained that 
there were buying extra and also using other illicit drugs. The 
methadone dose ranged from 20 mgs to 150 mgs in the sample 
(Appendix 7 Table 13). 
Erica I don’t think the patients have as much choice as the doctors seem to like to 
think that they have! 
A misconceived readiness to reduce or have control was also apparent 
as the nature of poly­drug misuse appeared ‘’chaotic’’ to the researcher: 
Niamh (150mls still using heroin & cocaine ) I was offered up up up up I tried to 
say no I don’t want to go up…(doctor) you’re going to have to go up you need your life 
on track you can’t go round smoking heroin so I went up…… look it I’m just going to 
say I don’t care how Christmas goes whether I come in with a dirty urine with gear, 
crack, coke whatever I don’t care, come January I was only told about of my charter of 
rights about this the other day I didn’t know about it, I want to detox in January and 
get… I’m going to lay down the law, I want to reduce and I am going to start reducing 
from that day. 
Olwyn revealed how she feels she controls her methadone dosage: 
R Do you feel you are in control of your treatment or do you think (doctor) is in control

of your treatment?

Olwyn (Prescribed 90mls­ takes 25 and sells the rest) well at the moment I am you

know what I mean?

R I do!
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Olwyn (ha, ha) at the moment I am but that could be very easy, that could be very 
easily taken away like 
R to change? 
Olwyn like if I was put on dailys tomorrow that’s… my control is gone 
R OK and if you wanted to, suddenly you went in and you came clean and said look 
I’m on 25 mls, I want to go down to 25 mls do you think (doctor) would do that for you? 
Olwyn automatically 
These responses demonstrated that reduction strategies are available 
in general practice and there is potential for service users to have 
control over their own methadone dose. However the service user can 
manipulate their dosage for their own benefit. 
5.1.3 THE DOCTOR/PATIENT RELATIONSHIP 
All service users described the doctor /patient relationship and 182 
references to the concept of relationship were made from the 25 
sources in the study. There were voluminous data and these responses 
were further broken down from tree nodes to child nodes which 
identified both positive and negative experiences. Overall 100 
references from the 25 original sources indicated that although there 
were some negative experiences in relationship building the 
overwhelming picture was that general practice provided service users 
a place to develop relationships and the majority acknowledged a 
good relationship with their own respective GPs. Twelve sources 
recognized negative experiences. These were expressed in relation to 
past experiences with GPs and what service users understood were 
their present relationship with GPs in general. 
A) POSITIVE RELATIONSHIPS 
Positive relationships with both GPs and nurses were discussed. The 
relationship with the GP was central however and the benefits of 
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continuity of care in general practice were explored. The following 
descriptions emphasize the importance of the relationship with the GP. 
Seamas I’ve known him (GP) that long like we seem to nearly grow old together like… 
so it seems like … we’ve grown up together in a different way you know… I’ve been 
here probably fifteen years with him,…I wouldn’t see anybody in the week or the only 
person I’d see would be Dr.X I call him (Christian name) and I actually felt a lot better 
walking away like he does… he’s a caring man. 
Robert Well I kinda bonded with (GP) than any other doctor I ever done… 
Niamh he (GP) knows by looking at me, I have to say I have a great relationship with 
the doctor 
R yeah, it seems to be… tell me what that means like what does a great relationship 
mean? 
Niamh like I can come in and say to my doctor look it I’m just fucking pissed off, what 
the fuck is wrong with me? I’m like a bull all the time you know? and I … But I think he 
actually appreciates me doing that and being honest with him you know? 
This relationship involved being listened to, being heard and valued­a 
therapeutic relationship. 
Daithi Oh no, no, I wouldn’t be here otherwise, on me life, I’ve built up the trust now 
the doctors you know I could come in here and talk to them about basically anything 
and they’re genuine they listen to me … I come in here and you’d talk and he would 
listen to you, to me and another time you just want to come in to talk like and you’d be 
listened to. 
Rosin …She’d sit there and she asks you and she listens to you, what you have to 
say and she gives you that’s it… and that to me meant an awful lot, right, that in itself 
is a cure you know what I’m saying? 
However this relationship has the potential to become complicated as 
highlighted by two service users when they disclosed to the service 
providers that they had bought extra methadone. 
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Anastasia it wasn’t that I was afraid to tell them (doctor and nurse) but I didn’t know 
what way but I did tell them in the end… I think I was on something like 45 mls, I like 
couldn’t handle it you know like? So they brought me back up to me 60 and they said 
if you ever have any problems again, tell us, don’t go into your own little world and 
just, you know what I mean? 
Bracketing Interview 2

P what sort of personal challenges apart from the clinical side what‘s going on there?

what sort of personal emotional challenges are coming up for you?

R I think the emotional challenge is this constant internal discussion about the reality

of the experiences of the drug misusers and the reality of my experience looking after

them.

This extract details the frustration of the researcher when something 
like this happens in practice. The service user finds it difficult to trust the 
professional and the professional in this instance is striving for a more 
mutual trusting relationship. Overall these responses identify the 
importance of relationship building within the framework of methadone 
treatment. 
B) NEGATIVE EXPERIENCES IN RELATIONSHIPS 
There were however details of negative experiences elicited. The 
following extract reveals a dichotomy in this service users’ approach to 
relationship: 
R So you were never on a clinic?

Erica I used to be.

R Years ago?

E Years ago and I was treated like a dog.

R So you thought general practice would be different to that anyway?

E I was hoping so, well I knew (says name of GP) and I knew I would be respected.

Despite references to feeling respected the following extract described 
a divide: 
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Erica (80 mls continues to use heroin, cocaine, benzodiazepines and extra 
methadone) Well it is a bit different to being a patient of a doctor. Ehm, it is a little bit 
like us and them. It is a little bit, yeah… It’s a bit sad that they can’t say that to the 
doctor that they haven’t developed a relationship with the doctor and that, that’s the 
way it has to be. 
Erica described the experiences of other drug misusers and elaborated 
on her current relationship with her doctor. This relationship was 
expressed positively but there was evidence of previous mistrust when 
relating to doctors. 
Erica Coming here, it’s grand, it’s handy. It is a lot more personal than going to the

clinics. (GP) She will talk to you till the cows come home. Do you know what I mean?

She always says how are you? how are you doing and you’re there kinda, is she in a

hurry?

R and how does that make you feel?

E it takes a bit of getting used to, to be quite honest, yeah it does actually. ..Like the

way I had never experienced doctors, you know that way…if the relationship was

different if you had, like you’re going back years here, of very very bad treatment.

You’re going back to (original treatment centre) and the older crowd are telling the

newer crowd ‘don’t trust them’ you know what I mean? So that’s going on!

R So there is a kind of culture there of mistrust?

Erica There is, yeah there is…and an awful lot of crap has happened do you know in

(names Treatment centre) and I’d have stories meself and all …

R Do you think general practice is different to that now?

E…oh I would

R Or your experience here?

E Yes.

Relationship issues were explored further by three participants when 
they found their own GPs would not look after them for methadone 
maintenance. However there was an ability to renegotiate and find 
another GP for MMT. 
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Daithi… if you can’t go to your own GP and get help who can you go to? So I had to

go out and find another doctor to take me on.

Rosin yeah well I had a GP in (locality) and as I said I was breaking my head off the

wall trying to get on the Methadone programme.

R and your GP didn’t do it?

Rosin and he was a quack basically right …so I said I have to get off this man so.

R He didn’t help your drug addiction at all?

Rosin No he didn’t whatsoever!

R Did you have a GP like for your normal kind of health issues?

Ken Yeah I had a GP and when I went to him about me drug problem the first thing.

was – I can’t give you methadone, I can’t give you any sleeping tablets.

Definitive negative responses were elicited from three participants who 
described a very rushed consultation pattern with their current GP 
methadone prescriber. This pattern was recognized during the pilot 
phase and described by the following key informant: 
Sean Some doctors they come, in they get the sample, they look at it yeah, grand 
right there’s your script... go! you know what I mean? Out! 
These observations were confirmed by the following three responses: 
R Like would you just think that what you say is important to her?

Helen No, no because (doctor) is just…. this is what (doctor) does (mimics looking

down at prescription pad) oh what are you on again? I say 80 and what day are we?

Ok, ok there it is come back to me 6 weeks now there it is!

Tadgh But the doctor doesn’t really know like he’s there to write a prescription and

that but…

R And have you had that discussion with him, have you told him you’re splitting

doses?

T Aw yes he knows that I split the dose.

I And has he suggested that you don’t?

T Well he doesn’t… I don’t think he knows too much about Methadone!
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He probably wouldn’t know the difference like between two different tablets like he be 
the same with the Methadone like I don’t know whether he’d know what it does!. 
Olwyn Yeah when I was younger so I would be always over there, I’ve known him 
since I was grown up kind of you know? what I mean like he’s always been the family 
doctor. 
R Yes that’s what I mean, so tell me about being a family doctor what does that mean 
to you? 
Olwyn It doesn’t he doesn’t mm … things definitely have changed since… I’ve 
become his methadone patient 
R Right tell me about that? 
O I go in the door now and automatically it’s just, check me urine and he’s writing out 
a prescription and he’s trying to get me out the door as quick as possible … yeah like 
all he is to me, now phy to me ……write it down …push it across see you next 
week…! Yeah he just automatically assumes that once you’re come in you’re coming 
in for your phy prescription and nothing else. 
Bracketing Interview 4

R So what they use the doctor for has been informed by partly what we do (GPs &

Practice Nurses) and partly by the fact that they have no expectations of care beyond

that Methadone script?

This response identifies that the researcher is beginning to understand 
how professionals can prevent full engagement on health issues and 
deflect opportunities to discuss treatment issues within the confines of a 
methadone consultation. Opportunities for full engagement on other 
domains of health are missed which should usually be addressed within 
the confines of regular GP consultations. These descriptions highlight 
the potential for two very different relationships which can develop when 
the service user attends general practice. 
5.1.4 ACCESS TO SERVICES IN GENERAL PRACTICE 
Service users described the services available to them when they 
attended their GP. General practice afforded them a place to sort 
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things out. There were 127 references extracted from 23 sources 
where research participants referred to what was and what was not 
available for them when they attended their GP. These were further 
broken down to identify service structures such as appointment times 
and services provided by the medical team. These were described as 
when you can get sorted i.e. appointment times and availability and 
what you can get sorted. Lack of services are described as what you 
can’t get sorted. 
There were thirty four references from 15 sources discussing 
appointment times and when you can ‘’’get sorted’’. All attested to the 
fact that they knew when they were to arrive. In general, appointment 
times suited and the majority complied with the surgery structure. 
Ken Yeah, I have me own time you know what I mean, I have me own time to come in 
and sort things out. 
Only one service user was negative about attending weekly. 
Erica I think it’s ok but like every week fifty bleeding ­two weeks a year!…I do think it’s 
flexible all right but like I work and I have to turn down some parts of my work so that I 
haven’t got it on (says day of week) morning. 
ICGP guidelines on attendance: Drug misusers on methadone should be seen 
regularly for review. The frequency of review will depend on the stage of their 
treatment programme. (ICGP2008:22) 
There were 98 references extracted from 23 sources describing the 
services provided in general practice as what you can ‘'get sorted’’. 
Services which were described ranged from care for minor illness, child 
health, womens’ health (smears and coil insertion) asthma checks, 
health promotion including weight reduction, advice on hyperlipademia, 
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phlebotomy and viral screening, investigations of infertility, antenatal, 
pregnancy and post­natal care, blood pressure taking, dermatology, flu 
vaccinations, childhood vaccinations and managing depression and 
back pain. Ten women and 2 men described using general practice as 
a place to have their children looked after. Overall there were 19 service 
users who had children (Appendix 7 Table 3). 
Niamh It’s a place where you can bring your kids.

Sibh Yes if I’m sick I come, if they’re sick, I come.

AR Oh you bring the kids as well?

Sibh Oh yes, he’s the kids GP as well.

AR OK, so and it’s fine for all that kind of thing.

Sibh Yeah it’s brilliant!

Olwyn… but no all in all, it is a good general practitioners like, I can’t say it isn’t, like

anything that I’ve ever needed I’ve got.

Eleven of the service users spoke of the practice nurses in terms of 
seeing the nurse (7), talking with the nurse (1) and the nurse testing 
urine (3).’’Seeing the nurse’’ involved phlebotomy, cervical smear 
taking, ante­natal care and urinalysis. 
R So what does the nurse do for you then?

Olwyn I’d go in and give her supervised urine.

R Oh she goes into the loo with you?

Olwyn Yeah.

Saoirse…when you go in (doctor or nurse) they spend the same time with a

Methadone patient than they would with a non methadone patient. You know for

different needs any thing like that but like they’re very good and (Nurse) is great cause

she reminds you of your appointments like, she was chasing me for the past three

years for a smear test and she actually got it from me.
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Bracketing Interview 4 
R I think one of the big issues is the under resourcing in general practice by the 
practice nurse and I’m disappointed because the original research which was started 
in 2001 when I went into practices and spoke to the practice nurses involved in the 
same general practices that I’m back in now, they felt they had a huge part to play. – 
This is further illuminated by the following extract 
Masters Research: Informant 3 (69) You contribute, you’re not just liaison because 
of their protocol, they’re seeing you because they have needs and issues like every 
other patient …you know its very much holistic care rather than… ehm they are not 
just methadone protocol. 
This bracketing interview and previous research extract illuminates how 
although the nurse feels she contributes significantly to the care of the 
service user, the role of the practice nurse is viewed as one which is 
task orientated, providing services but not specific psychological care. 
There were 59 references from 19 sources describing counselling 
facilities which revealed that there was a general lack of this type of 
service provision in general practice what you can’t ‘‘get sorted’’ 
Although counselling was available on site in four of the practices and 
service users had access to services outside the practice in the 
community, it was a service need understood as being important when 
receiving treatment. Geographical boundaries affected access to on site 
counselling as highlighted from this extract: 
Sean… as I was saying its a bit ridiculous that I can’t access a counsellor from here 
do you know what I mean ?even though I’m in (names locality) now … that’s the good 
thing about the counsellor I’m linking in with , he’s an ex addict, he knows exactly what 
its like. 
There was concern that emotional well being was being overlooked. 
Erica …you get someone who has gone through misuse as a child and it doesn’t have 
to be sexual misuse, emotional, physical, anything you like. It’s stuff where they can’t 
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relate to people, they can’t develop relationships, they are not socially capable of just

communicating …. Going into restaurants and having a meal, that’s not part of their

life cause they find it difficult. General practice isn’t helping any of that!.

R You don’t think?

Erica No, I don’t think so I really don’t! And I think there should be a way of

incorporating that into methadone treatment.

Even though the relationship with GPs was considered to be good it 
was considered by all who described their experiences that counselling 
was a service which provided a specific need whether they wished to 
attend or not. This need was considered to be outside of the remit of the 
GP. 
Craig Like I’d started talking to (doctor) what I’d started talking to the counsellor 
about, I started off talking to (doctor) first like (doctor) acted as a counsellor first, for 
me problems and all… 
Daithi Yeah I went to counselling myself separately; I never used my GP for that. 
R Do you have counselling here? 
Niamh No, in the community drug team…. yeah I can talk to the doctor but I wouldn’t 
go in and deep and talk to me doctor but I do find I can talk to me doctor, which is 
good but also the doctor doesn’t have the time to sit and talk and listen 
On site addiction counselling was available for Craig who revealed: 
C ‘I’d rather that time kill two birds with the one stone’. 
Field Note re Craig 
He was uneasy at first but then settled down during the course of the interview and 
began to engage with the process of telling his story. 
Difficulty was expressed in accessing counselling in a treatment clinic 
as this means that the service user has to re­engage with this 
environment and other drug misusers to attend. 
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Tadgh No, there’s nothing here like you have to go down to see the… you’d have to 
go down to (clinic)…but that’s where they go for the phy, all the worst of the worst go 
there you know that way? 
This overall description of ‘’getting sorted’’ describes the users’ 
perception of what services are provided for them in general practice. 
The slang of ‘’getting sorted’’ is often also applied to the process of 
obtaining heroin. 
SUMMARY 
The findings of this first theme described service users’ lived experience 
of attending a GP for methadone treatment. The overall description of 
the experience was described by comparing past experiences within 
treatment clinics to present experiences in general practice. The 
transformed meanings were expressed as a place to be treated as an 
individual, a place to get clean, a place which is confidential, a 
place to reduce, a place to develop relationships, a place to sort 
things out and what you can’t get sorted. These findings will be 
discussed further in chapter 6. 
Bracketing Interview 5 
R They knew that this was a different place, their identity would change almost by 
going into general practice. 
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5. 2. THEME 2

THE SIGNIFICANCE OF METHADONE FOR THE SERVICE USER

Figure 2 The significance of methadone for the service user. 
(NVivo Model) 
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5.2.1 THE SIGNIFICANCE OF METHADONE FOR THE SERVICE USER 
This theme was derived from the developed meaning statements where 
service users described their lived experience of methadone and the 
significance it has in their lives. Methadone as a drug and its effect on 
their lives was described in various ways. Meaning units derived from 
the data were: what methadone does for the service user, what 
methadone means to the service user, how methadone defines the 
service user and the importance of street trading. 
5.2.2 .METHADONE AS A SUBSTANCE 
Descriptions derived from 131 references extracted from 22 sources 
pertained to the experience of taking the substance of methadone and 
how service users felt methadone affected them. This was described as 
what methadone does for the service user. Strong emotions were 
expressed about the drug itself as these extracts illustrate: 
Erica (80 mls continues to use heroin, cocaine, benzodiazepines and extra

methadone) Yeah I just hate the drug, I fuckin hate it! God forgive me, I fuckin hate it!

R Would you suggest that you prefer heroin?

E Yes, I don’t get stoned… I take heroin, I took heroin before I came here do you

know?...No it’s the bloody drug! It’s just so much harder to get off then heroin...I think

there’s a market after just being developed!

The addiction to the substance of methadone was described by Sean: 
Sean (20mls) I actually despise it, yeah I do I genuinely despise it, taking it every 
morning, every morning I get up and I’m taking it and I’m like, you know what I 
mean… why? 
Positive aspects of the substance were also described and the overall 
benefits of methadone were highlighted by 15 sources with 24 
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references attributed to the beneficial aspects of either the substance or 
substitution therapy. 
Anastasia Like I honestly believe that Methadone saved my life you know, I really 
believe that one hundred per cent you know because ehm, I just don’t think I could of 
got off drugs without it. 
Daithi I mean the methadone programme,that I mean, it basically changed me life you 
know what I mean? it gave me back my life, it meant I could hold on to me job, I could 
work. 
The other benefits of methadone were attributed to what the 
participants believed to be health outcomes. The following extract 
illuminates a perceived benefit of maintenance: 
Robert Well I think it’s like this!, if I was going to give up methadone now and be as 
clean as a whistle I’d end up with toothaches, back aches, eh your stomach not being 
able to eat, its not withdrawals, its not withdrawals, like, its just old injuries because 
when you take your methadone all them… old injuries kinda go away you don’t feel 
them. 
Overall the majority of service users were positive about the effect 
methadone had in transforming their lives and lifestyle. 
Seamas I’ve come in here now, a lot of the lads now that would have been pretty bad 
years ago, they'd have cars now, they have girlfriends, they’d be looking well, their 
teeth and they keep themselves clean. Whereas years ago they would have been 
rampant heroin addicts you know?… I was just sitting here now (sitting in doctors 
chair) picturing me there (researcher sitting in patient’s chair) now eight years ago, my 
life was a crock of shit! and if I’d have been the doctor I’d have been thinking, that sort 
of man is capable of doing anything when he goes out that door!, I don’t know what 
he’s up to but yet, if I give him this prescription, it’s somehow handling him and 
somehow going to do something. 
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Crime reduction as a direct result of methadone maintenance was 
identified from 7 sources with 21 references related to criminality. Eight 
of the sample reported that they had been in prison with 13 admitting to 
past convictions. The following extract details how methadone has been 
beneficial in preventing further crime. 
Seamas …yeah the likes of meself, I was in (says name of prison) prison and the 
worst prisons and I’ve done some of the worst things you know in prison and there’s 
no doubt I was capable of some crazy shit and when I started on the methadone that’s 
all not going to happen…eh like people in the neighbourhood would notice me not 
running around with balaclavas jumping in and out of cars stealing, you know…? 
…me, the doctor and everyone else that’s in this place …we would’ve seen people 
coming in here about 8 years ago , swallowing bullets and being chased all around the 
country by police in an awful condition , coming in all cleaned up and looking well and 
they’d be going off to work!. 
One participant attributed being involved with a GP within the context of 
a methadone maintenance programme as a way of reducing the 
possibility of contracting HIV: 
Padraig I said Id be HIV positive only for him! 
However 3 participants who were HCV positive described both the 
treatment received and education given for HCV while attending 
general practice. 
Ado… but I’m saying like the heroin, you know, like cause I used to always have the 
needle you know? like a brand new needle like, the doctor said you can get it like from 
the spoon you know?…He said if I was squirting it through there onto the 
spoon…straight onto the spoon and stuck on that… it never even dawned on me that, 
didn’t you know like? and he said it to me. 
One of the service users who wished to stay connected with the study 
provided poems­ the following one describing his views on how HIV is 
contracted. 
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5.2.2.1. 
A BULLET IS QUICKER 
At the start it is just a game

Everyone else is doing it why should you feel shame?

Get the foil chase the dragon

After a while nothing happens

Injection is next on your mind

But you can’t get a vein of any kind

So your mate gives you his syringe to get a hit

After a while you feel like shit

Darkness falls but the cravings awake

Your stomach, back, legs and head ache

You go out to find a cure; even then you are not sure

A stranger offers you a hit, you use his works, you don’t give a shit

Suddenly you are catching colds and flu

You think they’ll pass but they never do

You’re not eating, sleeping, don’t feel well

You are in a living hell

You go to your doc with a cold and a sneeze

Then he tells you, you have a serious disease

You can’t believe it; you fall to your knees

So be careful whose needle you share

Look out for yourself and take more care

Cause before you know it we will be offering you a prayer
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There were 8 references from 15 sources describing both what the 
service users understood about methadone and any education they had 
received about the drug. Thirteen service users identified the 
phenomenon or urban myth of the substance ‘’getting into your bones’’, 
1 did not believe it affected bones while 3 identified this to be the 
reason why they perceived methadone withdrawal to be so difficult. 
Molly… and I’d always heard that methadone gets into your bones

R Has anyone ever given you information on methadone?

Molly No

R The information you are getting is from other…?

Molly Yeah it would be from my experiences and from, I know people as well.

There were inaccuracies expressed about the effects of methadone 
from a number of sources. 
Robert… you know what I mean? so that’s what people were thinking, it dries up or

you know the way there’s supposed to be wet in your spine or something fluid ?

R…cerebro spinal fluid?

Robert … yeah its (methadone) supposed to dry that up or something?

Saoirse Yeah I think that definitely the methadone in the long run, if you’re a long

term methadone user that it can actually bring on suicidal tendencies in people.

Where information about methadone was obtained varied. Three had 
received written information from their own GP, 1 from the pharmacist 
and 2 spoke of the expertise of the nurses in the treatment centre. 
R Have you ever been given any books on methadone?

Robert Yeah I was given, he (doctor) gave me a book straight away, it was one of

those green books…
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In general the lack of education received was described in the following 
extracts: 
Niamh Yeah like everybody, I’d make sure that everybody was fully aware of the 
consequences of going on methadone. 
R Ok tell me about fully aware of the consequences, did you ever get any education 
about methadone, did you ever know what methadone did? 
Niamh no, I knew it was just… if you had no gear. you’ll get a sup of phy you’d be all 
right 
R Even though you set up a service users group? 
Niamh…oh them, oh that’s oh I knew like enough about methadone and I knew like 
when you were on methadone it was really hard to come off it, and this is why the 
services users’ forum they set up was, because we wanted to have answers from the 
doctors you know like… why..? Is there anything we can do to come off the 
methadone? and basically the only answers was, go with the treatment, come off the 
methadone, detox and go though your sickness­out of here. 
5.2.3 WHAT METHADONE SUBSTITUTION MEANS TO THE SERVICE USER 
Methadone substitution emerged as important in terms of how service 
users’ lifestyle can be transformed due to treatment. The meaning 
attributed to methadone substitution was consistently one associated 
with both normality and stability. There were 119 references from 25 
sources describing the benefits of consuming methadone. This was 
perceived as a way of feeling ‘‘normal and stable’’ as the following 
extracts illuminate: 
Saoirse… for many people it’s like a security blanket you know, it’s something they 
can fall back on and something they do not want to let go… but like methadone is 
good in many ways, like it gives people who have been on heroin it gives them that 
stability .. 
Kaitlin Yeah, and then after when I was stable I found that when I stopped doing gear 
I settled…I could actually think and function properly you know? you know I could be 
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reliable… you know? I actually started going to …this course and I loved it …I was on 
methadone and that’s how I got into college through that. 
Field Note re Kaitlin: 
She seemed determined to change her life and slowly reduce her methadone. 
Niamh (150mls still using drugs erratically)… it helps you get structure back in

your life but... it helps you get your old one off your back, do you know what I mean? I

know people who are saying, I’m going on that phy, that old one’s doing me head in,

they don’t want to be on it but just to shut their ma’s up.

R… and what does stability mean to you now?

Cara To get up in the morning, to get your daughter out to school.

R So what does methadone help you with?

Cara ehm… I have a life.

R That’s interesting, tell me what you mean you have a life?

Cara eh I just… I can get up in the mornings, I can get me daughter to school and

can go out and do a bit of work, I can come home, I can even get the house done up a

little bit you know so?

Bracketing Interview 5 
R...the significance of methadone is that it gets me ‘’normal’’ and gets me ‘’stable’’ and 
those words were used by them not by me. 
5.2.4 HOW METHADONE DEFINES THE SERVICE USER 
Methadone was described as a substance which defines the service 
user conferring a new and transformed identity from that of heroin 
addict. Lifers, Maintainers and Reducers emerged as categories 
related to the phenomenon of receiving methadone. These 
categorizations were both self defined by the participants and co­
constructed by the researcher. 
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I 
Bracketing Interview 5 
P I’m just interested in this whole idea of the perception of the client as a ‘’reducer’’

and you say heretofore you did not see them as that?

R No well I didn’t see them as a category of person…but it became clearer and

clearer and clearer ….where they saw themselves on that scale you know.

A) LIFER 
There were 29 references from 10 sources describing a life long 
process of methadone maintenance. These sources described 
themselves and others as ’’lifers’’ or dependant on the substance of 
methadone. 
Saoirse (80 mls buying extra methadone) Yeah I know people that’s on methadone 
thirty­five years you know and that’s their life now you know? and one man, I think 
he’s sixty­seven now but he’s still on methadone, you know? and he can never see 
himself coming off because he’s after been on it so long that… that’s life! 
Seamas (140 mls 12 years in treatment) well the bad aspect of it I’d class meself as 
a lifer! 
R You mean addicted still? 
S No, I’m a lifer, I’m going to be on this for the rest of me life, and I know that, I’m not 
afraid of it, I’m not ashamed about it or anything else and I don’t care what anybody 
else, what they think. I look at some kids and I think they think there’s a lot... they 
don’t … that it’s not something that they’re going to be on it for the rest of their life. 
Daithi I’m taking methadone on a daily basis for 14 years with GPs and clinics and 
doctors and my body is chemically dependant on it…that methadone. 
R There is one who calls himself ’’the lifer’’, I’m on this for life, I have no expectations 
of coming off and I’m actually… that’s what I’ve accepted. And I think that’s a sad 
model but I don’t know how much more we can do about that? 
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B) REDUCER 
The term ’’reducer’’ was constructed from the service users’ perception 
of their methadone dosage. There were 28 references from 13 sources 
describing this process. 
Kaitlin (70mls buys extra benzodiazepines occasionally, 3 years in treatment) I 
will be coming down. he was already bringing me down 2 mls and then I asked him to 
stop… He said he’d bring me down off the valium so I’m actually in the process of 
coming down. 
Rosin (70mls obtains benzodiazepines occasionally, 5 years in treatment)… it’s 
when I feel stable I’d usually come in and I’d say look… I’d like to drop another 5. 
Bracketing Interview 4 
R these are the people who are taking control, we call them…I call them,’’the 
reducers’’ because they are reducing right down and they have got it!They’ve got it but 
it is a long haul, getting them to that stage…It takes ten years for some people…! And 
then there’s the small proportion of reducers and we have them and terrific stories and 
that’s what keeps motivating me. People who’ve been on a huge amount of 
methadone and coming right down and maybe, responding hopefully, to the brief 
interventions that we have been doing with them. You know? challenging them about 
their behaviour…weeks upon weeks upon weeks! 
This passage reveals the researcher’s value judgments that reduction is 
a preferred goal rather than life long maintenance. Examining this 
attitudinal prejudice has resonance with the findings from the 
foundational study. This extract explored the practice nurses’ opinions 
regarding methadone as a treatment option. 
Masters study Informant 5…but they’re still dependant on a drug , which you know I 
wouldn’t be totally happy with,I would love to think you know, we were having a better 
success, that people were off it and not dependant on something. 
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C) MAINTAINER 
Thirteen references from 7 sources described being maintained on the 
substance of methadone as ’’happy the way things are’’. 
Cormac (5 years in treatment)… it’s further down the road you know but right now 
I’m happy, I’m after going through it, I’m after doing the treatment for me hepatitis, I’m 
after… you know and it’s like giving up giving up giving up and like I feel like I need to 
take a break of giving up things you know? 
Anastasia (8 years in treatment) yeah, well the thing is I’m very happy the way 
things are at the minute, in saying that I would love some day to be able to stop taking 
methadone, but at the minute I don’t feel ready for that you know, I’m not ready for 
that, I know I’m not you know 
Attracta (5 years in treatment) yeah it’s keeping me away from all the people that 
are nearly mad because you get just a methadone person that is happy on the 
methadone, delighted to get their methadone. 
Bracketing Interview 5 
R The other one is the patient who is happy the way things are and that’s where I see 
the role of counselling hugely, the ‘’happy the way things are’’, because they feel 
everything impacts on them. Life issues impact on them! family issues!, the fact that 
they have always been surrounded by death and suicide and horrific crime!. They’re 
the ones that seem to be the most vulnerable in terms of need. They need an extra 
provision in general practice. 
5.2.5 THE IMPORTANCE OF STREET TRADING 
The importance of street trading emerged when discussing the 
significance of methadone in the lived experience of the service user. 
Methadone diversion, both in the buying and selling of methadone and 
benzodiazepines appeared to be enmeshed in the culture and rituals of 
receiving a methadone prescription. There were 91 references from 23 
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sources which described the implications of being on a methadone 
maintenance protocol and street trading. 
Olwyn described the economic benefits of her maintenance dose as 
follows: 
Olwyn (Prescribed 90mls­ Takes 25 and sells the rest)… yeah and then when I got 
me own place and that ,it’s very hard to run a place on your own on the labour (social 
welfare) kind of so like the phy money, I rely on that money, to be honest … yeah I 
wouldn’t take phy like Tuesday, Wednesday sometimes I’d go to Thursday and mm 
it’d be just when I feel it when I start to get sweats then I take my 25 …And because I 
have a house, I have me own home now so I have to keep me bills in order, the whole 
shebang you know, get me shopping and pay the bills, kind of … 
Further incentives associated with remaining on maintenance treatment 
were described by Erica. 
Erica (80 mls continues to use heroin, cocaine, benzodiazepines and extra 
methadone) Ahh… I could have 1000 but at the minute I just have 700 I count it at 
the weekend …I’ve loads of methadone at home. No, come here and I tell you most of 
the people who are doing very well who are still on 100mls and I’m telling you this and 
its not a word of a lie, they’re selling their methadone, the incentive there is to be, 
ehm, all drug free, get your two weeks methadone and sell most of it and take thirty a 
day and there are hundreds of people out there doing that, right? 
Obtaining extra methadone and or benzodiazepines appeared to be 
relatively easy for those on maintenance (Appendix 7 Table 15). 
Darragh (80mls): but I know of other people … and they can go in and say, in other 
doctors, they can go in and give the sad story and get put up a little bit more (on 
methadone dosage). 
Attracta (80 mls+ buys extra benzodiazepines)… just down there at the (names 
area in locality) and mm if you wanted to go down there you could get extra tablets, 
your extra dalmane or whatever…yeah, yeah, right opposite, the minute you see 
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anybody coming out of the chemist they’ll either do that (gives a nod) and say go 
round the corner and keep walking or else!. 
R So you buy an extra 50 per week or 100 per week? 
Padraig (90 mls buys extra methadone) 140 some weeks!. 
Field Note re Padraig 
He openly admitted to buying more methadone and was afraid that he would be 
thrown off his programme (he had negotiated a higher dose in the past). 
Bracketing Interview 5 
R Street trading of course is part and parcel of it so I mean that’s a cultural issue as 
well. I didn’t understand the significance of the street trading, I didn’t understand the 
significance of the culture in terms of, this is what they have done and this is what they 
continue to do whether they maintain or not, whether they are on maintenance or not. 
The reducers are not involved in street trading. 
SUMMARY 
The findings of this second theme describe service users’ experience of 
taking methadone as a substance. Meaning units derived from the data 
were: what methadone does for the service user, what methadone 
means to the service user, how methadone defines the service 
user and the importance of street trading. These aspects of 
treatment together contributed to the overall lived experience of being 
prescribed methadone and the meaning attributed to the substance and 
substitution treatment. These findings and the implications for practice 
are discussed further in chapter 6. 
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5.3 THEME 3

SERVICE USERS’ UNDERSTANDING OF THE MTP

Figure 3 Service Users’ Understanding of the MTP 
(NVivo Model) 
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5.3.1 SERVICE USERS’ UNDERSTANDING OF THE MTP 
This third theme was developed from the meaning statements where 
service users described their understanding of the Methadone 
Treatment Protocol. Meaning units developed were: why the protocol 
was necessary, what the protocol means to the service user and 
understanding what influences the implementation of the MTP. 
5.3.2 THE REASONS FOR THE INTRODUCTION OF THE MTP 
Service users described their past experiences with doctors who 
prescribed methadone on the black market. Within these exemplars the 
reasons service users attributed to the historical development of the 
MTP were explored from their perspective­why the protocol was 
necessary. There were 75 references from 21 sources describing 
service users’ experiences both past and present with ’’rogue doctors’’. 
These rogue doctors were described as ’’bogey doctors’’ similar to the 
colloquial use of this term which is used in the context of providing a 
false urine specimen. These descriptions identify for the first time in the 
literature the black market system which influenced the introduction of 
the MTP and also uncovers current practice. 
Daithi The protocol started in 1998 and basically what happened was doctors, certain 
doctors, were over prescribing methadone and there was a lot of methadone on the 
street and at that stage doctors were prescribing eh physeptone… but basically the 
eastern health board they wanted to take control of basically heroin and methadone, 
(how it) was going to be dispensed, they sussed out all the bogey doctors there was a 
lot of them giving out prescriptions just for the money. 
Molly… but basically the Eastern health board, they wanted to take control of 
basically heroin and how methadone was going to be dispensed, they sussed out all 
the bogey doctors, there was a lot of them giving out prescriptions just for the money. 
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Sean explained that the chemists were also affected by the rogue 
doctor system. 
Sean I used to know a chap who got two bottles per week, he was on with two 
different doctors, this was before the whole methadone protocol came in. ...like you 
could get a prescription, go into the doctor, pay the money under the table and …he 
would write you a script and the thing about it was that you could practically go to any 
chemist and change it there and then people were going then like!. 
There were economic benefits associated with the ’’rogue doctor’’ 
system in the past and a chemist refund could be obtained when a 
certain amount of money had been paid to the chemist for a specific 
quantity of prescribed medication. This was considered to be a major 
economic benefit of the rogue doctor system and one that is no longer 
available. 
Olwyn… BUT nothing has changed really.

R Now that’s interesting, tell me that, nothing has changed?

Olwyn Nothing has changed…the whole, yes like it might feel, like you mightn’t be

paying your forty quid, I think actually I would prefer back to the way it was cause at

least you knew like you were paying your forty quid blah and you knew you were

going to get that back in a lump sum so many months later.

R Like get the refund in the chemist you mean?

Many such as Erica and Saoirse attested to the fact that they had 
sought out ’’rogue doctors’’ in the past: 
Erica Yeah, I used to hit loads of doctors to be quite honest. Ah some of them are 
mad, ah Jaysus… I hit on doctors. 
Saoirse… That was the very first time I was on a methadone programme but he was 
like… he used to be drunk (ha ha)...He is not a doctor, he was struck off in ’98 when 
the protocol came … but he didn’t care once he was getting the money like, he’d open 
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a drawer and he’d have a big bottle of whiskey there, but next to the whiskey there’d 
be loads and loads of 20, pounds notes at that time like … I think that turned me off 
like … 
Others, such as Olwyn, had a reciprocal arrangement in place: 
Olwyn there was a doctor that I used to go to now for me tablets and…he’d pay me 
to clean up the surgery and then he’d pay me in scripts… no I’d get paid in scripts! 
Helen and Cormac recounted current practice and how to negotiate 
obtaining a prescription of benzodiazepines or night sedation from 
doctors other than the methadone prescribing GP. 
Helen (70 mls Obtains extra benzodiazepines) (my own GP) she wouldn’t give 
them (benzodiazepines) to me she doesn’t like giving them to her patients, fair play to 
her cause everyone asks her for them but Dr.X. he wouldn’t take me on as a patient, I 
have to pay him… but he’d give me them 
R So she’s not prescribing you your benzos and you’re buying? You’re going to do a 
private prescription with a private GP for €50? 
H No I don’t need to see him, just get the prescription…he doesn’t ask why don’t I 
bring the kids down or anything, he doesn’t come out of his office you don’t even see 
him like …two a day, so every time I take the methadone I take the two. 
R but if you did, if you had a chest infection which doctor would you pick to go to, you 
know what I mean, would you go to the one who is going to give you a prescription for 
benzos? 
H oh I wouldn’t go near him! I think he just does the prescription! 
Cormac in this day and age yeah, there is a doctor in (locality) who gives it, drives a 
big huge car, you went in with €50 he'll tell you to make up an address in (locality) 
right,? (doctor says) ’ if anyone asks you, you come in, you told me…you told 
me…you’ve only come over from England, you were working with a crew over there 
you’se were drinking all the time, you were on with a doctor you came in to me with a 
couple of valium in a jar and you were coming to the last of your Valium, you were 
clean off the drink, the valium is working for you the dalmane for sleeping and I took 
you on that way like...I write you a script… just take your €50...that’s it! 
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5.3.3 WHAT THE PROTOCOL MEANS TO THE SERVICE USER 
The meaning of the MTP from the perspective of the service user was 
developed from a total of 140 references from 25 sources describing 
aspects of the MTP. These descriptions involved understanding the 
protocol, knowing the rules and working the system. 
There were 26 references from 12 sources pertaining to the service 
users’ understanding of the MTP. Some service users had a clear 
understanding of regulations governing the protocol while others did not 
understand the term protocol and thought that they were being initiated 
onto a programme for detoxification. 
Anastasia… to me the methadone protocol just means, it’s a new thing, it kind of

brings it out to be less taboo than it was, you know what I mean? That’s what it means

to me.

R when you call it the course, I call it the methadone protocol have you heard that

word?

Tadgh yeah eh no I haven’t heard of it but… it wasn’t a maintenance course that I

came on to it was a detox I came on to.

R That’s what you thought you came on to here?

Tadgh That’s what I thought I came on to like.

R who told you it was a detox?

Tadgh The doctor actually said it was a detox…I felt I was duped in to it

Despite being uninformed as to the full meaning of the MTP, the service 
users knew what rules were attributed to the protocol. Forty references 
from 18 sources described knowing the rules which they felt affected 
their treatment management in general practice. These rules applied to 
1) urinalysis, 2) attendance schedules 3) supervision of ingestion 
at the chemist and also how these rules could be circumvented 4) 
‘’working the system’’. 
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1) URINALYSIS 
All of the service users were in favour of the necessity of urinalysis 
which implies a compliance with this aspect of the protocol. There were 
99 references from 25 sources describing the process of urinalysis and 
what that entailed in practice. 
Daithi Yeah I come here and give me doctor a sample, yeah I mean there’s no point 
in being on a methadone programme, if you don’t give a sample. 
However how the urine was obtained caused variable responses. Three 
participants from the same surgery explained that the reception staff 
would request the urine sample. 
R On that, do you mind the receptionist asking you for urine? 
Kaitlin No, no, it can be a bit you know like…? when you are asked to go to the 
bathroom. She’d always wrap it in tissue now like and I’d go in and I’d have it 
wrapped in tissue. Give it back to her and she’d just put a glove on, you know? it 
doesn’t really bother me that much, but other people would be looking. I don’t mind. 
There was considerable strength of feeling about the frequency of 
urinalysis. Most were in favour of random urinalysis which was 
supervised. Two service users had rarely if ever had supervision of 
urinalysis. 
R Are you saying that in all the time you’ve been here, five years, you’ve never been

supervised in the loo?

Darragh (80mls) No.

Helen (70 mls obtains extra benzodiazepines with another GP) No, I never have

had it. I’ve actually have had a supervised the whole time I’ve been here only once!

R Only once?

H Yeah the whole time once yeah the whole …
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R In six years? 
H Yes! 
In the same practice a different story emerged. 
Rosin (70mls obtains benzodiazepines) Occasionally the doctor herself she’d spot

supervise you.

R So you don’t have any trouble with that?

Rosin It needs to be done.

The practice of giving ’’bogey urines’’ was discussed at length and 
service users expressed anger about the lack of supervision. 
Helen He’s (brother who attends the same surgery)going up now to actually get it he 
takes that every Friday and now he’s getting it weekly and he takes that and he sells 
the whole lot of it and like he keeps that 80mls cause he has to be supervised drinking 
it…and he just gets a urine, gets the urine off someone every week, they don’t 
supervise, but the thing about it is, its it’s obvious, oh my god like, how do they not 
know this these people?… but the minute he done that eh he’s not supervised he’s 
back on the gear. So definitely there should be more supervised, like at least it’s what 
do you call it, I think we should be supervised every week, I really…. every week! 
The following informant discussed the economic benefit of providing 
another service user with a ‘’bogey’’ (false) urine. 
R And have you, have you been asked outside the door? 
Cormac Yeah, I’ve been asked outside the door, I’ve been phoned to give urines, you 
know people have talked to me and told me about, they’ve made urines up, their child 
did urine into a bottle and then put a bit of valium in it and then put methadone …it’s 
funny that you say that like now like only last week I was actually asked to sell one of 
me urines to somebody like…’ill give you methadone… I’ll fix you up with methadone 
if you give me urine to get me methadone, you know like? 
However actually providing a urine poses other problems. 
Cormac He cant urinate with someone watching him, right, so what he does is he 
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gets… he’s after using it to his benefit now, what he does is he fills a 5 ml barrel with 
clean urine, someone else’s urine now, squirts it up behind his foreskin and then he’d 
say, oh right I’m ready to go! lets it go, there you go and just goes to the toilet …will 
not get a bogey urine but he does it you know and that’s you know it’s disgusting to 
think of doing that like…you know what I’m saying with girls squirting it up them and 
letting it back out… someone else’s urine. 
ICGP (2008:23) Where possible the urine sample should be directly supervised. 
However in the primary care setting this may not always be possible for logistical 
reasons. In this situation all reasonable precautions should be taken to ensure 
integrity of the sample e.g. check temperature strip on the urine jar; no coats or bags 
allowed in the toilet; laboratory testing for methadone metabolites and creatinine. 
2) ATTENDANCE SCHEDULES 
Attendance which involves the ongoing monitoring and review of 
service users was reported as erratic. Some service users attended 
weekly, others two weekly and others 4­6 weekly regardless of 
methadone dosage. 
Helen Every month yeah Dr X though sometimes only makes it every 6 weeks…well

other Dr she puts me on every four weeks every month she’s a bit more careful, but

Dr x is a.. a bit more easy going so like …

Niamh (150mls) I come down for Methadone like I would only see him six times a

year probably.

R And tell me this much if you only see him six times a year how many times do you

get it from the chemist then?

Niamh Oh I go twice a week because me dose is so high.

ICGP (2008:22) Once stable i.e. urine samples negative for opiates, a weekly review 
by the doctor is appropriate. Patients stable on methadone for a period of a year with 
urine samples free from illicit drugs may be seen fortnightly if it is considered clinically 
safe to do so. 
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3) SUPERVISION OF INGESTION 
Six service users were not having any supervision of ingestion in the 
chemist despite methadone prescriptions as high as 90mls. 
ICGP (2008:19) Once stable it is recommended that at least one dose per week is 
supervised in the chemist .Exceptions may be Stable patients on very low doses (e.g. 
<15mls) may not need supervision. Higher doses (>80mls) are potentially more 
dangerous if given in large take away doses. It may be prudent to have twice weekly 
supervision in such cases. 
Daithi (60mls) No I’m not on supervision, not at the moment.

R In the chemist?

Daithi No!

R So you take the bottle away?

D Yeah!

R You don’t ever have to take it at all in front of the chemist?

D No, no cause I’ve built up that trust you know? If you give clean urines the doctor

knows you are genuine after a while

R And when do you get your two weeks takeaway you were telling me are you

supervised in the chemist?

Padraig (90 mls and buys extra) No!

R …. No so when you go into the chemist you could take… would you take one bottle

away or would you take two bottles away?

Padraig I was at the start I just take the one away, Jesus if I took the two!

R So you can just go in and take your bottle you never have any supervised?

Molly…unless sometimes the doctor makes a mistake and he puts supervised on it

because there is a supervised box and sometimes he forgets and just marks it yes but

if they say to me you have to take it there, I have no problem taking it, once there is

nobody in the chemist.
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Follow up telephone Interview with Molly – (This is a discussion in relation to the 
fact that Molly divulged that subsequent to our interview she now had to collect her 
methadone and have supervised consumption for the first time. I explained that I had 
not fed anything back to her GP and that I was ethically bound to protect her 
anonymity). 
Molly this is not going to mess us all up is it? cause I couldn’t take it if I had to collect 
it more than once –I never had to collect it in general practice before! 
(It is unknown why this practice suddenly was changed 6 weeks post interviewing.) 
Six of the service users were not supervised at all in the chemist and 
another had only recently been started on supervised consumption of 
their methadone. This facilitated the leakage of street methadone. 
Follow up telephone interview Daithi on the subject of ’’buying extra’’ ­ its down to 
trust tightening the dose...every GP should take on patients, spread it out, its up to the 
doctors prescribing to take control, to monitor and he has to make a judgment, they 
are prescribing, tick daily supervisions, they have the final say!. 
Bracketing Interview Final 
R there is no point in having that guideline either its been made for a very good 
reason and there is very good research to suggest that patients should have their 
methadone supervised in the chemist, cause of the methadone deaths and 
methadone related deaths and letting methadone leakage out into the streets and the 
basic rule is that you tick the supervision box so the patient has to have a supervised 
dose in the chemist. 
D) WORKING THE SYSTEM 
Regardless of the fact that the supervisory details had been 
documented by the GP there were ways of circumventing the system. 
Twenty six references from 14 sources revealed different ways of 
’’working the system’’. Olwyn described her way of working the system 
in detail in relation to the pharmacy. 
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Olwyn (prescribed 90mls­ Takes 25 and sells the rest 
O Yeah, well no if I’m going anywhere now I tell the chemist. No! I need to take it in 
two doses because… I have things to do!...And that’s what I do say to him, I’ve things 
to do today, so I’m going to take half me dose and your man’s fine with it!. 
R OK so you only take half in front of him and he gives you the rest to take away? 
O Yeah I take it. 
R But in fact that day you probably would not have to take it? You’ve got even extra so 
some Mondays you can get away with that can you? 
O Eh yeah if I want to like if I want to I just ask for it, like can I take 40 mls now? I take 
45 at the moment, I’ll take 50 now and I’ll take 45 when I go home or whatever you 
know what I mean? but eh some weeks I will just let him see me taking 95 just so that 
he doesn’t be… 
R The status quo? 
O Yeah that’s it! That’s it exactly! 
R And he lets you do that? surely he knows what you’re doing then? 
O Yeah well that’s what he thinks that I’m doing! you know what I mean?...but I just 
tell him that cause I do say to him look it...that 95 mls affects me because it affects me 
eye­that’s why I go all funny…so I can’t take it all together so eh he kinda has to go 
with me like, its years of being in the system!. 
Working the system involved by­passing the guidelines for supervisory 
practices. This is in turn further influenced by the role of the pharmacist 
and communication between professionals. 
Final Bracketing Interview 
R I’m ethically and morally bound to expose this and I will be exposing the lack of 
adherence to guidelines…and in that chain of events it wasn’t just the GP, it was 
definitely the chemist who was at fault and giving divided doses of methadone and 
that wasn’t the only incidence, there were several situations where patients were not 
having supervision in the chemist and I couldn’t have predicted this was happening.I 
couldn’t have any bias because I didn’t even know this was happening.I presumed 
that everybody was ticking supervision. 
ICGP2008:19 The pharmacist is a very valuable member of the care team. Regular 
communication with the patients’ pharmacist may often have a useful insight into 
patient progress by virtue of the fact that they are seeing the patient every day. 
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5.3.4 UNDERSTANDING WHAT INFLUENCES THE IMPLEMENTATION OF THE MTP 
The MTP was initiated to provide a response to heroin misuse however 
service users described the structure of the scheme as it affected them. 
This structure was perceived to both effect and benefit others such a) 
drug misusers b) general practitioners and c) pharmacists. 
A) INFLUENCE OF OTHER DRUG MISUSERS 
The influence of other drug misusers featured prominently in 
discussions when exploring the issues of maintenance. There were 35 
references from 11 sources highlighting the responsibilities and 
pressures exerted on service users ’’to look after’’ other drug misusers. 
Attracta described how she looked after her brother giving him her 
methadone. 
Attracta (80 mls+ buys extra benzodiazepines… I was on heroin for about six

months every Sunday, just to help me brother out for a sup of phy, cause he always

done a double dose!

R So you had your methadone and then you’d not have it on the Sunday?

Attracta Sunday and I’d have heroin!.

R… give him some methadone is it and you’d have the heroin yeah?

A…only once every week, skin pop on a Sunday, every Sunday!

Other ways of carrying out reciprocal care were revealed as follows: 
R Do you feel obliged to give somebody else your urine?

Cormac ehm...some people I would because when I when I was probably using I

would’ve been with them and they probably would’ve looken after me in other ways,

you know? and you know I’d be sick and they’d say right! I’ll give you a squirt; do you

know what I mean? Just to get you sorted!
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Olwyn if it was some mad junkie came over and said, give us a urine, I’d tell him to 
fuck off! but if it was well, some people slip up all the time and they’d be afraid of their 
lives going into the doctor with a dirty urine, it’s like everything it’s like they are holding 
life and death over you, you know that way? 
Olwyn who described earlier her way of working the system also 
recounted how she had many people to ’’sort out’’ with her supply of 
methadone. 
Olwyn… he (friend) needs it ‘cause he’s going to be sick so I don’t want to be leaving

him so it’s usually getting him to meet me somewhere with his car like…

R Your brother has already met you? (For extra methadone).

Olwyn He’s already met me yeah halfway somewhere…

Two service users explained that they could respond with authority to 
the pressure exerted to provide either extra tablets or clean urine for 
‘’bogey’’ purposes. 
R So do you feel that you should look after other drug misusers?

Niamh Would in me nuts, nobody looks after me when I’m strung out!... if you want to

jeopardize your recovery for somebody else that doesn’t give a shit about you, you go

ahead and do it, but don’t come crying to me!.

Others such as Seamas who would have a clear identity as a criminal 
can be put under different pressures. 
Seamas….every gangster in the area knows me and knows me as an OK fella, anti 
police, anti things like that, … they’d be friends all my life that have done favours, 
done things for me, I couldn’t really say no if you know what I mean?, well I could say 
no, but I’d be opening meself to intimidation and all sorts then you know what I mean? 
I’d end up fighting with me own people …I grew up with, you can’t turn your back on 
everything, some people say you can, you have to make new friends but I’m forty 
years of age now, it’s not friends it’s a way of life, it’s not some fella’s got to make new 
friends these people I’ve known since I’m a young fella and what do they say? Birds of 
a feather flock together? 
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B) WHAT INFLUENCES GENERAL PRACTITIONERS? 
Exploring what service users felt influenced the GP there were 66 
references from 23 sources all of whom had an opinion on what 
influences GPs to register methadone patients. 
R Would it influence the GP if money was involved to take on methadone patients? 
Molly Oh I don’t know! Yeah, yeah, I don’t think my doctor it wouldn’t. He gives me 
the feeling that he wouldn’t, every treatment should be available for everybody, that’s 
the feeling he gives me, professional? 
One service user who is very happy with his ’’methadone doctor’’ is 
registered with another GP who recently has been signing on 
methadone patients. He described the situation: 
Daithi… he (own GP) has now started taking them on and each time I go into his 
practice to see if I’m sick he’s always pestering me, oh I’ll take you on, I’m your family 
GP, you should be coming to me, and all this…But I know, I remember Dr X telling me 
he could make a lot of money out of it and he said the more patients you take on. I’m 
telling you he’s (own GP) trying to poach me, when I go to see him I’ve told him look! 
I’m happy with my doctor (who prescribes methadone).He doesn’t give a shit about 
me to do that! To get me on his books so he can get money from the eastern health 
board and I know that! 
Others had a pragmatic response. 
Olwyn I think maybe, maybe someone, maybe someone might go in there that has a 
story that whatever might hit a nerve and it might make them think, shit like well 
maybe I should be doing something, like I have the power to do something whatever. 
Seamas who identified himself as a ’’lifer’’ displayed an ownership of 
the maintenance system and identified that his doctor recognized his 
professional responsibility to their community which he describes as 
follows: 
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R What do you think influences your GP? 
Seamas Well him himself, I think he …it’s not just a flimsy overnight thing he just 
decided to give methadone, he has. he’s prescribing it so long now and looking at the 
position the people are in now to what they were before he gave it to them, he’s put a 
lot of thought into it, it’s not just a sideline gimmick going on down here! …completely 
serious you know and we would have seen people now ... when I say we, me the 
doctor and everyone else that’s in the place…we would’ve seen people coming in 
here about eight years ago swallowing bullets and being chased all around the 
country by police in an awful condition, coming in all cleaned up and looking well and 
they’d be going off to work. 
C) THE INFLUENCE OF THE CHEMIST 
The influence of the chemist or pharmacist was described in­depth. 
There were 100 references from all 25 sources commenting on 
pharmacy services and relationships within the chemist with both 
pharmacists and staff. Influencing factors such as financial gain were 
discussed as follows: 
Saoirse …like the chemist for every patient …, yeah I think I’m not a hundred per cent 
sure but I think it was €100 for every patient for probably a month or you know which 
some chemists could have like up to probably a hundred to three hundred patients 
which is an awful lot of money. 
Negative attitudes of staff members to methadone clients were 
revealed: 
Ken The only thing, this talk about GPs, the only thing I would change is the 
chemist…go into a chemist right and like, say I’m the first customer in there, I’m sitting 
there and say four people come in and I’m sitting there for around say fifteen twenty 
minutes because there’s people coming in and out and the chemist they treat you like 
a second class citizen. It’s like, I know like it’s, how can I say this, it’s like being back 
in America in the sixties when there were the blacks and the whites, that’s exactly … 
you’re classed as a second class citizen, you know what I mean… and it’s horrible, do 
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you know what I mean, you’re just sitting there… and in the end of the day like I do… 
like they are getting paid big time for us, you know what I mean? 
Issues such as privacy as well as waiting to be dispensed methadone 
were addressed frequently: 
Niamh it’s a fucking kip!…you go into the chemist and if you walk into that chemist 
and there’s nobody there and you hand your prescription over, you’re first in that 
chemist, if six thousand people walk into that chemist behind you looking for 
prescriptions that aren’t methadone you will be put to the back! 
R is there a place in the chemist that you can have it privately take your methadone? 
Niamh no no a little fuckin a little pole and you walk behind the pole... but everybody 
knows what you’re doing when you walk behind it. 
However there were some good aspects to pharmacy encounters as 
four participants stated that they had been moved from difficult 
situations at their own request to more suitable chemists. This shows an 
ability to negotiate a change of pharmacist similar to the ability to 
negotiate a change of GP. 
Sean …but the one I go to now…he treats me with the upmost respect like every 
Christmas he gives me a Christmas present, do you know what I mean? The girls that 
work there as soon as I walk in every Tuesday morning it’s… How are ye Sean? Are 
ye alright Sean? 
Service users described how they influenced the pharmacist. 
Erica But I would still like to cut down to a lower dose. Like I went into the chemist

right and I said to the chemist, which I shouldn’t have been doing cause I said give us

40 mls!, I don’t want 80 but give me 40 and right I was delighted!.

R And the chemist did that even though the prescription said 80?

Erica Right!
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Final Bracketing Interview 
R …the really annoying thing was that the patients were being prescribed huge 
amounts of Methadone and only taking a quarter of it in terms of, you know, the fear 
that patient would withdraw and also would overdose you know so I felt I had to say to 
that patient afterwards, look, you know you really are dealing with a lethal dose here if 
you reduce that much?. 
The frustrations of the researcher are also echoed in the previous study 
where informants considered the importance of having confidence in 
dealing with deception. This took time and experience to achieve. 
Masters study Informant 1...if people are not being truthful I will let them 
know…there is no point in letting them think that they’re getting one over on you …so 
you have your antennas out all the time. 
SUMMARY 
This third theme was developed from the meaning statements where 
service users described their understanding of the Methadone 
Treatment Protocol. Meaning units developed were: why the protocol 
was necessary­ what the protocol means to the service user­ and 
understanding what influences the implementation of the MTP­
These findings will be discussed further in Chapter 6. 
138

5 .4 THEME 4

THE EXPERIENCE OF ADDICTION AND

IT’S EFFECT ON FAMILIES

Figure 4 The Experience of Addiction and Its Effect on Families. (NVivo Model) 
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5.4.1 THE EXPERIENCE OF ADDICTION AND IT’S EFFECT ON FAMILIES 
This theme was derived from the developed themes in which the 
service users described their individual experiences of addiction and the 
effect it had on their families. Throughout the interviews the essence of 
the lived experience of addiction was evident. Expressed were 
descriptions of identity as opposed to the self descriptors associated 
with the dosage of methadone consumed, identified in Theme 1. Also 
evident in the descriptions were scenes of family life which involved the 
effects of drug misuse on children and how family is both valued and 
seen as a significant issue in both recovery and relapse. Meaning units 
were described as: identity, pregnancy and post­natal effects on the 
mother and baby and the support of general practice for women. 
As the study is oriented to the experiences related to general practice 
the meaning units which were not directly related to this experience 
have been omitted in the results. These experiences are important as it 
is the responsibility of the family practitioner to provide care for families. 
5.4.2 IDENTITY 
The perceptions service users hold about their identity as a drug 
misuser receiving methadone sheds light on how that identity is 
constructed by the environment in which they live. There were 80 
references from 24 sources exploring the feelings attributed to the 
stigma associated with being an ‘’addict’’, a ‘’junkie’’ or an ‘’ex addict’’. 
These feelings were expressed as what I am called and what I have 
seen. 
a) WHAT I AM CALLED 
Six service users expressed a wish not to be called ’’junkie’’ while 16 
referred to themselves or others as ’’addicts’’. 
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Niamh I don’t know but a lot of people would be ignorant toward the whole drug thing 
in their eyes maybe I’m a ‘’junkie’’, in my eyes I’m an ‘’addict’’! 
R or an ex­addict? 
N no, I’m an addict 
R Addicted to what though? 
N I’d say I would be addicted to methadone now right but I am just an addict and I 
have an addictive personality like… I smoke like heroin you know what I mean like? I 
would just say, I’m an addict and I have an addictive personality, so I can’t kind of get 
sucked up in all that drug thing again because of the addictive personality, it’s going to 
lead to death. 
Feelings were expressed in relation to attitudes of doctors in the 
treatment clinic and how that impacted on issues of identity. 
Sean You feel subservient yeah as if the health board are trying to keep you that way 
but in a way …but even people that work in certain places even say the same thing 
about (doctor in clinic) she thinks she’s just up here and we’re all down here like with 
the attitude she has towards addicts especially, that’s why I can’t understand why she 
is working with addicts doing all this like when she this awful god complex about her 
just because she is a doctor. 
The following extract identified that stigma and marginalization are 
features of the difficulties that drug misusers encounter regularly­ this 
extract features the attitudinal stance of nurses: 
Attracta… yeah there’s always one, you’ll get one I’d say out of six nurses that has it

for drug addicts, they just think you’re a needle user, well everybody does when you

say you’re on methadone!

R Everyone?

A Everyone insinuates oh God, Jesus she’s stuck needles in herself and that’s it!

Two service users expressed other aspects of identity which were 
defined by past criminal activities. 
Seamas… no and I am what I am in the community…I was like a band of thieves and 
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we had an old fella Fagan and all and my father Lord rest him, he was a thief was an

armed robber himself! Himself and me mother tried her best but she wasn’t there all

the time you know? She worked and stuff so we were ehm I won’t go as far as saying

we didn’t know any better you know, like twenty years ago, the recession in the

country and things was different.

Cormac… that’s probably you know, the dealers in the area would know that I’m not

buying so like obviously I’m doing all right you know?

R So now you’d be a target for people?

C… yeah they’d be trying to pull me back in or get me selling one or the other like you

know he’s clean get him …!

Identity and stigma were interwoven concepts throughout the interview 
dialogues and the new or transformed identity of attending a GP was 
considered an advantage. 
Saoirse Like they’re very respectful and you know you’re not treated ehm any

different from any other patient.

Assistant Researcher So the whole thing about being treated the same like kind of,

you’ve acknowledged that you have tried to move away from that to be treated with

some …not looked down on that’s very important?

Anastasia yeah that is important.

AR and you get that here?

A You do you definitely get that here… I’m treated the way other patients are treated

yeah.

Bracketing Interview 5 
R we’re back to the fact, and part of the whole experience is that patient’s moved from 
one identity to another. The identity of being a ’’chaotic drug’’ addict in a treatment 
clinic, to the identity of somehow progressing and transforming that identity into one 
that now is a ’’normal’’ identity and a ’’stable’’ identity which is attributed to Methadone 
and general practice. 
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B) WHAT I HAVE SEEN 
Identity was also described within the descriptions of the social 
environment that service users found themselves immersed in. There 
were 34 references from 13 sources describing the experience of death 
both as a result of drug overdose and suicide. This was described as 
what I have seen. 
Erica And though I ended up in hospital that time, me mother died, me sister killed 
herself I got a load of money, I had a car I just went on a fuckin mad one and I just 
ended up giving meself a…. And I found my groin! 
Ken I was only twelve when I seen me first OD, I seens a bloke going blue to white to 
grey… I was only twelve and like that’s not nice for a kid to see. 
Robert… there with a big branch sticking out I think they’ve taken it down now and he 
hung himself there, and he had his methadone in his pocket and his tablets in his 
other pocket you know what I mean? yeah I seem to be cursed I am, sometimes I feel 
cursed or something… yeah like if its someone close or someone that you know too, 
you’re like Jesus Christ anywhere I go someone croaks it or something. 
The effect of drug misuse on families was described by numerous 
participants: 
Cormac… and there used to be another chap whose brother died of an overdose in 
the meantime, he only died two months ago like from an overdose a drug overdose 
you know… his father hung himself over them going on drugs like he was dead and 
his family is from (locality)who were all big drug dealers. 
Kaitlin My boyfriend died and it’s just …

R I’m very sorry was that through drugs?

K… it was actually mm it said in the Coroner’s report that there were excessive

amounts of methadone in his system.

R… and were you told the cause of death was excessive methadone?
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Kaitlin That’s what they had down on the report yeah …nobody ever discussed with 
me about it; they only discussed it with his mother. I still don’t know to this day was it 
methadone, you know he was my long term boyfriend. 
Field Note Re Kaitlin 
She said her own mother had died 6 weeks ago – I wondered and asked her if it was 
alright to continue – she said she had told the nurse and it was ok­ she wanted to do it 
… the coroners report showed an excessive amount of methadone in her boyfriend’s 
system­ no other drugs. She had been given no explanation. 
These excerpts highlight the world of drug addiction which the service 
user is exposed to on a regular basis. No service user expressed that 
they had received counselling in general practice in relation to these 
events. 
Final Bracketing Interview 
R I’ve learnt so much about methadone deaths, you hear so much about it you almost 
become inured to it until you see somebody in front of you saying you know he died 
from a methadone overdose. 
5.4.3 PREGNANCY AND POST­NATAL EFFECTS ON THE MOTHER AND BABY 
Service users described how they attended the GP surgery with their 
children. Nineteen service users had children (37 children Appendix 7 
Table 3). Twelve service users (n=10 Female, n=2 men) utilised general 
practice for their children’s’ needs as well as their methadone 
prescription while 19 of the sample had children. Describing their 
treatment while pregnant or in the post­natal period, the benefits of 
general practice were described in comparison to the treatment 
received in both treatment clinics and hospitals. Maintenance 
prescribing is the core treatment for managing pregnant women 
dependent on heroin. Those on methadone in pregnancy are noted as a 
special group which can be looked after by a Level 2 GP using a shared 
144

care ante­natal model. 
Ten women and 1 male participant described their experience of 
pregnancy while they or their partner were taking illicit opiates and or 
methadone. These responses were divided into a) professional 
attitudes b) neonatal effects and c) post­natal difficulties. 
ICGP (2008:27) Attracting and maintaining women in treatment is important and 
should always be prioritized. 
A) PROFESSIONAL ATTITUDES 
Most of the discussion revealed that the service users focused on 
negative professional attitudes in maternity services both in relation to 
pregnancy and the use of methadone. 
Molly Going in and giving your details, everything’s OK and as soon as you say you’re 
on methadone they would change, how could you do that to a baby? 
R And do you feel that you could have one now? 
Molly I wouldn’t have one now, it’s too late now, I’m thirty­six now and I thought I’d be 
well off the methadone by now yes. 
R So what you’re saying is that you have two concerns about being on methadone the 
effect on a baby and the other thing would be how people treat you. People that you 
are talking about, am I right, would be people like me? doctors? what about other 
people? 
Molly. Well not really cause in the way that they treat you different, like… mm I just 
won’t have another child! 
The following extract highlights the feelings expressed when Attracta 
who had been cared for during her pregnancy in general practice went 
in to the maternity hospital: 
Attracta.It’s like you get a gown thrown at you the minute you hit the door, little holy 
angels it’s called when something’s wrong with your baby, if it’s a baby addict I 
think!(Tearful). 
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Masters Research (Informant 8) 
I worked in a hospital for a long time...I mean they were treated like lepers, you know, 
we were gowned and masked. 
Rosin, who was also cared for in general practice throughout her 
pregnancy, expressed her feelings about how her care was managed 
post­natally in the hospital. 
Rosin Now I wanted to breastfeed me baby because he was so small right and the 
nurses made that virtually impossible! 
R Why? 
Rosin They ran me around the hospital like a blue arsed fly saying, there’s a breast 
pump downstairs! No there’s a breast pump upstairs! No it’s downstairs! go up to the 
first floor and they’ll give you one, up to the first floor, oh I’m telling you now it’s 
downstairs…he missed out on the colostrum right? he ended up… he did get an odd 
bit of breast milk here and there but it just messed the whole thing up on me. A doctor 
called x came up to me and tried to talk me out of breast feeding the baby saying that 
I was HCV positive OK? and that I shouldn’t be breast feeding the baby, that if I had a 
cut on me nipple that basically the baby has a fair chance of getting it …but I was sent 
back up again and then a nurse sat in with me, spoke to me and she more or less 
gave me her opinion and I could hear the judgmentalism coming across and I told her 
well, look, even monsters love their babies! and if that’s what you think I am, I still love 
me baby regardless OK? 
Two participants spoke positively of liaison midwives. 
R Did you meet a liaison midwife?

Niamh Yeah aw she was great she was very good very ordinary… very open and I

didn’t feel mistreated, I didn’t feel that…

Linking up services from primary care to the maternity hospital is the 
remit of general practice as outlined in the guidelines as follows: 
ICGP (2008:27) Liaison midwives appointed by the HSE, work in the three Dublin 
maternity hospitals. Their role is to provide a link between drug treatment services. 
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However professional attitudes were also negative as Erica described 
her past experiences when she asked if she could commence 
methadone while pregnant. 
Erica Now I waited until seven months thinking I could get on the methadone… Now I 
wanted some guidance from the clinic… do you understand? 
R What’s the right regulating dose? 
E Yes because if… I didn’t understand what’s the best thing I could do for my baby 
and ehm now I was taking methadone and I stopped using MSTs at night but I wanted 
their guidance and your woman said we can’t give you methadone on your last 
…(Trimester)…I went onto the Temgesics myself. Somebody else told me who was a 
drug misuser­ they’re not addictive cause they’re not as strong, go on to them! 
This extract highlights a missed opportunity of engagement at the time 
of pregnancy. 
B) NEONATAL EFFECTS 
Seven participants discussed neonatal withdrawal symptoms with two 
stating that phenobarbitone was required for their babies. 
Erica …they didn’t recognize it though. She was a little twitchy, you could just see a

little twitch in her eyes, you know but she did cry out and she fed OK… Now a fella

came in….. All my eh, withdrawals left me through birth when I gave birth. I came out

of it and I had no withdrawals, it was grand.

R Did she have any withdrawal?

Attracta She had jaundice, no and I was looking at her I kept saying what am I waiting

on her to do like?...yeah I did the legs!

R…The legs, they twitched?

A …twitched, the knees and all just goes up and down and it broke me heart, cause

the poor little thing I felt so sorry for her!

Helen Oh I’ll never forget it, yeah and like all through the child had a problem taking

her bottles and she just kept getting sick!
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Field Note Text message from Helen (post interview) 
Thanks for the gift voucher but there was really no need. I found it therapeutic to talk 
even though it brought back painful memories I’d rather forget of my child being in 
hospital for 126 days. 
Four participants admitted taking heroin at the time of pregnancy. 
Niamh I ended up using when I was pregnant!

R Did you?

N I used when I was pregnant (whispers) it was like you can’t do that and I was like

yes! I fucking can! I want to do it!

Sean she found out she was pregnant she was after using that morning I went straight

out then and I got I bought a bottle of methadone on the street …and I regulated the

dose so that she would be ok she wouldn’t feel any withdrawals but at the same time

she wouldn’t be stoned do you know what I mean?

C) POST­NATAL DIFFICULTIES 
Five participants recounted post­natal difficulties and described how 
they reacted, with 3 increasing their methadone dosage and 2 taking 
illicit drugs. 
R Did you go back on anything then?

Erica Somebody came in and brought me in Temgesics and I went to the toilet and I

banged them up, I found one of them CIN bins got works out of it went to the toilet

banged them up came out and breast fed her.

Helen was cared for in general practice and recounted her experience 
of requiring extra methadone. 
R and did you feel like getting any extra methadone then or any extra drugs 
Helen …like that’s the thing like when I came actually home from the hospital I went 
straight to doctor and and I got straight back up to to 40 I got 60 mls and then up to 
80, I didn’t want to stay up to 80 like 
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R Why did you think you needed extra then?

H The strain I just needed something to calm me down and what do you call it get me

through this… l and seeing me baby like that …

Saoirse opted to have ante­natal care in the hospital but attended her 
GP weekly also for methadone maintenance. Post­natal relapses were 
revealed: 
Saoirse… was down to 20 mls and I relapsed. It wasn’t relapsed on heroin it was on 
methadone. After I had a, I had a baby seventeen months ago and he was in 
intensive care for six weeks and with the other four kids, it’s no excuse like you know 
but I was up and down from the (Maternity hospital) three times a day and then back 
to school and I just started taking an extra sup of methadone for the energy like and 
but it built up and it built up and it built up like, you know where I was on 20 mls then I 
got back up to 80 mls which was an awful lot for me cause I wasn’t used to taking that 
amount that was a big jump like but I’m coming back down like slowly now so …I think 
it was to meself as well the doctor, like I didn’t want to admit kind of that I needed 
more you know what I mean cause I was doing so well you know ….(Saoirse 
renegotiated with her GP and her methadone dose was increased). 
Rosin I was down I think to 30 mls at the time and I had to go back up to 80 mls 
cause the baby was taken and I was hoping to cut down more 
R How soon then after that did you feel that you needed the gear again? 
Niamh The week after she was born I had a slump it was like I deserved it! 
5.4.4 THE SUPPORT OF GENERAL PRACTICE FOR WOMEN 
Three service users described the support they received in general 
practice both during pregnancy and post­natal care. All three were 
cared for under a shared care model. 
R But who looked after you during your pregnancy when you were on the methadone? 
Attracta Oh here yeah I came here of course! 
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Helen Dr X has always been my GP...since I had my first child…I saw that nurse

when I was pregnant … actually (doctor) was here she was with me when I was

pregnant through me pregnancy.

R … and during your pregnancy your doctor looked after you here as well?

Rosin Oh yeah!

R And she changed the methadone dosage?

R yeah!

Rosin… eh I had that (coil) done two or three weeks ago.

R Great and the nurse or the doctor did it for you?

Rosin Both.

All expressed confidence in their GP and described continuity of care. A 
follow up telephone interview with Helen revealed that she felt she had 
possible post­natal depression (the baby was then 7 months old) but 
was being monitored by her GP. 
Follow up Telephone Interview …you basically captured everything(in the interview) 
­ doctor is very helpful ­ very caring –she has put me on a watch, monitoring me ­ all 
the services are there… 
SUMMARY 
This theme was derived from the developed themes in which the 
participants described their own experiences of addiction and it’s effect 
on their families. Meaning units were described as: identity, 
pregnancy and post­natal effects on the mother and baby and the 
support of general practice for women. This theme explored the 
meaning of addiction and how that impacted on service users home 
lives and shed light on where general practice fitted in within the context 
of family. These issues will be discussed further in chapter 6. 
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CHAPTER 6: DISCUSSION OF THE FINDINGS

6. 1 INTRODUCTION 
This chapter discusses the findings in relation to the general body of 
knowledge, reflecting on the original literature review, the objectives of 
the study and the outcomes of the analysis. Prior to this 
phenomenological study there was a scarcity of literature pertaining to 
service users’ views of methadone treatment in general practice in 
Ireland. These views and experiences are an important resource in the 
substitute prescribing process (Neale 1999) and give insight into the 
professional intervention of service providers in the lives of service 
users. Considering the perspective of these service users in the context 
of current practice, the aim of the study was to explore how the MTP 
was being implemented in general practice. The objectives of the study 
were to describe the users’ lived experience of treatment and their 
experiences of being involved in decision making and management of 
their treatment. The findings enable us to discern both the benefits and 
shortcomings of methadone treatment in General Practice in Dublin and 
identify what steps may be required in addressing any limitations or 
deficiencies in treatment. 
6.2 THE LIVED EXPERIENCE OF THE MTP IN GENERAL PRACTICE 
The essence of the lived experience of receiving methadone treatment 
was described in a myriad of ways which reflected the multiple complex 
interplays between what the service users had experienced as a result 
of their personal history of drug addiction and what they now depicted 
as their experience of treatment in general practice. 
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Describing their past experiences of addiction most of the service users 
expressed their views in terms of what I am called and what I have seen 
as if these experiences together were connected to their current 
identity. The stigma of what I am called was described as one which 
was embedded in a past identity of ‘‘junkie’’, whereas now those who 
were registered on the MTP viewed themselves currently as an ‘’addict’’ 
or ex ‘’addict’’. ‘’Junkie’’ was seen as an unacceptable identity. This 
transformation seems to have occurred due to the decision to opt for 
methadone treatment which was viewed as more acceptable in the 
inner city community of Dublin than being categorized as a ’’;junkie’’. 
The concepts of this past identity or what researchers have labeled as a 
‘spoiled identity’ were laid bare as service users spoke retrospectively 
of their drug misuse and described the environment they lived in. Issues 
such as these are often not voiced or heard (Etherington 2008). 
McIntosh & McKeganey (2001:51) speak of the central feature of a 
spoiled identity as being the realization by an individual that he or she 
exhibits characteristics that ‘are unacceptable both to themselves and 
significant others’. This invokes the concept of stigma which although 
felt acutely by the service user, gets little attention. It is clear from the 
findings that consuming methadone provides a differentiating social 
identity. These findings have resonance with an ethnographical study 
carried out among an opiate consumer community in Barcelona (Spain) 
from 1994 until 2000 which analyzed the meanings that consumers 
build and handle around the substances that they consume (Albertín & 
ÍÑiguez 2008).Their approach emphasized the consumers’ 
understanding of drugs and the type of relationships they maintain 
between themselves and their social environment. Those taking heroin 
were recognized as active members of the group of consumers while 
those who took methadone were considered former ‘mates’ who had 
opted for methadone treatment. The findings of the current study 
describe a new identity which has been constructed not only by entering 
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a treatment environment and leaving the addicted lifestyle but also as a 
result of taking methadone. Methadone identities were described further 
and self definers such as ’’lifer’’, ’’maintainer’’ and ’’reducer’’ evolved 
and were developed. ‘’Lifers’’ appeared to choose to remain on 
maintenance, ’’maintainers’’ identified themselves as happy with current 
treatment although many topped up their methadone or bought extra. 
‘’Reducers’’ were enabled to have a treatment plan over which they had 
control. The community environment where treatment was situated 
constituted a significant deterrent for both lifers and maintainers to 
change to a more transformed identity. Those who were reducing their 
dose of methadone did not report being involved in diversion and as is 
consistent with the established literature on recovery (McIntosh & 
McKeganey 2000a, 2000b, 2001) appeared to be managing to 
construct a life outside that of drug addiction and were developing 
strategies which did not seem to pose a threat to their new status. 
These self definers or descriptors signaled a new identity which was 
reconstructed subsequent to the service users’ existence as a heroin 
addict. This process of change communicated a transformation to a 
new and in most cases preferred identity of methadone user. 
The concept of treatment identities constructed by the substance of 
methadone has been discussed in the literature review (Fraser & 
Valentine 2008). The data prompt further consideration of how service 
users constitute their experience of methadone and what social roles 
this treatment creates. This has more than descriptive power and 
attention needs to be paid to the formation of these new identities. This 
challenges service providers in general practice to become cognizant of 
how service users view themselves and the identity that is created by 
not only the dosage of methadone that is prescribed but also how that 
translates into practice and the controlling aspects of treatment . 
The concepts of stigma and identity were further constructed by the 
experiences associated with the past environment of drug misuse – 
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what I have seen. The trauma of suicide, drug related deaths, sexual 
abuse and violence in the home was an integral part of the stories 
expressed in the interviews. These descriptions of multiple deprivations 
associated with drug misuse which synergistically exacerbate one 
another have also been described in Dublin by Saris (2008:11). He 
postulates in most respects that these are impervious to easy solutions. 
What each service user had in common was a desire to rebuild this 
aspect of their identity and their future. 
General practice is a place where these issues could potentially be 
discussed and receiving treatment in general practice rather than a 
treatment clinic was viewed by service users as both transformative and 
beneficial. Similar to the study by Lawless and Cox (2003) a key 
advantage of GP involvement in MMT was seen as a reduction in 
stigma. There were several other beneficial aspects identified in relation 
to this treatment environment, described as a place to be treated as an 
individual, a place to get clean, a place which is confidential, a place to 
reduce, a place to develop relationships and a place to sort things out. 
As identified previously in the literature, general practice in Dublin had a 
history of being involved with drug misusers prior to the introduction of 
the MTP (O’Kelly et al 1986, 1988, 1996) although GPs initially began 
methadone maintenance prescribing because of the problem in their 
practice, rather than a special interest in drug addiction (Langton et al 
2000). Historically the response was reactive rather than one of planned 
care. Nevertheless service users in this study spoke positively of the 
current treatment environment. This ‘place’ was different and distinct 
and a place where the overall experience of care was valued in 
comparison to past experiences in treatment clinics. 
These descriptions were meaningful in the lived experience of service 
users as the clinical environment of general practice was defined as a 
place to be treated as an individual. There are several pragmatic 
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reasons for valuing individuality. Many of the informants had children 
(76% Appendix 7 Table 3) and most described care which was carried out 
by the same GP who prescribed their methadone. The reality of 
attending weekly, having designated appointment times ‘‘just like every 
other patient’’, having problems sorted out at this time and being 
afforded the opportunity to normalize their lives was described as 
distinctly related to the setting of general practice. Those that attended 
frequently other than at their designated time for methadone, attended 
with their children. 
Clinical guidelines on drug misuse and dependence in the UK stress 
that when providing appropriate care for drug misusers the clinician 
should focus on the patient themselves but also take into consideration 
the impact of their drug misuse on other individuals–especially 
dependent children–and on communities (DoH England 2007). It is 
known that Illegal drug misuse tends to cluster within families (Forsyth 
2003) and children who have been exposed to opiates in combination 
with additional drugs can have a high risk of delayed development and 
behavioural disorders (Sandtorv et al 2009). Service users recounted 
their experiences as mothers and fathers and their accounts provide an 
insight into the lives of families affected by drug misuse. Prior to this 
research the vulnerability of female drug misusers and their babies 
during pregnancy and immediately post partum had been relatively 
ignored in the Irish literature, although female drug misusers and their 
children have been identified in Ireland as having particular needs that 
require careful consideration in service planning and provision (Farrell 
et al 2001). The numbers of females in treatment are increasing in 
Dublin and the ratio of male to female opiate users is estimated as 3:1 
(Comiskey 1998) with 28% of female drug misusers who present for 
treatment living with another drug misuser compared with 18% of men 
(Moran et al 1997). The support of general practice for women was 
evidenced by the stories told by the women (14) who described 
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services they received both for their children, and themselves. Women 
described support in addition to methadone treatment as specific to 
womens’ health issues such as ante­natal care; post­natal care; cervical 
screening; weight reduction information; investigations of infertility; and 
provision of medical care for childhood illness. Effective treatment of the 
parent can have major benefits for the child. Frequently high levels of 
unmet service needs have been reported among drug misusing women, 
particularly for legal, housing, medical and employment assistance 
(EMCDDA 2009, Smith & Marsh 2002). The data suggest that the GPs 
in this study were providing gender specific services for female service 
users and thus fulfilling an important service need for this cohort. 
However, as was evidenced in this and the foundational study (Latham 
2003), stigma and marginalization was experienced from professionals 
both in ante and post­natal care within the maternity services. It is 
recommended that women on MMT are encouraged to breastfeed 
(Jansson et al 2008) and two of the women in this study did, although 
one who was HCV+ was actively discouraged in the maternity hospital 
regardless of the fact that she herself was aware that the risk of 
transmission during breastfeeding is low (Polywka et al 1999). A recent 
National survey of neonatal units in Ireland and the UK supports this 
finding as it identified that mothers on methadone whose serology was 
positive for hepatitis B and/or C were four times more likely to be 
discouraged from breast feeding (O’Grady et al 2009). 
It has been recommended that better treatment for drug misusing 
women should involve the whole healthcare team from receptionist to 
doctor and that assessment, triage, case coordination and referral 
services should be provided in a supportive, culturally sensitive, and 
non­judgmental environment (Winklbaur et al 2008).This was not 
evident in these findings. Recounting their experiences of pregnancy 
and the post­partum period, service users discussed their fears 
surrounding their babies potential withdrawal and their own difficulties at 
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that time. From the concerns expressed it was clear that specialist 
services had failed to assume full responsibility for their clients and that 
service provision was not individually tailored in the maternity hospitals, 
although two service users spoke positively about liaison midwives. 
Toner et al (2008) when exploring the views of professionals and 
service users with regard to maternity drugs service provision in Bristol, 
UK, found that effective multi­agency and multidisciplinary working; 
early engagement; a service­user centred approach; positive and non­
judgmental staff attitudes contribute to good maternal and child 
outcomes. Consistency and clarity within and across complex services, 
and continuous service development were identified as necessary to 
effectively meet the needs of an extremely vulnerable population. This 
was not evident from the reports of service users in this study. In the 
short and longer term international literature relates that mother and 
child do best if multi­disciplinary treatment is initiated as soon as 
possible in pregnancy, maintenance prescribing is permitted, and there 
is regular monitoring (Winklbaur et al 2008). The potential effect of 
maternal methadone dose is very important (Lainwala et al 2005) and 
infants of women included in substitution treatment programmes have 
been shown to be at high risk compared to infants of women without 
such an addiction. Level Two GP’s skilled in combined care services 
were caring for these women in general practice and had the ability to 
maintain this specialist service within the treatment environment of 
general practice (ICGP2008)­(At present Level One GPs are 
encouraged to refer pregnant drug misusers to liaison midwives and 
specialist services).This is a significant issue for general practice as the 
use of opiates by pregnant women may result not only in a withdrawal 
syndrome in their newborn infants but also disruption of the mother­
infant relationship, sleeping and feeding difficulties, weight loss and 
seizures. Coghlan et al (1999) have described the baby with neonatal 
abstinence syndrome as the ‘most vulnerable victims of drug misuse’. 
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They carried out a twelve month review of infants admitted with 
neonatal abstinence syndrome to a Dublin neonatal intensive care unit. 
The study revealed that the duration of withdrawal symptoms is loosely 
related to drug type, but an increasing duration of symptoms was noted 
for infants exposed to benzodiazepines. As documented in the review of 
the literature this is also a significant issue in practice and the findings 
also reflect a prevalence of benzodiazepine misuse which is particularly 
prevalent in Irish females (NACD DAIRU 2008). Problems with 
parenthood and managing these mothers and babies can be 
challenging for the GP in the inner city (Latham 2009). Six of the 
women in the study reported that they did not use benzodiazepines, five 
were prescribed benzodiazepines and bought extra as well and three 
reported that they just bought their own supply. This finding is not 
unexpected as Quigley (et al 2006) identified a pattern of higher 
diazepam prescribing in areas of greatest deprivation, where 
prescription sedatives play a complex role within troubled families. 
Female patients living in the most­deprived areas were found to be 
more likely to receive diazepam than those living in the least­deprived 
areas and the neighbourhoods where GMS benzodiazepine prescribing 
was highest tended to have the highest rates of treatment for opiate 
addiction. 
Considering the views expressed by these female service users it 
seems essential that women are provided with continuing support both 
while in general practice and also when they transfer to maternity 
services from the gateway of general practice. This study has shown 
that women on methadone maintenance do attend with their children 
and receive gender specific care which they value. The findings suggest 
that the co­ordination of care and support for women during the 
vulnerable period of pregnancy is available in primary care however 
these findings highlight a need for co­ordination of care to be 
strengthened between specialist services and general practice. 
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Men also valued their GP and this was expressed by the majority of the 
participants. This value placed on general practice has resonance with 
the recent ‘Essence’ study carried out in the UK which sought to distill 
the essence of general practice from the experiences of the general 
public and doctors themselves (Gillies et al 2009). This work was 
conducted over four years as a constructive response to changes in 
general practice and used commissioned short pieces of 100 words 
from GPs and patients. Questions such as­ What do you value from 
your GP? identified similar concepts such as being treated as an 
individual, valuing the GPs’ attention and time and valuing the ability to 
consult well. Feedback from service users both male and female in this 
study have identified for the first time the importance of the treatment 
encounter with their GP who ‘’knows them’’ in relation to methadone 
treatment. This is noted as being significant, as rather than being 
treated as part of the collective drug using cohort that attends a 
treatment centre, they are treated individually. This is important finding 
as recognising individuation is an important component in a process of 
transformation from drug misuse to recovery (Etherington 2008). 
Identities are defined within interactions with others and are dependant 
upon the social discourse that is available. An important part of the 
process of maintaining and reforming one’s identity lies in the 
individual’s ability to interpret the messages which he or she receives 
from others and to accept, reject or modify them (McIntosh & 
McKeganey 2001). The treatment encounter with the GP has the 
potential to influence this process of recovery either negatively or 
positively. The training and equipping of GPs in this respect needs 
further focused attention and as identified in the review of the literature, 
there have been calls for the specific training of GPs in the RoI which 
equips them in reflective approaches to patient encounters (O’Riordan 
et al 2008).This reflection on the consultation may assist GPs to 
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recognise those service users who require psychological care in the 
recovery process from addiction. 
General practice was indeed identified as a place to develop 
relationships. The doctor­patient relationship appeared to be facilitating 
the ‘’normalization’’ of the service users’ drug treatment and therefore 
fulfilling one of the primary reasons the MTP was initiated into general 
practice from the perspective of service providers. Many of the service 
users (70% Appendix 7 Table 9) were attending their GP for five years or 
more and as identified in the literature review, length of time in 
treatment has been found in many studies to be one of the most 
consistent predictors of favourable post treatment outcomes among 
drug misusers (Gossop et al 2001). However despite the emphasis on 
treatment duration which is a measure usually attributed to treatment 
effectiveness from a service provider perspective, the majority of 
service users described personal relationships with their GPs and being 
listened to, described by Rosin as in itself a cure. Continuity of care with 
the same doctor was described and service users told of a repeated 
consultation pattern with the GP who knew them. In many cases 
‘’knowing the patient who has the disease’’ has been identified as 
important as ‘knowing the disease that patient has’’ (McCormick 1996). 
As identified by Holt (2007:1938) this ‘know ability’ of the treatment 
context and also the apparent change in status of the drug treatment 
client from ‘autonomous agent’ to ‘participant in treatment’ is significant. 
Experiences of the service users attested to a long term personal 
doctor–patient relationship which has previously been identified as 
important (Freeman & Hjortdahl 1997, Stokes et al 2004). This was not 
only defined by the unique nature of the doctor­patient relationship 
(Balint 1964) but also described by service users as (similar to the 
RCGP definition) a ’knowledge’ and ’trust’ engendered by a familiarity 
with past care where their doctor recognized their professional 
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responsibility to their community (RCGP 2009). This past care was 
identified succinctly by Attracta: sure he knows me since me mother 
had me, she’s been bringing … well lord have mercy on her she’s a 
long time dead now but I remember going to him when I used to sit on 
the big huge pram. General practice has been described ‘as a place’ 
where diseases come and go but patients stay whereas hospital has 
been described ‘as a place’ where patients come and go but diseases 
stay (Heath 2005). Recent changes in family practice in some countries 
encourage large multi­physician groups where it is unlikely that a 
patient will continuously see the same doctor (Agarwal & Crooks 2008) 
yet in the RoI this situation is not commonplace. Continuity of care is 
seen as an indicator of quality in general practice and was valued by 
the frequent attender on maintenance therapy. Some patients such as 
Erica saw their GP every week ­like every week fifty bleeding two 
weeks a year. This relationship building underlines the importance of 
what Lilly et al (2000) described as ‘sociality’ in treatment. This study 
emphasises that the interaction with the GP is viewed not just as a 
medical encounter but fulfills an important social function. I wouldn’t see 
anybody in the week or the only person I’d see would be Dr.X,.. and I actually felt a lot 
better walking away like he does… he’s a caring man. 
However although the majority of service users described a good 
relationship with their doctor paradoxically the potential for another type 
of relationship was also described in the data­‘’the phy doctor’’ 
(Physeptone). Three service users recounted a rushed consultation 
pattern when attending their GP. They perceived a lack of interest in 
their emotional well being and lack of experience in understanding drug 
addiction. This finding highlights the importance of the GPs’ ability to 
consult well as identified in the Essence study (Gillies et al 2009). 
Investigating methadone dosing in Victoria investigators found that for 
their service users, a proactive and even interventionist approach was 
favoured in the consultation–this was an approach that required greater 
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resources for service providers to either spend more time with patients 
or to have support staff who could do so (Lintzeris et al 2002). As 
discussed in Chapter 1, lack of therapeutic engagement (Wilkinson & 
Mistral 2003) and physicians attitudes (Fitzpatrick 2001,Grehan 2007) 
can affect the relationship between patient outcomes and elements of 
the therapeutic process which should be addressed in the consultation 
(Simpson et al 1997, Towle et al 2006). Thus significant factors in the 
experience of effective treatment appear to be the building and 
preserving of relationship and rapport between service users and 
service providers and providing a quality service which is dependant on 
the caliber and characteristics of the service provider and respect and 
dignity of the individual (Fletcher et al 1997, Lilly et al 2000). 
In the light of this data consideration of the proper role of the 
methadone­prescribing doctor is required. Issues of prescribing power 
identified in the literature review present an opportunity for control and 
the potential creation of obedient subjects rather than a partnership 
approach to care (Burgois et al 1997, Keane 2009). Drug misuse is 
associated with a range of health and social problems for both the 
community and the user (Ward 2002). Acting first to reduce social 
suffering, the GP needs to be cognizant of the whole picture. Patients 
can consciously conceal problems because of shame and or guilt and 
they can avoid disclosing painful facts. Non disclosure and denial 
coupled with the GPs lack of time and perhaps specific training means 
that the goal of the consultation is not achieved. These goals are 
expressed as obtaining accurate information about the substance 
misuse, achieving consensus about what behaviour requires attention 
and arriving at a mutually acceptable plan for treatment. These may 
conflict with the patient’s pattern of avoiding acknowledgement of the 
problem (Billings & Stoeckle 1999). This highlights an approach to 
practice advocated by Rhodes which understands how context 
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influences health and vulnerability in general as well as drug­related 
harm specifically (Rhodes et al 2003, Rhodes et al 2005). 
As identified in chapter one, the role of environmental–contextual 
factors in limiting the ability of drug misusers to embrace individual 
behaviour change in order to reduce drug­related harm has not been 
addressed adequately up to this juncture (Moore & Dietze 2005:1). How 
the addict identity and lifestyle are developed and the changes that 
must occur in order to create a transformed identity have great 
significance for treatment. General practice needs to be aware of this 
transformation and reconstruction of identity and not assume that 
identity is fixed by the identity constructed due to the substance of 
methadone. Pathways to recovery and transformation have been 
advocated in this respect but specific training is required (Etherington 
2008).These issues need to be divulged in a confidential and safe 
setting and service users spoke positively about the assurance general 
practice afforded them within the GP/ patient consultation. 
Confidentiality described as, a place which is confidential, was seen as 
paramount. These views were again described in contrast with service 
users’ experiences in treatment clinics. Reflecting back on the initial 
literature review, the importance of confidentiality was identified by O’ 
Reilly et al (2005:9) who detailed this expressed concern of service 
users attending treatment clinics. These participants recounted that 
people who should not know their business, did. Some users regarded 
the use of identifying stickers on their charts and the use of signage, 
such as ‘‘infectious diseases’’, as insensitive and stigmatizing. Recent 
research from a consumer satisfaction survey by service users at the 
National Drug Treatment Centre also suggested that service users have 
sought more privacy while accessing treatment. (Ambreen et al 2008). 
When confidentiality was lacking, as in the reception area, informants 
felt exposed and three incidences were described in two separate 
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general practice sites which were attributed to the lack of confidentiality 
among reception staff. In light of these findings, GPs need to consider 
the lack of privacy in the reception area and how this aspect of service 
can negatively affect the treatment encounter. Recent observational 
research in general practice has shown that small changes would make 
a big difference in terms of improving confidentiality at reception. 
Breaches could be minimized to enable practices to comply more 
closely with codes of practice for handling patient­identifiable 
information, which in turn would improve the patient­clinician 
relationship (Scott et al 2007). 
Describing general practice as a place to get clean, service users 
experienced a place where they visited as a regular attendee and could 
have their medical needs met at the same appointment, if they 
considered it necessary. This study shows the location of the treatment 
environment of general practice to be beneficial for the service user. 
The treatment centres in Dublin provide methadone through a 
multidisciplinary team approach and typically are large centres 
providing services to between 100­300 patients (Delargy 2008) where 
dealing in the vicinity is widely known (Ambreen et al 2008). It is not 
surprising therefore that they are not seen as a place to get clean as 
congregation of other drug misusers is commonplace. Service users 
described a place where there was little if any congregation outside the 
surgery doors although there was a specific area to buy extra diazepam 
and/or night sedation identified by two service users­this at a location 
away from the surgery. 
Service users described that general practice provided an opportunity to 
consider reduction strategies and offered a place to reduce. The 
experiences of those who chose to reduce with the support of their GP 
were reflected in the data. Sometimes this support caused 
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complications in relationships as two participants expressed that they 
did not wish ’’to let the doctor or nurse down’’ by not reducing their 
methadone dosage. These service users also expressed anxiety about 
not ‘’coming clean’’ in relation to buying extra methadone. They did 
however feel comfortable after a period of time and did discuss these 
issues subsequently with their GP. Both were satisfied that their dosage 
of methadone was increased until they felt ready to reduce again. 
Reflecting on the literature review, Parr et al (2008) suggested that 
raising the issue of cessation of benzodiazepine use systematically with 
every patient who had been prescribed benzodiazepines for longer than 
three months and recommending that they gradually reduce the 
benzodiazepine dosage, is likely to result in better cessation rates when 
compared with continuation of routine care. This also holds true for a 
slow reduction of methadone advocated in general practice as one 
approach to treatment which requires flexible, separately negotiated 
dose reductions (ICGP 2008).In this study the data implies that there 
was evidence of care planning and shared decision making in reduction 
strategies. This is in contrast to the findings of O’Reilly and O’ Connell 
(2006) who described a ‘one size fits all’ approach that favoured 
maintenance. Service users were included in decisions about the dose 
of their prescribed methadone and as the literature suggests, attention 
was paid to strategies that support reduction and cessation of 
maintenance and thus improve patients’ expectations (Chalmers et al 
2007). Partnership in care was evident as service users attested to 
treatment approaches which were individualized with the service user in 
control and active as partners in their recovery process. Self reported 
data from two of the sample described their own erratic drug misuse 
and buying extra methadone. In this situation the GP was described as 
being in control of dosage. A partnership approach was described in 
relation to the doctor/patient relationship which facilitated reduction 
strategies. 
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Multi­morbidity is common among problem drug misusers attending 
general practice for methadone treatment and the identification of a 
place to sort things out reflects the spectrum of care and level of service 
provision required for those on MMT. The data suggest that this 
provision of service is a priority for the service user. Addiction treatment 
systems in many western nations (and Ireland is no exception) 
developed in relative isolation from primary health care and mental 
health treatment and have focused on alcohol and or drug misuse. 
Miller & Miller (2009) argue that such an approach is outdated for 
mainstream treatment for addiction to drugs such as heroin. They 
suggest that when entering specialist treatment, people bring with them 
a ‘vast array of other concerns’, some of which are often of higher 
subjective priority than stopping substance use. These require 
additional support services than what is available in the majority of 
general practices. Cullen et al (2009) conducted a recent cross­
sectional study of patients attending three large urban general practices 
for methadone treatment in Dublin and this sample was compared with 
a control group matched by practice, age, gender and General Medical 
Services (GMS) status. A wide range of chronic illnesses that had not 
been predetermined were recorded among patients on methadone 
treatment and these patients attended their GP and other healthcare 
professionals in the practice for issues other than their addiction care. 
The authors concluded that primary care has an important role in 
primary and secondary prevention of chronic illnesses among this 
population. 
The findings suggest that, similar to the findings which identified service 
users’ ‘ideal methadone service’, physical needs were attended to at 
the same time as the ‘methadone consultation’ (Jones et al 1994). 
There was one exception to this as one general practice had a separate 
time for drug misusers. This echoed the views of O’Reilly and O’Connell 
(2006) who highlighted this situation as one which they felt enforced a 
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segregation which prevented the holistic approach of partnership in 
care in general practice services. The service user interviewed in this 
practice however spoke of a good relationship with the GP although a 
separate appointment for physical health care was required. This was 
the outlier in the study as all other service users could avail of medical 
services at the time of contact. Sorting out general issues that need 
sorting has been described as an activity related to the scheduling of 
methadone dosing in Ireland specifically in the context of treatment 
clinics (Saris 2008). General issues are sometimes key issues for 
service users such as housing concerns, social and forensic problems 
which require the all important GP letter for the Housing Corporation 
and social welfare systems. For many clients, the provision of these 
services from GPs, leave little space for targeting lasting change in drug 
misuse until these issues have been addressed (Best et al 2008).This 
co­ordination of care is the daily stuff of inner city general practice 
(RCGP 2005). Joint working across health and social care is therefore a 
key feature of effective treatment. 
One of the special features and strengths of drug treatment in the UK is 
the valuable partnership between statutory NHS drug treatment 
services and non­statutory or voluntary sector drug treatment providers, 
which comprise up to half of service provision in some local areas (DoH 
England 2007).This is not the case in the RoI and drug misusers with 
‘complex needs’ are a resource­intensive group, which provide the 
greatest challenge for service providers (Cox et al 2007). Many drug 
misusers have a myriad of health and social problems, which require 
interventions from a range of providers. This provision of care requires 
a multidisciplinary approach however the influence of nurses was 
relatively unexplored by the service users and practice nurses featured 
sporadically in their dialogue and more often than not in relation to task 
orientation. Although GPs and practice nurses are central to the 
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delivery of primary care services in the United Kingdom the role of 
practice nurses is still underdeveloped (Mistral & Velleman 1999, 
Copello et al 2009). The unexplored and hidden role of the practice 
nurse in the RoI had been highlighted in the previous study undertaken 
by the researcher Perceptions and Experiences of Practice nurses in 
relation to patients on a Methadone Treatment Protocol (Latham 2003). 
The findings of that study identified that nurses felt they had a 
significant contribution to make in the day to day management of 
patients on a MTP. This contribution was identified as practical input 
into relapse prevention, providing a relationship of support, non­
judgmental attitudes (therapeutic neutrality) and an important function of 
‘just being there‘ for the patient (Latham 2003:98). Opioid misuse is 
often characterised as a long­term, chronic condition with periods of 
remission and relapse and abstinence although it may be one of the 
long­term goals of treatment, is not always achieved (NICE 2007).The 
requirement for additional psychological assistance within the 
framework of service provision in general practice is therefore 
important. Nurses themselves identify a psychological domain of 
practice as central to their work ((WHO 1996, Latham 2003, MacNeela 
at al 2007) and recognize that they can deliver psychosocial 
interventions. In this study service users did not recognize this nursing 
support as particularly significant to them. Two nurses had completed 
the Level I training course (one being the researcher). The 
management of a population of patients with chronic and often complex 
medical, psychiatric and social conditions without the ancillary support 
of nursing or a primary care team poses the question: is this an 
adequate model of care? Given the slow implementation of primary 
care teams and rolling out of the primary care strategy nationally, the 
further expansion of teams has been documented as an unrealistic 
expectation (Stewart 2008). A more proactive role on the part of 
practice nurse may be required to effect change in this respect and the 
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ICGP should acknowledge their role in this respect, although 
overcoming what has been described as ‘professional straitjackets’ 
where roles are clearly demarcated and rigid has not traditionally been 
easy for practice nurses (Muncey & Parker 2001). As highlighted by 
Fischer et al (2008) structural factors such as these which affect service 
provision all require consideration. 
The lack of service provision in relation to the availability of formalised 
counselling emerged from the data, expressed as–what could not get 
sorted. Service users described their wish not to have to re­engage with 
treatment clinics for this service as they had progressed in their 
treatment trajectory to general practice. These findings are in broad 
agreement with similar findings described in the literature review. GPs 
in Dublin had expressed the necessity for improvements in a range of 
services notably counselling, psychiatric support and nursing services 
(Wilkinson & Mistral 2003). More recently GPs participating in the MTP 
were asked what additional services would enhance the care they could 
provide for patients and 52% of respondents chose addiction 
counseling as their first choice (Delargy 2008). Although service users 
have endorsed concerns about their psychological health within HSE 
addiction services in Dublin (James et al 2008), many within this study 
did not wish to attend counselling. Three of the surgeries visited for the 
study had on­site or co­located counselling available. The idiosyncratic 
nature of responses to counselling resonate with the findings 
highlighted in the literature review (Wilkinson & Mistral 2003) however 
location of services was not considered. The HSE employs a total of 
around fifty one whole time equivalent counsellors to assist persons 
with addictions in the greater Dublin area (Buckley 2009). Presently two 
types of psychological services are provided in primary care. They are 
known as '’co­locational'’ and '’autonomous models’'. Autonomous as 
the name suggests, is a stand alone service providing psychological 
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support to a selected community in a building designed for this purpose. 
All clients are referred from their individual GPs and travel to the 
centralised location for therapy. The co­locational model affords the 
client the opportunity of attending the psychological service in the same 
building as their medical team (O’Grady et al 2008). O’Grady explored 
the experiences of clients who are currently engaged in psychological 
therapy in a primary care setting in Dublin and found that the co­located 
nature of the service provided a familiar but anonymous and 
confidential setting which had the result of reducing stigma of attending 
the psychology service. This location of service and setting again 
reflects the importance of treatment context within general practice, 
however these co­located models are scarce and may not in the 
current economic climate be replicated for some time. Martin et al 
(2009:284) when documenting psychological services for adults in 
primary care in Ireland have stated that anecdotal evidence from GPs 
suggest that assessment at primary care level is their first choice for 
patients and for some patients, primary care is the only acceptable 
route into psychological services. The psychologist as an integral 
member of the primary care team was not the original model envisaged 
by the Irish Primary Care Strategy (2001). Recognizing that 
psychological services are a relatively new concept in the Irish context 
its integration represents both a cultural and cognitive shift. This shift is 
not one which is only required by the medical profession but also ‘within 
the societal framework as represented by the service user’ (Martin et al 
2009:287).These issues need further exploration. 
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6.3 THE SIGNIFICANCE OF METHADONE FOR THE SERVICE USER AND THE 
EFFECT OF SUBSTITUTION TREATMENT ON THEIR LIVED EXPERIENCE. 
Service users described their experience of methadone and the 
significance of substitution treatment in their lives. The feelings service 
users attributed to methadone and their descriptions of what methadone 
does for the service user vacillated between their past experience of 
their addicted lifestyle and how they felt about the substance of 
methadone as treatment for heroin addiction. Most realized the 
significance of methadone in the recovery process but many also 
despised the drug and their subsequent dependence on it. Despite 
these negative feelings consistent with the established literature (Fraser 
& Valentine 2009), service users recognized the benefits of methadone 
in terms of their personal health, reduction in crime and virus protection 
(Ward 2002). 
General practice was recognized by service users as a place which 
provided access to viral screening and individual viral status was known 
by the majority of the participants however hepatology treatment did not 
feature as being important. Only two of the service users described that 
they had followed up on treatment for HCV with the encouragement of 
the GP. General practice has demonstrated that the majority of patients 
have been screened (Cullen et al 2007) but follow on care for those 
infected with HCV has been poor. This situation points to the 
importance of scaling­up harm reducing interventions for HIV and HCV 
prevention (Aceijas & Rhodes 2007). This is a global priority especially 
in settings where available estimates suggest high HCV such as the RoI 
(62­80% ICGP2008). This data emphasises that further efforts are 
required to encourage service users to attend for treatment once HCV 
is detected. 
171

Feelings about the drug itself and dependence on it (liquid handcuffs) 
provoked responses about the meaning of being addicted to the 
substance of methadone and the urban myths which surrounded the 
use of it. The lack of knowledge about methadone and the accepted 
myths about its use such as methadone ‘’getting into your bones’’ and 
the various other attributes drug misusers ascribed to methadone, 
highlights a lack of health education in general practice. This finding has 
resonance with the work of Winstock et al (2008) who identified a 
significant lack of knowledge about some of the effects of methadone 
and buprenorphine among 956 clients receiving treatment for opioid 
dependence at 9 public clinics and 50 community pharmacies in New 
South Wales, Australia. As a result of lack of education suboptimal use 
of medications and ambivalence over treatment can be problematic and 
the provision of written material can potentially prevent this. The 
availability of such literature is in question as the ’’green book’’ which 
was alluded to in the interviews was the Irish edition of the Methadone 
Handbook (Preston & O’Connor 1998).This resource has not been 
available in the RoI for several years and is only accessible on­line. 
This poses a barrier to effective education which is significant as it 
would have to be imported at a cost to either the service provider or 
user. There are other aspects to education which require specific 
guidelines. Opioid treatment programmes in the United States have 
recently been challenged with providing education specifically in relation 
to integrating cardiac arrhythmia risk assessment into routine care. New 
concerns about methadone and its pro­arrhythmic properties have 
emerged and clinical guidelines recommend disclosure about multiple 
factors which may contribute to drug­induced arrhythmia. Guidelines on 
clinical history taking, screening, risk stratification and drug interactions 
have been issued (Barclay 2009). This type of disclosure has not 
evolved in the RoI despite the fact that the Report of the Commission 
on Patient Safety and Quality Assurance (2008) recommends 
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communication and open disclosure with service users on a range of 
issues. No service user described educational forums in general 
practice which explained to them either the pharmacology of 
methadone or the side effects associated with taking the drug. This data 
has implications for professional practice and suggests the urgent need 
to consider systems to ensure that clinical information concerning 
treatment is received and understood by clients. 
Methadone is currently the only licensed treatment for heroin addiction 
available to GPs in the RoI. Buprenorphine is not licensed for use in 
general practice although available in HSE treatment clinics. The 
absence of any other form of treatment other than methadone fuelled 
responses such as that by Sean: they could have coming up with a 
better drug than Methadone and is there a better drug to get, have they 
got a better way of getting you off drugs? This notion of 
pharmacological optimism requires further investigation and has been 
discussed in a limited way in recent literature (Keanna & Wood 2008). 
There is limited evidence comparing buprenorphine with methadone, 
but a recent Cochrane review suggests that completion of withdrawal 
may be more likely and withdrawal symptoms may resolve more quickly 
with buprenorphine (Gowing et al 2009). Consideration of other forms of 
pharmacological treatment options is well overdue in the RoI. 
The importance of normality and stability was frequently emphasized 
throughout the interviews as participants described what methadone 
means to them. Feeling ‘’normal’’ was attributed to being able to carry 
out everyday tasks, looking after children and learning to be stable. 
Normality was understood as functioning with methadone, keeping a 
job, going back to education, keeping to a routine and structure. 
Stability was described as being able to move on with life without the 
need to look for heroin, being able to relax, being ‘‘like other mothers’’. 
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Another hidden aspect of stability was the economic benefits accrued 
from both selling methadone which required non­compliance with the 
treatment regime. The average cost of street methadone is currently 
€23 per 80 mgs (Roche et al 2008).Chalmers et al (2007) describe two 
issues here, selling prescribed methadone to obtain a source of income 
and non­adherence to methadone as originally prescribed (for e.g. 
halving doses).There are substantial harms such as overdose 
associated with both non­compliance and diversion. Both undermine 
the viability of the MTP and systems need to be put in place which will 
address these issues. 
Descriptions from service users identified the importance of street 
trading. The data show clearly that the environment of drug addiction 
co­exists in parallel with harm reduction treatment. Methadone 
treatment related problems such as diversion of methadone are 
associated with maintenance programmes (Fischer 2000). Both street 
methadone and benzodiazepines were traded. As identified in the 
review of the literature the local level drug dealing environment is an 
important feature of local economies in marginalised communities 
(Fitzgerald 2009). Buying extra and diversion of methadone highlights 
the issue of reciprocal care and responsibility towards other drug 
misusers, the economic disadvantage of service users and often the 
unmet demand for treatment. These dynamics have been identified by 
Fraser et al (2007) who reviewed MMT in South Australia. They warn 
that the issue of methadone diversion should be a major concern for all 
MMT programmes and highlight that the potential for diversion is 
increased with take home privileges. The majority of methadone related 
deaths have been directly related to illicit methadone diversion 
(Varenbut et al 2007). There is no doubt that when methadone 
dispensing is commenced initially concomitant usage is the norm and 
expected and is a reason for adjustment of dosage (Heinman 2000). In 
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this study however the majority of service users had been receiving 
methadone for more than five years. Methadone related deaths are 
associated with maintenance programmes (Roche et al 2008). Data 
from Ireland estimates that opiate related death rate among the opiate– 
using population was 64 per 10,000 in 2001 (Long et al 2005). Two– 
thirds of the opiate users who died tested positive for three or more 
drugs (Byrne 2001). Ward and Barry (2001) estimated 84 opiate related 
deaths in 1999 and identified that 45 (54%) were methadone related, 15 
(33%) were receiving prescribed methadone. Roche et al (2008) 
identified that illicit methadone use was readily available among a 
cohort of 81 young people (15­25) attending a Dublin treatment clinic 
where a culture of methadone diversion was evident. It appears that 
poly­pharmacy, the co­prescribing of benzodiazepines, tricyclic 
antidepressants, and other opiates, will have contributory effects on the 
risk of sudden death in patients on a methadone treatment programme, 
particularly in patients with co­morbidities that affect drug metabolism 
(Fahey et al 2003). Concurrent benzodiazepine misuse in the 
management of MTP patients is a problem and evidenced in this study. 
This problem is widely known and has not been consistently tackled 
(Corrigan 1986, Farrell et al 2000). Only 45% of doctors surveyed in the 
recent ICGP survey felt that training had prepared them satisfactorily for 
this associated co­addiction and as a recommendation of the survey it 
was suggested that GPs become familiarized with the guidelines on 
benzodiazepine prescribing issued by the DOHC (2001) (Delargy 
2008). The recommendations of the benzodiazepine committee set out 
to address this inappropriate prescribing and suggested a monitoring 
system. This has not been put in place. These findings support the 
identification of a monitoring process in relation to benzodiazepine 
prescribing. 
The need to buy extra methadone also raises the discussion about 
optimal dosing which has arguably been set at doses in the range of 60­
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100 mgs (Chalmers et al 2007). Service user preference for lower dose 
methadone has been identified as a significant barrier to optimal 
treatment (Lintzeris et al 2007). The findings highlight the need to revisit 
the rationale for prescribing benzodiazepines and low dose methadone. 
This may also be achieved by developing the communication and 
negotiation skills of doctors in this respect. Logistical difficulties created 
by perhaps patient load and time constraints may need to be addressed 
and alternative treatments such as buprenorphine and valid non­
pharmacological alternatives to benzodiazepine use should be explored 
(BYAP: 2004:15). 
6.4 SERVICE USERS’ EXPERIENCES OF BEING INVOLVED IN DECISION MAKING 
AND MANAGEMENT OF THEIR TREATMENT. 
Service users described their experiences in the past of being involved 
in a system which historically laid the foundation for the current 
protocol. They described why the protocol was necessary, what the 
protocol currently means to the service user and what their 
understanding is of what influences the implementation of the MTP. In 
this way they also described their level of involvement in their treatment. 
As discussed in the review of the literature most Irish GPs were 
disinterested in, if not antipathetic to the idea that they should play a 
major role in the management of drug addiction prior to the introduction 
of the MTP in October 1998. Butler (2002:312) suggested that a very 
small minority were enthusiastic and were ‘committed to doing so to a 
high professional standard’ but there was at that time a small but 
indeterminate number of ‘rogue doctors’ who were exacerbating 
societal opiate problems and bringing their profession into disrepute by 
prescribing irresponsibly. Prior to this study these sentiments were only 
every supported by anecdotal reports comparing ‘rogue doctors’ with 
backstreet drug dealers (Delargy 2001, Butler 2002,Saris 2008). 
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Regulatory scrutiny of private practice in the UK has also been 
identified as being inadequate (Strang & Sheridan 2001). Service users 
described in detail their dealings with these private doctors and 
attributed the establishment of the protocol to this historical situation 
identifying why the protocol was necessary. What was concerning in the 
study was that service users insisted that the practice in relation to 
benzodiazepine prescribing was still ongoing and told of elaborate 
stories which their associates were encouraged to fabricate in order to 
legitimize their procurement of a prescription. The DOHC (2001) 
recommended that the small number of doctors, who may have been 
prescribing inappropriately, putting their patients and others at risk, 
should be identified, investigated and dealt with accordingly. Over the 
years these powers have been availed of on only a few occasions and 
(Buckley 2009). These findings urge further considered focus in this 
respect. 
Descriptions of what the protocol means to the service user involved 
service users’ understanding of the daily workings of the protocol rather 
than the semantics of the word protocol which did not appear to be of 
significance for the service user. What the protocol symbolized was 
described as an escape from the ravages of heroin addiction although 
some respondents initially understood the protocol as providing a 
method of detoxing. When commencing a MTP it was apparent that full 
understanding of what it would mean to be on maintenance in the future 
was not understood. There was acknowledgement on the part of 
service users that the government was ‘‘stepping in’’ and that 
something had to be done to prevent poor prescribing practices 
however the daily working out of the protocol or regulatory rules were 
understood in terms of knowing the rules and working the system. 
Knowing the rules involved 1) urinalysis, 2) supervision of ingestion at 
the chemist and 3) attendance schedules. Working the system involved 
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intricate ways of circumventing these rules. 
All service users understood the importance and agreed with regular 
urinalysis which was a significant part of knowing the rules of the 
protocol. This is a finding which is in stark contrast to the findings of the 
UISCE report (2003).This report suggested that the process of 
supervised urine collection was degrading and there was a lack of 
confidence in urinalysis as many claimed to have obtained incorrect 
results. This was not a finding attributed to this study but rather the 
contrary view was upheld. The participants were concerned that not 
enough attention was attributed to the guidelines on supervision of 
urinalysis which they felt had a significant effect on treatment. Stories 
emerged of drug misusers dealing in ‘’bogey’’ urines, providing some 
one else’s specimen and the deception involved in avoiding giving a 
specimen contributed to the problem of methadone diversion. Service 
users described situations where they felt guidelines were not being 
adhered to which led to feelings of frustration and injustice. Two of the 
service users who expressed their concern about their relationship with 
their GP had urinalysis every week which was supervised. However 
once this aspect of the consultation was achieved they felt that the 
clinical assessment was lacking. Aaslid in his thesis on Facing the 
Dragon identifies that successful treatment should not be measured 
primarily by the number of clean urine samples but by the extent to 
which clients are able to consciously connect with and process their 
own patterns, integrate them into a lifestyle that works for them and 
allow transformation to emerge at its own sustainable pace and rhythm 
(Aaslid 2007: 222). The ICGP guidelines (2008:12) point out that urine 
screening is not a substitute for clinical assessment of the patient. One 
of the service users was selling a vast amount of her prescription and 
another was supplying his wife with a weekly dose as she did not want 
to sign up for a maintenance programme. Attendance schedules were 
not consistent and deviated from recognized guidelines. One service 
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user who was unimpressed with her 4­6 weekly consultations reported 
that she had never had a supervised urinalysis in six years and was 
supplying her brother (who was registered with the same practice as 
she attended for MMT) with bogey urines. All of these issues could 
potentially have been clarified by open dialogue at consultation and 
adherence to recommended guidelines, which is what the service users 
claimed they wanted. 
Other factors such as supervision of ingestion in the chemist revealed 
further deviation from ICGP guidelines. It is recommended that a 
minimum of one dose should be supervised weekly even if the patient is 
stable (Chapter 6). Six service users were unsupervised in the chemist 
and were allowed to take away doses as large as 90mls without 
supervision of ingestion. Further deviations from guidelines exposed 
attendance schedules as erratic and inconsistent. Some service users 
attended weekly, others two weekly and others described seeing their 
GP six times a year despite a methadone dosage as high as 150mls. 
Another attended four to six weekly despite a methadone dosage of 
80mls and being prescribed benzodiazepines by a GP who she was not 
registered with for MMT. 
The descriptions proffered by service users regarding supervision 
practices in the chemists warrant further investigation also into an 
important link in the chain of care. Historically, the Report of the Expert 
Group on the Establishment of a Protocol for the Prescribing of 
Methadone (DOH 1993) recommended that methadone should be 
dispensed in the same manner as any other similar medication. In her 
review of the pharmaceutical services for patients in methadone 
treatment in Ireland, O’Connor (2003:143) stated that while respondents 
to her questionnaire supported the theoretical idea of on­site 
supervision; they experienced difficulty with its delivery. She also 
described an underlying tension in the relationship with service users 
which is still prevalent. The suggestion that negative experiences hinder 
179

engagement with pharmacies has been visited in the literature (Neale 
1999b) and service users have frequently expressed the desire to be 
treated ‘normally’ (Matheson 1998). Scott and Mackridge (2009 a &b ) 
undertook a recent study in the UK to examine involvement of 
pharmacy support staff in delivering services to drug misusers 
investigating a random sample of 10% of UK community pharmacies 
(n=1,218). Six hundred and ninety (56.7%) pharmacies responded, and 
1976 completed questionnaires were returned from 610 (50.1%) 
pharmacies. A further 80 (6.6%) opted out.This was the first known 
study that examined attitudes and involvement of UK pharmacy support 
staff in service provision to drug misusers using a nationally drawn 
random sample. It was identified that nearly three­quarters of staff 
working in pharmacies that provide drug­misuse services had not 
undertaken training on such services. A relationship between attitudes, 
training and service provision was identified, with practice exposure and 
training combined linked with more positive attitudes than either aspect 
alone. Similar to O’Connors’ study, the quality of the service 
experienced by the drug misuser in this work has been found to be 
questionable. The Pharmacy Act (2007) empowered the 
Pharmaceutical Society of Ireland to commence a review of pharmacy 
services and pharmacy practices in the state. One of the 
recommendations of the society was to critically appraise the strengths 
and weaknesses of the current pharmacy system in Ireland (Pharmacy 
2020).This system of care, expertly documented in O’Connor’s thesis 
has changed little with service users still expressing difficulties with lack 
of confidentiality and conflict at the interface with supervisory 
arrangements. Other issues such as non­adherence by the pharmacist 
to the GPs prescription were described by Olwyn, Erica and Molly who 
negotiated dose division and change of supervisory details. 
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Multifactorial contributions such as these are critically important in 
methadone­related deaths. The issues described here are important in 
relation to professional practice. As identified in the literature review, 
deviation from guidelines is common in practice (Matheson & Pitcairn 
2003) however prevention of methadone related deaths requires 
adherence to prescribing regimens from both the prescriber and 
dispenser. There should be a willingness on the part of the GP to 
modify prescribing practice when faced with changing patient behaviour 
(Fahey et al 2003). Behavioural change can be elicited by knowing the 
patient and recognizing the factors that influence the regulation and 
implementation of the MTP. Factors such as these are complex and 
involve the dynamics of treatment encounters, treatment programme 
design and structural factors which were identified in chapter one as 
affecting service provision (Fischer et al (2007, 2008). 
The rules of the protocol and the myriad ways by which they were 
interpreted by GPs, and pharmacists were inherently known to the 
service user. Service users found a way of working the system to their 
own advantage as Olwyn explained you learn how to play them you 
know what I mean? This involved an understanding of what influences 
the implementation of the MTP which made allowances for the 
integration of many players in the system. These players were identified 
as other drug misusers, GPs and pharmacists. There are in fact four 
main beneficiaries of the MTP who all benefit in financial terms from the 
MTP as this includes the service user themselves. The data describe 
the significant pressure which is exerted on those on methadone 
maintenance to look after or ‘‘sort out‘’ those who are not stable, 
whether it be family, friends, acquaintances or simply those they know 
from their previous identity such as those involved with criminality. 
GPs were identified by the service users as those who wished to help 
their patients first and foremost but it cannot be denied that a generous 
remuneration package is provided (Barry 2002) which may influence the 
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future implementation as more doctors are encouraged to take on 
patients. Daithi identified that the GP could make a lot of money out of 
the MTP. 
Pharmacists have a significant influence on the protocol also and 
benefit financially from each patient. A pharmacist recently commented 
in Irish Pharmacist that he had hoped that the MTP would ‘put his kids 
through college’ (Jordan 2008:28). It is interesting that the total cost of 
Irish primary care based methadone maintenance treatment in 2007 
was approximately €14 million. Of this total, fees to GPs amounted to 
€5.3 million, while fees to community pharmacists were €5.9 million, 
and the total cost of ingredients was a further €2.8 million (Buckley 
2009:41). 
The final beneficiary however is the service user themselves as unlike 
other countries such as Australia (Chalmers et al 2007) methadone is 
free to the user and they in turn can and do benefit from selling it on the 
black market. 
These findings arising from the data require further investigation. As 
highlighted by Farrell et al (2000), there is a clear need for ongoing 
training, support and the development of innovative modes of 
communication between clinicians, pharmacists and service users to 
address these issues related to professional practice. 
Conclusions and recommendations for practice are summarized in the 
following chapter. 
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th 
4 Bracketing Interview 
P How in terms of the practice you work in, how could you see this evolving into a 
more comprehensive patient care model…now assuming of course that they would 
agree to a more comprehensive patient care model. Could you see yourself moving 
beyond the quick fix as a practitioner? 
R Yeah I personally feel that I have moved beyond that because I have the benefit of 
a multidisciplinary team and the benefit of a counselling psychologist in the practice. 
We have the benefit of the services that are provided there. However of our 65 
patients not a huge amount of them opt for that because we haven’t educated them to 
know that there is another piece to this addiction, partly because we haven’t got the 
time. Mostly... but partly because it isn’t seen nationally as something that would 
involve a multidisciplinary team and that is very different to the models anywhere else 
in the world … 
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CHAPTER 7: CONCLUSIONS AND RECOMMENDATIONS

7. 1 INTRODUCTION 
This study investigated the micro­setting of methadone treatment in 
general practice in Dublin illuminating the social meaning and practices 
associated with this harm reduction treatment. It also cast light on the 
macro setting of policy context and methadone protocol design. Results 
from this study can be transferred to other contexts and settings as 
transferability has been enhanced by richly described data. The data 
provides the research community with enough information to judge the 
themes and constructs of the study and it provides enough information 
to judge the appropriateness of applying the findings to other settings 
(Byrne 2001). The study design was not without its limitations. Self 
report may have affected participants responses where the researchers’ 
position, as nurse, may have given rise to both participant and 
researcher bias. However the usefulness of addressing the service 
users’ experience which has largely been neglected so far in the RoI 
has been proved to be worthwhile as many practical suggestions for 
change have been proffered as a result of listening to the accounts of 
their experiences. New information has been obtained by using this 
approach and by utilizing these methods some contradictory information 
to previous studies has been demonstrated. Future recommendations 
for research, in the light of the knowledge which has been gleaned from 
the study, are discussed. 
Much of the grey literature up to this point in time has informed local 
knowledge and practice. The study findings contradict some of the 
small studies identified in the review of the literature (UISCE 2003, 
O’Reilly et al 2005, O’Reilly & O’Connor 2006). These studies asserted 
that service users were subject to methadone sanctions, discriminating 
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services and were being cared for under a ‘’one size fits all’’ umbrella 
method of service provision in general practice. The existing literature 
had overlooked ways of clearly viewing the phenomenon of MMT in 
general practice. The views which service users articulated provide 
insight into novel experiences which have up to now been left 
unheeded. The process of ‘’being heard’’ greatly improves our 
understanding of general practice provision and how it can be improved 
to benefit service users. 
The findings of this study are novel as unlike quantitative research 
which can summarize key findings with numerical data, this research 
has achieved a deep understanding about how service users 
experience their treatment and this has been expressed in their own 
original way and language. ‘Actual care versus ideal practice’ (ICGP 
2003) was investigated and found wanting. 
7.2. CONCLUSIONS AND RECOMMENDATIONS 
This study aimed to explore how the MTP was being implemented in 
general practice by describing the users’ lived experience of treatment, 
and their experiences of being involved in decision making and 
management of that treatment. What has been gained from this work is 
an insight into that experience and what the treatment trajectory 
creates. This work suggests that from the perspective of the service 
user there are both benefits and shortcomings in relation to receiving 
methadone treatment in General Practice in Dublin. The findings from 
these service users’ views can be translated into recommendations and 
there are many that can be proffered as a result of this exploration of 
their experiences.There are a number of implications for policy and 
service delivery that follow from the service users’ accounts of their 
experience of general practice however a tension remains as to how to 
involve service users effectively. 
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As acknowledged in the literature the presenting needs of service users 
accessing treatment services have been shown to be frequently 
bewildering in their complexity, often involving multiple substance use, 
physical and psychological health problems and relationship and family 
difficulties (Best et al 2008). Need has been defined, in the health care 
needs assessment literature, as 'ability to benefit' (Fountain et al 2000). 
The major advantage and benefit of general practice identified in this 
study is that it provides a place where service users can avail of 
methadone treatment within an environment that they value. There is 
growing recognition of the role that place and setting can play in 
shaping the health of individuals and populations (Kerr et al 2007). The 
significance and social meaning of place in relation to the setting of 
general practice has been heretofore absent in the literature. 
The overall personal, family and social functioning of the individual is 
being improved by methadone treatment however there were other 
issues of concern in relation to how child welfare should be addressed 
within drug treatment. Service users described differing issues in their 
lived experience of treatment which can be specific to gender or related 
to their past identity as drug misuser. Difficulties faced by drug­misusing 
women who are attempting to fulfill societal roles as mothers and 
provide the sort of childcare they and society wish for children has been 
highlighted in the literature (EMCDDA 2009). Female service users in 
this study attested to a supportive environment within general practice 
for their children and for themselves at varying intervals throughout 
pregnancy and child rearing. The development of a gender­sensitive 
perspective on how to support women who misuse drugs is long 
overdue (Grant 2009). Risk environments have been described and 
highlighted by Rhodes (2009). In this instance the risk setting affected 
not only the service user but also babies, children and families. 
Exploration is required into how the resilience of families and children in 
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particular can shape their own futures and how general practice can 
assist service users in this process. 
The findings identify service users’ satisfaction with the transformative 
environment of general practice which can assist in the development of 
a new identity as opposed to the past identity of ‘’junkie’’. Identity is 
challenged within the environment of heroin addiction and the trauma 
involved in that lifestyle. Moving out of that lifestyle was described as 
difficult as identity had been fixed within that known environment. If 
identity plays as central a role in this process as the data suggests, and 
if this is interlinked with past traumatic experiences it is important to 
ensure that service providers in general practice are able to address 
issues of identity formation and change. Individual contexts can enable 
drug misuse and local contexts can shape local phenomena. Issues 
such as control, loss of freedom, stigma and labelling exist in Dublin but 
receiving treatment in general practice may ‘’dilute’’ or ‘’normalise ‘’ 
these feelings to some extent. Appropriate training is therefore required 
in identity formation and change which can help build awareness and 
knowledge among service providers and equip them to assist service 
users in this process. Further investigation into environments that 
enable change is required (Duff 2007). 
The participants did identify that the treatment context of general 
practice provided a place which was fundamentally different from the 
environment of the treatment clinics, a place where potentially their drug 
treatment could be individualized. There was verbal evidence that the 
aims of the ICGP programme in relation to encouraging reduction 
strategies and supporting maintenance were being implemented by the 
majority of service providers. Service users spoke of valuing the 
confidential nature of the setting although there were instances where 
confidentiality was broken. Overheard disclosures can breech trust in 
the waiting room and among receptionists and all items of information 
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which relate to an attribute of an individual should be treated as 
potentially capable of identifying patients and hence should be 
appropriately protected to safeguard confidentiality (DoH 1994). 
Awareness of this could prevent stigma and unnecessary exposure for 
the service user. 
The doctor/patient relationship was paramount and in general 
contributed positively to the trajectory of treatment which had a positive 
effect on patient participation. The research also identified tension and 
negative experiences of treatment with the doctor who consults poorly. 
This is a significant shortcoming which was identified within the 
treatment environment. A different consulting style was described and 
the term ‘’phy doctor’’ was identified and contrasted markedly with the 
consulting style of the majority of the other GPs. The general practice 
sites which were surveyed were well established sites for methadone 
treatment. If this is a finding within these sites the potential for further 
poor consulting within other new or established methadone prescribing 
practices may be of great significance for future quality and standards in 
practice. 
The majority of service users reported being mainly satisfied with their 
treatment however service users have historically few expectations of 
care. What a consumer reasonably expects to receive from a service 
has been shown to be influenced by the concept of ‘expectation’ and 
‘relative experience’ (Madden et al 2008). Caution has to be expressed 
therefore as to what service users reasonably expect to receive from 
general practice as historically there is an absence of engagement with 
service users. Nationally negotiated service level agreements which 
include service users in the development process may assist this 
process. 
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This research showed that there is verbal evidence that the aims of the 
ICGP programme are being achieved in minimizing harm associated 
with opiate misuse such as crime and the associated health risks such 
as the risk of HIV and screening for HCV. Given the complexity of the 
service users self described needs it would be feasible to suggest that 
the GP needs assistance with care planning and delivery as is the norm 
with other chronic diseases in primary care. 
The findings point to service users’ satisfaction that general practice 
provides an environment which is providing a valuable service need for 
drug misusers. The general practice experience was sought after as a 
place where medical services were provided alongside drug treatment. 
This service may require significantly more resources and ancillary staff 
such as trained nurses and counsellors. There were variable responses 
to whether the location of psychological care offered mattered to the 
service user. 
This data calls for a comprehensive review of the MTP with particular 
attention paid to ensuring that mechanisms exist to allow service users 
to feed­back their experiences and opinions. This requires considered 
engagement with both drug treatment service providers and users of 
drug treatment services. The findings inform service providers to 
consider how GPs and the wider multidisciplinary teams engage with 
the service user who is prescribed methadone. Supports for service 
users which include improved access to counseling and assistance in 
responding to methadone related issues that may serve as barriers to 
optimal treatment should be explored. This would involve targeted 
education about treatment plans, treatment side effects, withdrawal and 
potential for overdose. Service users will need support and training in 
the active planning and delivery of their own treatment. The focus could 
be to address client perceptions of treatment and broader psychosocial 
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needs. This at present is not possible to assess within the current audit 
system carried out by the ICGP and there is considerable variation in 
what services are provided. These broad recommendations for practice 
are further translated as the following: 
•	 The ICGP who have responsibility for training and accreditation 
could consider a multidisciplinary focus which equips 
practitioners to identify psychological needs in association with 
prescribing methadone. The goals of the consultation need to be 
revisited and a comprehensive approach to service users’ needs 
could be addressed. 
•	 Practices should consider conducting patient surveys on aspects 
of confidentiality as a means of looking for ways to improve 
management of patient identifiable information. 
•	 Training initiatives are required for general practice service 
providers to better understand the gender issues of treatment and 
how these issues reflect on those receiving treatment. 
•	 Shared care planning initiatives and inter­agency working will be 
required to improve the liaison links between service users, 
general practice service providers and maternity and infant 
services which may assist understanding in this respect. 
The significance of methadone for the service user and the effect of 
substitution treatment on their lived experience were described. The 
objective of treatment according to the NDS (2001) is two fold. First, to 
enable those dependent on drugs to reduce dependency, improve 
health and social well being and ultimately to lead a drug­free lifestyle 
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and second, to minimize the harm to those who continue to engage in 
drug taking (Cox et al 2007).Treating care planning in general practice 
as ‘’treatment’’ is a realistic way to expect a treatment journey to be 
effective. The Report of the Methadone Treatment Services Review 
Group 1993 prior to the introduction of the 1998 protocol urged care in 
regarding methadone as an easy solution for a complex problem and 
warned that it should be regarded as an adjunct to treatment. The data 
suggest that methadone as a substitution treatment has emerged in a 
mostly positive light however as a substance negative emotions exist. 
As a drug methadone was both despised and lauded as a life saver. As 
an evidenced based harm reduction treatment, service users attested to 
its benefits in terms of reduction of heroin use, crime and virus 
protection. The meaning attributed to methadone maintenance was the 
provision of stability and normality for both the service user and the 
family but methadone was also described as economically valuable to 
the local drug dealing environment and provides an opportunity for 
reciprocal care for drug misusers. The importance of street trading was 
therefore enmeshed within the context of treatment. Service users 
expressed that an alternative to methadone should be made available. 
These findings highlight the important question of prescribing practices 
and have implications for the current policy of control on methadone 
diversion which has been established as a cause of opiate related 
death in the RoI. The data also highlight the importance of 
understanding how environmental influences shape peoples lives and 
understanding of methadone. This challenges general practice service 
providers to provide appropriate information, resource educational 
forums and raise their own awareness of how optimal dosing can be 
achieved by developing their communication skills in practice. 
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The findings also identified the meanings attributed to the substance of 
methadone. Three distinctive features of methadone identities were 
uncovered which are original findings in relation to the consumption of 
methadone. These were co­constructed categorizations which were 
defined as ‘’lifers’’, ‘’maintainers’’ and ‘’reducers’’. These new insights 
should aid practitioners to understand how service user’s view their 
treatment trajectory and inform them as to how this could be managed 
from their perspective. 
There was sparse evidence that service users were educated about the 
effects of methadone and the dangers of poly­drug misuse. Coming into 
contact with primary care provided virus identification of HCV but little 
education about the effects of methadone. The realities of the complex 
phenomenon of methadone treatment is that methadone, although 
criticized as a substance which produces negative emotions (such as 
the ‘’liquid handcuffs’’) is a substitution treatment which remains 
valuable in many ways. This creates a paradox. 
The research identified the risk associated with treatment which is 
inconsistent in its approach. There is a need to communicate 
information about treatment which is culturally appropriate to service 
users. The need to revisit the prescribing practices of GPs and the 
rationale for or against low dose methadone is called for. The findings 
indicate formal targeted education in this respect. This could include 
information about methadone, advice about the risks of overdose and 
emergency treatment. The data calls for consideration of these issues. 
•	 A more pro­active role on the part of the practice nurse within a 
shared care system should be considered with a specific emphasis 
on educating service users on the importance of understanding the 
effects of treatment. Educational material to enable the service user 
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to understand the potential for overdose and emergency treatment 
should be developed with the involvement of the service user. 
•	 Education for professional practice needs to be focused on 
development of interpersonal communication and negotiation skills 
with service users. This should incorporate a way of thinking about 
treatment dosage levels as a catalyst for change. 
•	 The provision of an alternative to methadone such as buprenorphine 
could relieve service users of daily dosing regimes but would require 
a policy review of regulation to introduce and adopt this treatment 
option. 
Service users’ experiences of being involved in decision making and 
management of their treatment identified that the regulations of the 
MTP were subject to interpretation by service providers and many 
service users, recognizing this, circumvented the guidelines. The 
historical existence of ‘’rogue doctors’’ was understood to be the reason 
the protocol was introduced in 1998. Illicit prescribing was still evident in 
relation to benzodiazepine prescribing. The protocol was well 
understood in terms of urinalysis, attendance and supervision of 
methadone. All these rules were subject to interpretation by service 
providers and many service users ‘’worked the system’’. A desire for 
more stringent supervised urinalysis was expressed which would not 
only improve the system but safeguard other drug misusers who were 
being supported by methadone diversion. 
Clinical practice guidelines are an important part of the evidence­based 
practice movement and one of the main tools intended to decrease 
practice variation, improve effectiveness, and establish which 
interventions in health care constitute ‘best practice’ (Bergmark 2009). 
Service users described ways in which these were not being adhered to 
in the delivery of methadone treatment and described a myriad of ways 
in which methadone is successfully diverted. This study suggests that 
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these avenues for diversion could potentially be significantly curtailed 
by the effective implementation of the ICGP guidelines. The 
interpretation of these guidelines needs to be explicit and rigidly upheld 
not only in relation to urinalysis and supervision of ingestion but also in 
terms of clinical assessment. 
There is little evidence that the use of non­prescribed drugs by the 
individual has been reduced and in some cases there is evidence that 
the principles of safe prescribing, which help reduce the diversion of 
drugs into the illegal market are not being adhered to. The suggestion 
that rogue doctors still exist places a burden on general practice to 
provide strict guidelines on benzodiazepine prescribing that are 
mandatory. The recently published interim report for the National Drugs 
Strategy (2009­2012) suggests that the monitoring of private prescribing 
has proved problematic and ‘needs to be addressed’ (DOCRG 2009 
4.37:48). 
General practitioners who were involved in the MTP were recognized as 
committed to the community but there was a minority who were deemed 
to be involved because of financial gain­the so called ‘‘phy doctors’’. 
Relationships with the pharmacist were not well developed and indeed 
in some cases very poor. The role of the pharmacist as an integral 
member of a drug treatment team was underdeveloped with no 
evidence of liaison with the GP although it has to be acknowledged that 
service users would not necessarily be aware of inter­professional 
communication. Echoing previous reviews, it is obvious from the reports 
proffered by service users that better integration is called for between 
these professionals to improve quality and coherence of the local 
service (Farrell et al 2000). Action is needed on a number of levels to 
address these issues. 
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There is significant room for improvement in understanding how the 
delivery of methadone maintenance is only in part influenced by those 
that provide the service such as GPs and pharmacists but is also 
influenced and shaped by the local context in which methadone is 
prescribed. A desire for more stringent enforcing of the ICGP guidelines 
was expressed which could to some degree prevent methadone 
diversion as guidelines are currently being circumvented and 
interpreted in an idiosyncratic way. Providing methadone as treatment 
without the necessary checks in place for co­prescribing of 
benzodiazepines has created a narrow and risky view of methadone as 
treatment. These findings place a responsibility on service providers to 
implement change in how clinical assessment is carried out and how 
best to encourage disclosure about treatment adherence. 
This study calls into question the effectiveness of current prescribing 
policies as the quality of medical practice in methadone and 
benzodiazepine prescribing was variable. Quality control of 
prescribing should be monitored and reviewed. 
•	 A National body that carries out external monitoring of quality 
in methadone services should be formed. There is currently no 
National body that provides accreditation of addiction 
treatment services or that carries out external monitoring of 
quality as recommended by the Department of Community, 
Rural and Gaeltacht Affairs (2009). 
•	 There is a need to review current practice in the effective 
implementation of the ICGP guidelines as they cannot be 
monitored by audit alone. An appraisal mechanism could be 
designed and implemented for this purpose. 
•	 Benzodiazepines could be prescribed in a similar way to 
methadone with treatment cards and specific prescribing 
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scripts which are identifiable and therefore can not be subject 
to duplication. 
•	 Service level agreements with service users need to be drawn 
up which establish a full description of services which can 
reasonably be offered in general practice. 
•	 Multidisciplinary training initiatives involving pharmacists and 
the primary care team could help to encourage 
interdisciplinary communication links. Service users could be 
encouraged to be part of this process. 
•	 A complaints liaison committee could be established to 
monitor complaints about the delivery of methadone treatment 
and to advise the ICGP/HSE and addiction services about 
potential improvements. To this end service users may need 
to elect a service user representative who could act as a 
facilitator in this regard within each practice. 
Dissemination is required not as the end phase of this study but rather a 
continuous process of discussion, feedback and review between 
researchers and their participants (Booth 1988). The needs and 
characteristics of service users in this study expand the dissemination 
process beyond the written word to oral discussion, seminar 
discussions and workshops which may be altogether more effective. 
However until there are agreed quality standards and formal 
mechanisms to educate service users about their rights and the 
standards of care to which they are entitled these recommendations 
may not be best served by service providers. 
7.3.REFLECTION AND CRITIQUE 
This inquiry has shown that there is wisdom in viewing service users 
lives respectfully through their own eyes. This approach flies in the face 
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of a tradition that has dismissed service users’ perspectives as 
hopelessly distorted, irrational and out of touch with reality (Miller & 
Miller 2009). This investigation of service users’ views has been proved 
essential in that individual users have been regarded as the ultimate 
authority on their own process of care (Aaslid 2007). It has been 
recognized in this study that ‘research for policy must be designed 
around users’ information needs rather than the knowledge building 
aims of the academic community’ (Booth 1988:248).With this in mind 
the gathering of information from those best qualified to give that 
information was vital to this study. 
With the benefit of hindsight limitations of this study could be that 
excluding service users with psychiatric co­morbidity rendered the 
sample unrepresentative of the broader population of those in receipt of 
methadone who attend a Level 2 GP. Bias is possible by employing the 
strategy of maximal variation purposeful sampling as identified in 
Chapter 3. Information­rich cases are those from which one can learn a 
great deal about issues of great importance (Patton 1990:169) and 
excluding these service users may have reflected a narrow view of the 
services that are available in general practice. 
Situating the research in the general practice surgeries where 
prescribing took place certainly placed service users in a situation 
where there was an inherent power imbalance. There is always a risk of 
bias when approaching gatekeepers and the study could have been 
impeded by too much reliance on gatekeepers ‘’to make it happen’’. 
This risk of bias by using gate keepers has been acknowledged 
(Chapter 3:2:1) however participants were provided who were able to 
articulate their experiences. These issues could not be fully controlled 
for but were considered to be useful pragmatic approaches to identify 
those in receipt of treatment within an environment that afforded ease of 
access and safety for the researcher and follow­on care for the service 
user. 
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Critiquing the methodological approach, it was recognized at the 
beginning of the work that qualitative research can be a prerequisite for 
understanding and responding to drug misuse and can encourage 
useful interventions in keeping with local practices in differing cultural 
settings (Rhodes 2000). Collazzi (1978) states that the success of the 
approach may be judged by the extent to which the approach tapped 
into the experience of the phenomenon, rather than the theoretical 
knowledge of it. Husserl’s philosophy embraces the concept that the 
‘‘lived state’’, an experience, is the basis of all knowledge however this 
approach is subject to criticism (Alvesson & Sköldberg 2005). 
Embedding the study in the specific research genre of descriptive 
phenomenology proved to be too vague to support claims of reliability, 
validity and trustworthiness. Thus the use of a phenomenological 
approach coupled with an explicit reflexive methodology which 
incorporated bracketing interviews and polyvocality informed the study. 
Multiple data sources and a blended methodological approach 
established credibility. These qualitative approaches enabled the 
researcher to understand the lived experience of methadone treatment 
from the perspective of the service user. Using these techniques 
provided openness to connect with the perceptions of service users as 
the bracketing interviews provided a method of laying bear the 
preconceived ideas and prejudices on the part of the researcher. 
Although it was assumed at the outset that knowledge existed from 
those who were living the experience it was also acknowledged that 
knowledge was also positional in that it is generated by the researcher 
within a specific context and from a ‘particular position’ (Piantanida & 
Garman 2009:65). Disciplinary perspective and the identification of 
researcher personal bias is therefore acknowledged as a limitation of 
this study, as the investigator in this research has considerable 
experience and expertise in managing patients on a MTP. Nevertheless 
use of the explicit discipline of bracketing interviews at the beginning 
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and throughout data collection, analysis and write up demonstrated a 
transparency which allowed the researcher to reduce the influence of 
her lived experience as a practitioner on the study of service users. This 
parallel process of encouraging reflection provided new insights into the 
world of both the service provider and service user. Phenomenological 
inquiry and reflexive methodology supports the view that locating these 
presuppositions and biases is useful for clarification and vital to the 
process of inquiry. Polkinghorne (1989) suggests that this awareness 
provides protection against the imposition of the researcher’s 
expectation of the study. The use of reflexivity, construction of texts that 
were credible to the experience and coherence of research conclusions 
reflected the complexity of the situation, and also prevented deception 
(Laverty 2003). 
Ultimately however as the approach was novel with a methodological 
ambition of creative reflexivity it is the reader who must judge how the 
work should be interpreted. 
7.4. SUGGESTED FURTHER RESEARCH 
Treatment providers must set their sights beyond the safe delivery of 
opioid substitution treatment which, in isolation, falls short of the mark of 
what would be considered reasonable health care by people with other 
chronic health conditions (Madden et al 2008). Of particular importance 
therefore in further research is the idea of challenging our self 
understanding as practitioners because professionals should call into 
question what they already think they know and it is only with new 
insights perspectives and understandings that they re­forge their own 
ontological stance. In this regard it would be beneficial if GPs and 
primary care practitioners challenged their own positions and engaged 
in collaborative research into service users’ needs and perspectives. 
This could be achieved initially by asking service users how best 
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service providers can engage with those affected by drug misuse. In 
this way others may have the opportunity to discern more carefully the 
intricacies of practice and to envisage new possibilities for how they 
practice (Piantanida &Garman 2009) and in so doing facilitate those 
they are in practice for­the service users. 
The general concept of focusing on the service user could be extended 
to ensuring that service user engagement becomes a formal and 
compulsory part of the treatment protocol. The validity of this approach 
could be tested in a larger more comprehensive study involving service 
users in all GP prescribing practices in the RoI. 
Specific Areas for Suggested Research could focus future studies on: 
• Replicating this study with a cohort of clients outside Dublin who 
have limited access to treatment clinics could identify if they differ from 
the cohort investigated. 
• Extension of this study to service users exploring aspects such 
as methadone diversion and buying extra. 
• Understanding the dynamics of how service users are influenced 
by drug using peers. 
• Investigating how maternity services engage with drug misusing 
mothers throughout pregnancy. 
• Identifying the role of identity of the client in methadone 
maintenance programmes. 
Investigating how the needs and desires of service users for control and 
freedom are balanced with the need to regulate the supply and prevent 
diversion of methadone by the service provider. 
200

Final Bracketing Interview 
I’m extremely motivated and always have been in terms of drug addiction and partly 
because of my role in delivering part of the substance misuse programme as you 
know, has been the motivation for me, educating others to see the other piece. 
However when you reflect on your own practice, you realise that educating anyone to 
the ideal is one thing. Actually putting it into practice is another…certainly in terms of 
my own practice I think I have been naïve, I think I have not seen the full picture, I 
think I have been part of a process of seeing people coming in, eh thinking that I’m 
dealing with the problems, thinking that I am dealing with the problem of drug misuse 
but in fact it is only skimming a very, very, very, fine layer. 
Sean Because you’re coming across sort of like on my level you’re not coming across 
as this like well, I’m higher than you, I’m the advanced nurse here, like you’re just an 
addict!, which I have got before.You know like nurses saying in certain clinics, like 
look! I’m the nurse and their practically saying I’m above you, you know what I mean? 
…so that what I say is right what you say is jibberish! that’s basically the way they go 
on basically telling me, they’re trying to tell you about the withdrawals and as I said to 
one or two of them­ what do you know about withdrawals ? Have you ever been 
addicted? No, but I’ve read about it.I said look! I could read about anything and I’d 
know about this or that, but until you experience it… then you’ll know. 
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APPENDIX I

SEARCH STRATEGY

Multiple sources were accessed for the study: Primarily the National 
Documentation Centre provided the following resources: 
�	 An Electronic Library of the National Documentation Centre 
which provided access to a compilation of electronic copies of key 
publications and grey literature. 
�	 Register of research on Drug misuse in Ireland which provided 
information on work currently underway. 
� DrugNet Newsletter and the Health Research Board Website. 
�	 Link to Virtual Library of EMCDDA – which provided access to a 
pan­European information network on drugs. 
OTHER SOURCES 
The Annotated Bibliography of Drug Misuse in Ireland (O’Brien et al 
2000) provided a comprehensive historical account of research and 
information relating to illegal drug misuse. Journal articles, grey 
literature, unpublished work and writings from the community and 
voluntary sectors are included in this work. Most of the available 
literature spans 1980­1999 and early 2000. 
The literature review for the study was also based on a search of 
relevant data bases (Embase, Pubmed, Google Scholar,PsychLit). A 
series of search engines used and websites of relevant organizations 
were accessed. Researchers in the area of addiction were also 
contacted for information. 
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DATA SOURCES 
ABS Australian Bureau of Statistics 
ADCA Alcohol and Other Drugs Council of Australia 
AIHW Australian Institute of Health and Welfare 
CDTL Central Drug Treatment List 
CSSA Canadian Centre on Substance Misuse 
CSO Central Statistics Office 
DMRD Drug Misuse Research Division 
EMCDDA European Monitoring Centre on Drugs and Drug 
Addiction 
HPSC Health Protection Surveillance Centre 
MPS Methadone Protocol Scheme 
NACD National Advisory Committee on Drugs 
NACDA National Campaign against Drug misuse 
NAPHP National Association of Public Health Policy 
NDC National Documentation Centre on Drug misuse 
NDS National Drugs Strategy 
NDTRS National Drug Treatment Reporting System 
UN United Nations 
Additional data were obtained from a range of sources: 
• National Centre in HIV Epidemiology and Clinical Research 
• National Crime Council 
• National Drug and Alcohol Research Centre. 
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Background information was also obtained from the following web sites:
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APPENDIX 2 
LEVEL 1 & LEVEL 2 ICGP TRAINING COURSES 
The educational aims of the ICGP drug misuse training programme are: 
�	 To ensure that all participating GPs have training in the 
management of opiate misusers before becoming involved in 
treatment. 
�	 To ensure that all GPs are supported in their attempts to provide 
services to drug misusers according to the best practice 
guidelines. 
�	 To ensure that GPs maintain their level of knowledge and are 
regularly updated on current issues.(ICGP2003) 
The aims and objectives of treating opiate dependant patients are 
stated as follows (ICGP2008:8): 
To improve the physical, psychological and social health of individuals 
by: 
�	 Minimising all harm associated with opiate misuse 
�	 Reducing the health risks associated with illicit drug misuse, 
particularly the risk of HIV, hepatitis B and C and other blood­
borne infections 
�	 Improving the overall personal , family and social functioning of the 
individual 
�	 Stopping or reducing the use of illicit or non prescribed drugs by 
the individual 
�	 Facilitating and fully supporting patients in achieving a life free of 
drug dependence while recognising that this may not be 
achievable for all individuals 
�	 Prescribing safely, which helps reduce the diversion of drugs into 
the illegal market 
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It is recommended that doctors when completing their training in 
general practice should have received Level 1 training and this training 
provides the foundation for treating stable methadone maintained 
patients in general practice. Stabilisation usually takes place in a health 
board treatment Centre but may also be offered by a suitably trained 
GP colleague (Level 2). 
�	 A GP is eligible to apply for Level 2 training once the following 
criteria are fulfilled: 
�	 The GP should have managed at least five patients on the MTP for 
a minimum of one year. 
�	 The GP should have successfully completed an external clinical 
audit conducted by the ICGP. 
A Level 2 GP may initiate treatment, stabilize a drug misuser and 
provide ongoing maintenance treatment in the primary care setting 
(ICGP2008). 
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APPENDIX 3 
RESEARCH PARTICIPANT CONSENT FOR RESEARCH 
TITLE OF STUDY: 
Methadone in General practice: Voices of service users 
CONSENT OF RESEARCH PARTICIPANT: 
I __________________________________

Give my consent to take part in an interview for the study named above.

� (Initial)

The researcher, Linda Latham, has explained to me the purpose of the

study � (initial)

I understand that I can pull out of the interview at any time and that this

will not affect the care I receive from this General Practice in any way.

� (Initial)

I agree to this interview being tape recorded. � (Initial)

DATE: _________________

SIGNATURE

OF RESEARCH PARTICIPANT: _____________________________

DATE: _________________

SIGNATURE OF RESEARCHER: _____________________________

I confirm that I have explained to 
_______________________________ the purpose and nature of this 
investigation and the risks involved. 
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APPENDIX 4 
You are invited to share your experiences of treatment for heroin 
addiction in general practice. 
What is the study about? 
The study is about methadone treatment. I want to find out about your 
experiences of methadone treatment in general practice. This study is 
about your views on how addiction treatment is delivered to you in 
general practice. 
Who is doing the study? 
The research is being conducted by Linda Latham, who is an Advanced 
Nurse Practitioner in Primary Care at the Liberties Primary Care Centre 
in Dublin. Linda is conducting the research as part of a higher 
professional degree (Doctorate) at the University of Bath in England. 
Linda is the researcher responsible for carrying out the interviews and 
recording / analyzing the information contained in each interview and 
her work is being conducted under the supervision of colleagues at the 
University of Bath and University College Dublin. 
Who can take part in the study? 
People who attend General Practice for methadone treatment. A 
maximum of 20­ 30 people will be interviewed in different practices in 
Dublin. 
Why have I been chosen? 
You have been suggested by your GP who is involved in your care 
because you are receiving methadone. 
What will I have to do? 
The doctor or practice nurse will explain the study to you. If you are 
willing to take part in this study, then I [Linda Latham] will arrange to 
have a private interview with you. Each interview will take approximately 
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one hour and will be situated in your own doctor’s surgery. During the 
interview, you will be asked about your experiences of methadone 
treatment, the services available to you and your views on if or how 
these services can be improved. There will also be time to comment on 
any other issues you may feel are important. 
What will happen to the information collected from me? 
The details of the interview will be recorded on cassette tape. Only the 
researcher and transcriber (the person who will help me to listen to the 
interview and type it) will listen to this tape. Your name will not be 
written on the tape, instead I will write on a code number. 
Personal information such as your name, address or date of birth will 
not be stored. Only the researcher and supervisory team will have 
access to the information collected. The anonymised information will be 
stored as an electronic computer file on a secure password­protected 
computer at the Liberties Primary Care Centre five years after the 
study’s findings have been reported. 
Might any harm result for me from this study? 
The risks of any harm resulting to you from the interviews are minimal. 
It is important that you understand that the interview is being conducted 
for research purposes and your GP or practice nurse or counsellor will 
not be informed of what you say in your interview and your treatment 
will not be affected by what you say. Sometimes speaking with a 
researcher about your experiences of addiction and methadone might 
raise some issues that need to be discussed with a health professional. 
Therefore it is advisable that should the interview raise any concerns for 
you an appointment with your doctor should be arranged. Likewise 
should anything arise during the course of the interview which would be 
considered a serious potential risk for you or to protect the rights of 
another, I will in those circumstances be obliged to discuss this with you 
and to inform your doctor. 
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What are the benefits of the study?

You will not likely benefit from being a participant. I hope and expect

that the outcomes of the research made possible by the study will be of

benefit to those involved in treatment for drug addiction in general

practice.

Will I receive any payment for taking part in the study?

No, payments for taking part in the study are not offered.

What is the procedure should I wish to withdraw from the study?

You may at any time pull out from the study as it is voluntary.

Your views are important but you do not have to take part. Should you

decide to pull out from the study after the interview is over, please

contact me [Linda] at [7085701]

When is the study being conducted?

The study is starting in September 2008 and is finishing in September

2010.

When are the results available?

The full results and implications of this study are unlikely to be unknown

until September 2010.You can have full access to the results of this

study once completed. No identifying information will link your interview

to you as data will be collected anonymously. It is possible that

information about the study might be published in scientific journals.

However, no information that might identify you will appear in these

publications. Any quotes used will be anonymised.

What if I have any questions now or at any time during the study?

Should you wish to discuss any aspect of this study now or at any

stage, you can contact me [Linda Latham] at [7085701].

Thank you for taking the time to consider this study.
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APPENDIX 5 
LETTERS TO GENERAL PRACTITIONERS & STEP BY STEP GUIDE 
Dear Dr, 
I am undertaking a research project called: Methadone in General 
Practice: Voices of Service Users. I would like to interview some of 
your patients about their experiences in treatment, the services 
available to them and if or how they feel these services need to be 
improved. With your consent and co­operation I will interview patients 
who you would consider suitable for this study. The study design 
proposes to purposefully select participants who have been exposed to 
diverse life experiences and are willing to participate in the study. The 
sample is not intended to be representative of the general practice 
population. I am more interested in understanding in­depth the 
experiences and perspectives of methadone maintenance from the 
viewpoint of the service user. I do not wish to generalize these 
experiences to a larger population. A small sample of 3­4 patients 
would be necessary only as I will be visiting other general practices in 
the city. I would be very grateful for your assistance with this study. I will 
ensure confidentiality and anonymity of both the practice and patients 
involved. I will follow up this letter with a telephone call to ask whether 
you would like to be involved. 
Yours Sincerely, 
Linda Latham 
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WHAT DOES THIS RESEARCH MEAN TO THE PRACTICE? 
Your practice has been chosen as you have previously granted me 
permission to conduct a study with you researching the perceptions and 
experiences of your practice nurse in relation to patients receiving 
methadone. 
Realistically any research carried out in your practice will cause some 
disruption although every effort will be made to minimize this. 
Potentially a member of the practice staff (e.g. Practice Nurse) could be 
designated as the main contact for the study to ensure effective 
communication. Patient recruitment can be carried out with the help of 
the practice nurse. As the overall clinical responsibility is yours, should 
anything arise during the course of the interview which would be 
considered a serious potential risk to your patient or to protect the rights 
of another for e.g. threat of suicide or child misuse, I will inform the 
patient that I must alert you. 
The use of surgery space will be necessary for one hour when it is 
deemed convenient for the practice. The service user may have to be 
interviewed in the afternoon after methadone has been consumed to 
avoid any withdrawal effect. 
The findings from the study may have several outcomes. Whilst the 
findings may provide evidence of high quality care in general practice 
for service users, equally, dissatisfaction with some aspects of the 
Methadone Treatment Protocol may be highlighted. My own practice 
will also be researched by an independent researcher. These findings 
could be considered an important aspect of patient management and 
could influence the future delivery of care. The results will be 
anonymised so no practice will be identifiable 
I have received ethical approval from the ICGP and University of Bath 
for the study. 
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STEP BY STEP GUIDE FOR CLIENT RECRUITMENT 
HOW WILL POTENTIAL PARTICIPANTS BE IDENTIFIED? 
A) IDENTIFY A CLIENT THAT ATTENDS YOUR PRACTICE FOR METHADONE

PRESCRIPTIONS.

B) CONSIDER WHETHER THIS CLIENT WOULD BE WILLING TO PARTICIPATE IN AN

INTERVIEW.

C) WOULD HE OR SHE BE LIKELY TO TURN UP FOR THE INTERVIEW?

* PLEASE DO NOT ASK A CLIENT WHOSE ABILITY TO PROVIDE INFORMED 
CONSENT TO PARTICIPATE IN THIS STUDY IS COMPROMISED BY ACUTE MENTAL 
OR PHYSICAL ILLNESS.* 
HOW WILL THEY BE APPROACHED REGARDING THEIR POTENTIAL 
PARTICIPATION IN THE STUDY? 
a) ASK THEM IF THEY WOULD BE WILLING TO BE INVOLVED 
b) GIVE THEM THE PARTICIPATION LEAFLET 
c) ASK THEM IF I CAN CONTACT THEM BY PHONE TO ARRANGE A TIME IN 
THE SURGERY FOR THE INTERVIEW. 
d) PLEASE GET A CURRENT PHONE NUMBER. 
HOW WILL INFORMED CONSENT TO PARTICIPATE IN THE STUDY BE OBTAINED? 
I WILL MEET WITH THE INTERVIEWEE AND OBTAIN CONSENT. 
SHOULD YOU HAVE ANY QUERIES RE THIS PROCESS PLEASE RING ME (087 
6500775) 
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AGENT NOMINATION FORM 
Practice Name________________________________________ 
As a General Practitioner representing the practice named above, I 
hereby nominate (Linda Latham) as an agent of this practice for the 
purposes of the Data Protection Acts 1988 and 2003, for the duration of 
the practice’s involvement in the study (Methadone in General Practice : 
Voices of Service Users). 
As an agent of the practice, (Linda) will be bound by the normal 
procedures governing patient confidentiality in this practice. Information 
about individual patients will be treated confidentially and will be used 
solely for the purpose of the research study. 
(Linda) will remove personal identifiers from the data to ensure that only 
anonoymised data is disclosed from the practice to the study. 
GP SIGNATURE : DATE: 
AGENT SIGNATURE: DATE: 
AGENT NAME __________________________ 
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____________________________________ 
______________________________ 
PRACTICE CONFIDENTIALITY AGREEMENT 
PRACTICE NAME: 
As a researcher working with the study (Methadone in General Practice: 
Voices of Service Users) I agree to be bound by the normal procedures 
governing patient confidentiality in this practice. Information about 
individual patients will be treated confidentially and will be used solely 
for the purpose of the research study. 
RESEARCHER SIGNATURE:________________________ 
DATE: ____________ 
WITNESSED BY (MEMBER OF PRACTICE STAFF): 
LETTER POST INTERVIEWS 
PRIVATE AND CONFIDENTIAL 
Dear Dr’s, 
Thank you for allowing me to visit your surgery. It was a pleasure to visit 
and all the staff made things so easy for me to interview your patients 
for the purposes of my research. 
For your information I interviewed your patients named below. 
All voluntarily consented to the process and no incentives were offered 
prior to the interview. I have a small grant from the ICGP and part of this 
enabled a 20 euro voucher for Dunnes stores to be given to each 
interviewee once the interview was completed. Each respondent’s 
verbatim interview will be individually posted to them if they wish and 
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any follow up after that will be by phone to ensure that I have accurately 
transcribed their ‘voices’. I hope that each respondent found the 
process of ‘telling their story’ in some sense therapeutic but if any harm 
has resulted from this reflection I would appreciate you letting me know. 
As you know all details of the interview are confidential and the results 
of the collated data will be anonymised and made available to you when 
the study is completed. 
Many thanks again for your help and should you wish to discuss 
anything with me about the study my phone number is 087 6500775. 
Yours Sincerely, 
Linda Latham
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APPENDIX 6 
INTERVIEW TOPIC GUIDE 
Thank you for agreeing to take part in this interview. As you know from 
the written consent that you signed, this interview is confidential, and 
your views will be treated anonymously. 
TOPIC 1 GENERAL PRACTICE 
�	 I’m interested in getting your views on what it’s like attending here? (GP 
practice­ for methadone maintenance) 
� What are your views on general practice? 
�	 Have you had a lot of dealings with GPs (before you started on 
methadone?) 
�	 How much have you used GP services for your health care? (E.g. 
women’s health, pregnancy? Men’s health etc?) 
TOPIC 2 METHADONE MAINTENANCE­(THE ROLE OF METHADONE AS A 
TREATMENT FOR DRUG ADDICTION) 
� Do you think /feel you have a drug problem? 
�	 How does it make you feel to be attending a GP for that problem /for 
methadone 
� Do you feel listened to? ­Are your views important? 
�	 Do you feel that methadone has helped you? ­ What does it help you 
with? 
� What more could be done to help? 
TOPIC 3 PARTNERSHIP /INVOLVEMENT IN CARE 
�	 If you are not happy with some aspect of how your treatment is going 
how able are you to voice your concerns? 
�	 Have you ever had an experience that you negotiated a change in 
treatment? ­ can you tell me about that? 
� What are your future plans? 
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TOPIC 4 PROTOCOL /INFLUENCING FACTORS 
�	 What do you understand by the term methadone protocol?(Examples 
Urine testing/ take away doses/attending the GP every week) 
�	 From your experience are there any aspects of this protocol that you 
would change? 
�	 What do you feel influences GPs in taking on patients who are on 
methadone? 
IS THERE ANYTHING ELSE YOU WOULD LIKE TO ADD? 
�	 Thank you for taking part. If you wish I will give you back the transcript of 
your interview so you can check whether I have accurately reflected your 
views. 
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APPENDIX 7 
DESCRIPTIVE STATISTICS 
Number Of Patients 
on Combined GMS 
Lists 
270,000 
Number of GPs 
42 
Number of Nurses 
13 
Number of 
Methadone Patients 
487 
Figure 5 Context of the Study. 
This table denotes the number of GPs & practice nurses employed in 
the combined practices. It also shows the approximate numbers of 
patients listed on the combined General Medical Scheme lists and 
number of methadone patients registered with their practice. 
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The central drug treatment list (CDTL) denotes those patients 
registered on maintenance in the Republic in the period April 2009. 
Central Treatment List Summary Report for period 01 April to 30 April 2009 
CLINICS 
Total 
Patients 
during 
period 
Total Patients at 
End of Period 
New (1st time 
patient on 
CTL) 
HSE Dublin Mid Leinster 2430 2385 19 
HSE Dublin North East 2038 1976 22 
HSE West 225 219 9 
HSE South 153 150 9 
Prisons 621 490 19 
Drug Treatment CENTRE Board 541 523 3 
Totals 6008 5743 81 
GENERAL PRACTITIONERS 
Total 
Patients 
during 
period 
Total Patients at 
End of Period 
New (1st time 
patient on 
CTL) 
HSE Dublin Mid Leinster 1874 1850 6 
HSE Dublin North East 1043 1030 4 
HSE West 147 146 0 
HSE South 57 57 0 
Totals 3121 3083 10 
Grand Totals 9129 8826 91 
Actual Patients Attending 8984 
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PROFILE OF THE PARTICIPANTS – DESCRIPTIVE STATISTICS 
Table 1 Gender Female =14 Male =11 
Table 2 Age Range =23­43 
Table 3 Number of Children (37) (Majority Had 2 Children)­6 had no children 
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Table 4 Current Drug Taking History 
Table 5 Prescription of Night Sedation 8 prescribed by GP 
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Table 6 Currently Taking Heroin 
Table 7 Currently Taking Cocaine 
282

Table 8 Current Methadone Dosage Range 20­150 mgs 
Table 9 Length of Time in Treatment 
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Table 10 Educational Level Achieved – Leaving Certificate =6 Junior Cert=18 
Hepatitis C Prevalence 
5 Female+ 
21% 
6 Male 
(Neg) 25% 
8 Female 
(Neg) 33% 
5 Male+ 
21% 
1 
2 
3 
4 
5 
Table 11 Prevalence of HCV 
284

Table 12 Age started any drug 
Table 13 Employment Status 
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Table14 Years in treatment and methadone dosage 
Low Dose Defined as 40mgs or lower 
High Dose Defined as 45mgs or higher 
Whereas some participants ran against the trend (low years/ high dose 
or high years/ low dose) this graph clearly shows a consistent pattern in 
the data. That is, a clear relationship between the length of time in 
treatment and the dosage of methadone with patients in treatment 
longer being prescribed higher doses. 
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TEMPLATE FOR BIOGRAPHICAL DETAILS 
Informant Number 
Service Users Group 
Age 
Gender 
Status/Living 
arrangements 
Age commenced drug 
misuse 
Other Drugs Currently 
Used 
A)Cannabis 
B)Cocaine 
C)Heroin 
D)Hash 
E)Benzo 
F)Other 
Current Employment 
Educational Standard 
Viral Status Hep C/B/HIV 
Years in Current 
Treatment 
Current Methadone dose 
Level One/Level Two 
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APPENDIX 8 
REFLECTION 
This study has forced me to engage in a reflective process in order to 
re­examine my biases. Etherington (2006) explains that a ‘bias that we 
are aware of, a passion deeply felt, may be the entree into the 
experience we choose to study’’. 
The motivating factor for the study, from my perspective, was the 
ongoing problematic opiate misuse in the Republic Of Ireland which has 
been concentrated in the Dublin area in localities with high levels of 
social and economic disadvantage. The inner city of Dublin is one such 
area where I have worked and have first hand experience of what I 
describe as the ‘chaotic situation’ of drug misuse prior to and since the 
inception of the Methadone Treatment Protocol in 1998. 
Past experiences of dealing with drug misusing clients may have 
influenced me to be in favour of the implementation of methadone 
maintenance. I have been present when mothers have begged on their 
hands and knees for treatment for their children and their frustration 
was coupled with the frustration I felt with my inability to provide help. 
The advent of the MTP provided a way of responding and reacting to 
the needs of the community. Many drug misusers were dying as a result 
of HIV in the 1980’s.I had worked as a casualty nurse seeing patients 
attending accident and emergency feigning renal colic in order to obtain 
an injection of cyclimorph. I remember vividly the day I was asked by a 
doctor to give an injection of normal saline to a drug misuser and to 
pretend it was pethidine. I inherently felt that this was the wrong way to 
treat drug misuse yet I knew no better either experientially or 
academically at that time. 
I moved from the hospital into general practice in the inner city and was 
immediately faced with an epidemic of uncontrolled heroin misuse. My 
GP employer (husband) felt duty bound to provide treatment for the 
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community and with a small amount of committed doctors joined the 
early drugs task force members who lobbied the government for the 
introduction of the MTP. 
The protocol has been in operation for 11 years and almost by default 
as I had gained experience from the early patients on methadone I 
became involved in the training of GPs and practice nurses. Since that 
time I set up a shared care system whereby GPs and practice nurses 
shared the care between them for their drug misusing clients. I am 
passionate about caring for drug misusers but acknowledge that the 
MTP provides only a partial answer to the treatment of the complexities 
associated with addiction. The reality of being addicted to this treatment 
modality creates in me certain unease at the very long term prospect of 
what many methadone clients call the ‘liquid handcuffs of treatment’. 
I have equally been committed on both a professional and voluntary 
basis in dealing with clients who are associated with faith based 
organizations whose approach to rehabilitation treatment is 
fundamentally different to methadone maintenance. This treatment 
requires total abstinence with no recourse to methadone. In many ways 
the ethos of treatment can be seen as the antithesis to long term opiate 
substitution. Both approaches work if tailored individually. 
My responses in the bracketing interviews to the challenges of being a 
practitioner/researcher illuminate a personal progression through the 
study as indeed I have lived the study, both in my daily work 
environment and as a researcher. 
The most intensely demanding work of the study has been this 
movement from the practical daily working with drug misusers­that is 
from the concrete, to the somewhat abstract act of collating findings and 
analysis. Yet the challenge was to remain immersed in the subject. I 
have recognized that I moved from the idiosyncratic to the universal and 
from the situational to the conceptual in my approach. 
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The study has changed me, I had assumed that I was experienced in 
managing drug misusing clients but now I find myself more tolerant of 
the diversity of patients’ wishes – the lifer, the maintainer and the 
reducer. Initially, in my study, I felt I knew what I was going to find out. 
As I listened further I realized how far my professionalism was clouding 
my reasoning. I had to return to my pre­training days and view others 
with a naive lens .It was only then that insight came. I learned to listen 
to the voices of those I had consulted with day in day out. I really 
listened and then grew to understand my own worldview more clearly. 
Furthermore I learned to listen to my own inner voice and that again 
was as a result of being instructed by those who told me of their 
experiences. As a result of listening to these service users I realize that 
once again, expertly, they have gently instructed me in how to care for 
them effectively. 
This study has shown me the resilience of the people of the inner city of 
Dublin, renewed my commitment to work with them and challenged me 
to teach others what I learned on my dissertation journey. 
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APPENDIX 9 
SCREEN DUMP I CREATION OF FREE NODES 
SCREEN DUMP 2 CREATION OF FREE NODES 
291

– - –
TABLE 1 – CODING HIERARCHY 
Theme Sub themes Rules for Inclusion & Proposition Statements 
These synthesized statements were 
collected and organized into further 
clusters of themes. The individual 
themes were then clustered to 
produce a further reduction into 
general themes that were common 
to all the subjects’ transcripts. 
0 0 
Name Description Memo Link Sources References 
THEME 1 -SERVICE USERS' 
EXPERIENCE OF ATTENDING 
GENERAL PRACTICE 
Type Name Description Memo Link Sources References 
Tree Node Benefits of General Practice This node refers to the co-
researchers references to the 
good aspects of General 
Practice 
23 106 
Type Name Description Memo Link Sources References 
Tree Node A Place to Develop 
Relationships 
Good Bad & 
complicated – both 
Developed 
Yes 25 182 
Type Name Description Memo Link Sources References 
Tree Node Bad This node denotes 
the relationships in 
general practice 
which were not 
beneficial 
Yes 12 33 
Tree Node Good This node Yes 25 100 
Place to reduce/Be listened to- 0 0 
Relationship with GP / have your 
general health checked/be 
respected & less stigma 
/confidential /swift access/ less 
loitering 
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– - –Theme Sub themes Rules for Inclusion & Proposition Statements 
Tree Node Men talking about 
relationships 
describes good 
relationships 
This node denotes 
the descriptions 
men attributed to 
relationships 
Yes 11 74 
Tree Node Women talking This node refers to Yes 14 108 
about relationships the descriptive 
statements women 
made about 
relationships 
Tree Node A Place to Reduce This node is the Yes 24 112 
Type Name Description Memo Link Sources References 
Tree Node Negotiating a 
reduction- no its my 
decision because I 
want to! 
This node refers to 
the participants’ 
control over 
methadone 
reduction - most 
are well able to 
negotiate but there 
is a feeling that in 
some instances it 
can be pressure 
from the 
doctor/nurse to 
reduce which is not 
welcomed 
Yes 21 71 
Tree Node Negotiating 
increase- I 
negotiated that real 
quick 
This node refers to 
what the 
participants felt 
about increasing 
Yes 11 20 
merged node of 
'control over 
treatment and 
reduction strategies 
a negotiated 
relationship of client 
in control 
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the participants’ 
references to the 
services provided in 
their own GP 
Practice and the 
services they 
choose to avail of or 
not 
Theme Sub themes Rules for Inclusion & Proposition Statements 
their dosage and 
what level of 
negotiation was 
required to achieve 
this - most did not 
want to go up and 
saw it as a failure 
Tree Node A Place to’ Sort Things Out’ This node refers to Yes 24 127 
Type Name Description Memo Link Sources References 
Tree Node What You Can 'Get 
Sorted' 
This node 
describes what 
services are 
available to the 
service user in 
general practice 
which they feel are 
beneficial to them 
23 98 
Tree Node When you Can 'Get 
Sorted' 
This node denotes 
the availability of 
these services 
15 34 
Tree Node Women talking 
about services 
This node 
describes how 
women define what 
services are 
beneficial to them 
14 71 
Tree Node A Place which is Confidential This node will 
contain references 
by co- researchers 
to confidentiality 
Yes 23 86 
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within the practice 
which is possible as 
there is less 
loitering around the 
practice than in 
clinics- merged 
nodes 
Tree Node Comparison with Clinics All references by 
co- researchers to 
the 'Clinic' In a clinic 
they’ treat you all 
the same’ in 
comparison to 
General practice 
Yes 22 84 
Type Name Description Memo Link Sources References 
Tree Node A Place to be 
Treated as an 
Individual 
This node refers to 
the participants 
views when 
general practice is 
compared to 
treatment clinics 
15 31 
Tree Node Not a place to get 
clean- cause its all 
around you isn’t it 
you know? 
This node refers to 
the participants’ 
views of getting 
clean - comparing 
the clinic to general 
practice 
18 36 
Tree Node Negative Aspects- Lack of 
Counselling 
This node describes 
counselling and the lack of 
defined counselling available in 
General practice 
Yes 0 0 
Type Name Description Memo Link Sources References 
Tree Node What you Can't 'Get Sorted' This node refers to 
the lack of services 
19 59 
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available to the 
service user 
THEME 2 -THE SIGNIFICANCE 
OF METHADONE FOR THE 
SERVICE USER 
Identity/normality/ stability/ 
Economic benefits/ Education/ 
crime reduction/ virus prevention 
0 0 
Type Name Description Memo Link Sources References 
Tree Node Buying Extra This node highlights the 
buying of extra methadone on 
the street and selling - likened 
to ‘writing a blank cheque’ 
Yes 23 91 
Tree Node Lack of Education & Urban myths This node merged ‘education’ 
and ‘urban myths’ This refers 
to the desire to learn more 
about methadone and the lack 
of educational opportunities 
available to discuss the effects 
of the drug resulting in urban 
myths about methadone 
Yes 15 68 
Tree Node Lifers/ Maintainers/ Reducers This node refers to the co-
researchers references to their 
plans for recovery but also 
identifies, lifers, maintainers 
and reducers so it will be 
merged into the sub theme 
with those three names 
Yes 23 54 
Tree Node Methadone as a drug This node refers to the co-
researchers references to 
methadone as a treatment for 
heroin addiction 
Yes 22 131 
Type Name Description Memo Link Sources References 
Tree Node Benefits Health Methadone benefits 
health 
Yes 15 24 
Tree Node Daily requirement not every 2 
hours 
Benefits of daily 
dosing 
4 6 
Tree Node Feelings About the Drug Itself Feelings about 
substitution with 
4 7 
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methadone 
Tree Node Happy the way things are Methadone identity 
defined by 
maintenance dose 
Yes 7 13 
Tree Node I’m a lifer Methadone identity 
defined by length of 
time in treatment 
Yes 10 29 
Tree Node Prevents Crime Methadone 
prevents pursuit of 
money /crime 
7 21 
Tree Node Reducer Methadone identity 
defined by 
reduction in dosage 
Yes 13 28 
Tree Node Virus Protection Service users 
views about virus 
protection 
3 6 
Tree Node Normality & Stability This merging was done as the 
participants described 
normality and stability as two 
aspects of the benefits of 
methadone 
Yes 25 120 
Type Name Description Memo Link Sources References 
Tree Node Its like a security blanket What methadone 
provides in 
personal terms 
24 76 
THEME 3 -SERVICE USERS’ 
UNDERSTANDING OF THE MTP 
Rogue doctors /Chemist / 
Urinalysis /Knowing the system 
/what influences a GP to look 
after drug misusers 
0 0 
Type Name Description Memo Link Sources References 
Tree Node Fear of Being Cut Off This node describes the fear 10 31 
the client has about being 
thrown off the MTP and the 
inequalities of how the system 
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is maintained 
Tree Node Influencing Factors for GP's- This node describes how the 
service users understood what 
motivates GP's to take on 
patients for methadone 
maintenance 
23 66 
Tree Node Looking after Other Drug 
Misusers-
This node refers to the co-
researchers references to 
other drug misusers and how 
they feel they should look after 
them as part of the 
expectations of their own sub 
culture 
11 35 
Tree Node Methadone Protocol- This node refers to the co-
researchers references to 
what they understand by the 
MTP 
25 140 
Type Name Description Memo Link Sources References 
Tree Node Knowing the Rules This node refers to 
the service users 
knowledge of the 
rules of the MTP 
19 40 
Tree Node What the MTP Means This node refers to 
the knowledge 
service users hold 
about the MTP 
12 26 
Tree Node Working the System This node contains 
the references of 
how service users 
circumvent the 
rules of the MTP 
14 26 
Tree Node Rogue Doctors This node refers to 21 75 
experiences with rogue 
doctors which has now 
influenced their current 
perception of the programme 
both positively and negatively 
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Tree Node Significance of the Chemist This node refers to the co-
researchers references to the 
dispensing of methadone at 
the pharmacy, lack of 
confidentiality in most 
pharmacies , and how some 
‘get away’ with collecting 
methadone without 
supervision 
25 100 
Tree Node Urinalysis This node refers to all the 
issues of providing a sample, 
bogey urines and supervision 
26 99 
THEME 4 -THE EXPERIENCE OF 
ADDICTION AND IT'S EFFECT 
ON FAMILIES 
family dysfunction, effect on 
children/stigma / other things 
going on 
0 0 
Type Name Description Memo Link Sources References 
Tree Node Effects on Children- This node describes the effect 
of drug addiction/ methadone 
maintenance on children 
19 96 
Type Name Description Memo Link Sources References 
Tree Node Length of time in treatment 0 0 
Tree Node Men talking about effects on 
family 
Men’s’ descriptions 
of their family and 
children and what 
they tell them 
7 29 
Tree Node Women talking about effects 
on family 
This node 
describes women’s’ 
feeling about 
methadone and 
what they tell their 
children 
12 67 
Tree Node Identity This node describes what a 
client feels about themselves 
in relation to addiction and 
23 79 
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stigma and identity in their 
community 
Tree Node Pregnancy and Post Natal Effects This node refers to the 
experiences of methadone 
users while pregnant, during 
delivery and the post partum 
period 
11 80 
Type Name Description Memo Link Sources References 
Tree Node Withdrawal This node refers to 19 66 
the co- researchers 
references to 
withdrawal 
Tree Node The Effects of Drug Misuse on This node details how 21 63 
Children supportive family can be in 
relation to addiction but also 
how 'family issues' can 
prevent progress 
Tree Node What I have seen & what I am 
called 
This node refers to the 
experience of death and 
tragedy associated with 
addiction 
12 33 
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